Structural insights into the human multifunctional protein RuvBL2 by Silva, Sara Teresa Neves da
Sara Teresa Neves da Silva
Dissertation presented to obtain the Ph.D degree in Structural
Biochemistry
Instituto de Tecnologia Química e Biológica António Xavier | Universidade Nova de 
Lisboa
Structural insights into the human 
multifunctional protein RuvBL2
Oeiras,
November, 2017
  
Photo taken after the oral dissertation and discussion, on the 27th November 
2017. From left to right: Sabine Gorynia, Édouard Bertrand, Pedro Matias 
(supervisor), Sara Silva, Tiago Bandeiras (co-supervisor), Sandra Macedo-
Ribeiro, Professor Maria Arménia Carrondo (president of the jury) and Teresa 
Santos-Silva. 
Sara Teresa Neves da Silva
Dissertation presented to obtain the Ph.D degree in Structural
Biochemistry
Instituto de Tecnologia Química e Biológica António Xavier | Universidade Nova de Lisboa
Oeiras, November, 2017
Structural insights into the 
human multifunctional protein 
RuvBL2
i 
Foreword 
 
The work described in the present dissertation concerns the study of the 
human multi-functional protein RuvB-Like 2. The main focus of this work was the 
elucidation of the crystallographic structure of this potential drug target, 
complemented by lower resolution techniques, in order to assess different 
conformations and elucidate the possible mode of action. These structural studies 
constitute the third chapter of this dissertation. The second chapter is constituted 
by functional analyses, necessary in order to gain an understanding of the 
characteristics of the target protein, both at the functional level, but especially with 
the aim of improving stability for the structural analyses. 
This dissertation is therefore divided in four chapters. The first chapter 
includes a general introduction to the RuvB-Like area, including published results 
from all areas of study of these proteins. The purpose of this introduction is to 
review and correlate the results produced by the several groups studying RuvB-
Like proteins, putting them in the cellular context. The second chapter includes an 
introduction to DNA-binding proteins, followed by a description of the results on 
DNA-binding properties of hsRuvBL1 and hsRuvBL2, and studies on the influence 
of tags on stability and oligomerization of hsRuvBL2. The third chapter focuses on 
structural analyses of hsRuvBL2, using X-ray crystallography, electron microscopy 
and small angle X-ray scattering. The final discussion aims to correlate the 
previously described results, and connect them with the state of the art, including 
data on the aggresome, produced with resource to protein produced during this 
work. 
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Dissertation Abstract 
 
RuvB-Like transcription factors, RuvBL1 and RuvBL2, function in cell cycle 
regulation and development. They have been attributed the functions of 
chaperone, transcription regulator and helicase, sometimes in an ATP-dependent 
fashion, but just how these functions are regulated in each protein is still a mystery, 
that many groups have been working to understand. There is already a vast, albeit 
scattered amount of knowledge gathered about RuvBL1 and RuvBL2 proteins. 
However, the functions of these important proteins still need to be placed into the 
context of the various signalling pathways of which they are a part. This may be a 
daunting task, since the functions attributed to these proteins seem to be used in 
various combinations depending on the complex in which they are included. To 
add further complexity, these proteins can work separately or in complex, and in a 
way that seems to be regulated either by their oligomeric state, binding partners 
and/or post-translational modifications. RuvBL1 and RuvBL2 have been found to 
be associated with the aetiology of a number of cancers and other diseases, such as 
heart hyperplasia and ciliopathies. As such, with this work, our group strived to 
provide a contribution to this area, a contribution we hope will be useful 
particularly in the health and pharmaceutical industry areas, since the structure of 
human RuvBL2 determined during this thesis is a widely recognized potential 
drug target. 
The path to a better understanding of any protein is through the 
observation of its structure, and that was the main purpose of this work: to obtain 
the atomic-resolution structure of the missing player in the human RuvB-Like 
family, RuvB-Like 2 (hsRuvBL2). We present the atomic structure of human 
RuvBL2 with a level of completion that provides novel insight into its biology. The 
hsRuvBL2 structure resolves the mobile domain II, which is responsible for protein-
protein interactions and ATPase activity regulation. We demonstrate how ATP 
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binding may lead to domain II motion through interactions with the N-terminal 
loop and further show that inserted affinity tags affect hsRuvBL2 oligomerization 
and stability in solution. A comparison with its homolog hsRuvBL1 shows 
differences in surface charge distribution that may account for differences in 
regulation. Finally, single particle EM data reveals that single-stranded DNA can 
promote the oligomerization of monomeric hsRuvBL2. The structural information 
that was gathered in this work shows that hsRuvBL2 presents specific motifs at the 
surface level that allow hsRuvBL1 and hsRuvBL2 to be distinguished in the context 
of a signalling pathway. Furthermore, this was the first apo structure obtained for 
a eukaryotic RuvBL2. Comparison of our structure with the structures of ADP-
bound truncated hsRuvBL2, and fungal ADP-bound ctRuvBL2 (Chaetomium 
thermophilum), suggests a putative mode of action for the coupling of ATP binding 
with a mechanical movement that could be the basis of ATP-dependent activities. 
Since crystallography provides a detailed, but somewhat static structural model, 
we used electron microscopy to gain some insight into the plasticity of the 
hsRuvBL2 complex. Curious, although of still unknown biological relevance, is the 
observation that hsRuvBL2 is also able to form heptamers. 
We combined the obtained structural knowledge with DNA binding 
assays, since the DNA binding mode of RuvB-Like proteins is still a major focus of 
discussion, and largely unknown. Our results suggest that hsRuvBL2 must be 
monomeric at the onset of activity in order to bind DNA, since we could not 
observe a DNA electrophoretic shift in the presence of hexameric hsRuvBL2. While 
the low concentrations necessary to obtain monomeric hsRuvBL2 precluded the 
observation of DNA binding by electrophoretic mobility shift assay, electron 
microscopy allowed the observation that monomeric hsRuvBL2 associates into a 
ring, possibly a hexamer, in the presence of single-stranded DNA. EMSA assays 
further showed that hsRuvBL1 monomers are also able to bind ssDNA, and seem 
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to be able to confer to hexameric hsRuvBL2 the ability to bind ssDNA, or 
alternatively to form bridges between DNA and hexameric hsRuvBL2. 
An analysis of the oligomerisation states of hsRuvBL2 with and without 
tags, shows that, as observed in yeast, tag presence and position interfere with the 
oligomerisation state. We also observed that they interfere with concentration-
dependent oligomerisation state, such that C-terminally tagged hsRuvBL2 is 
always a hexamer, while the N-terminally tagged form varies its oligomerisation 
state depending on protein concentration. 
 
Resumo da Dissertação 
 
Os factores de transcrição da família RuvB-Like, RuvBL1 e RuvBL2, 
funcionam na regulação do ciclo celular e do desenvolvimento. A estas proteínas 
estão atribuídas as funções de chaperone, reguladores de transcrição e helicase, por 
vezes de forma dependente de ATP. No entanto, a forma como estas diferentes 
funções são reguladas é ainda um mistério, que diversos grupos tentam elucidar. 
Existe já um espólio vasto de informação sobre a RuvBL1 e RuvBL2. No entanto, as 
funções destas proteínas ainda têm de ser colocadas no contexto das diversas vias 
de sinalização das quais fazem parte. Esta pode ser uma tarefa árdua, já que as 
funções atribuídas a estas proteínas parecem ser usadas em diversas combinações, 
dependendo do complexo onde estão incluídas. A dificultar o processo, estas 
proteínas podem funcionar separadamente ou em complexo, e de uma forma que 
parece ser regulada pelo seu estado oligomérico, parceiros de ligação e/ou por 
modificações pós-translacionais. Tanto a RuvBL1 como a RuvBL2 estão associadas 
com a etiologia de vários cancros e outras doenças, como hiperplasia cardíaca e 
ciliopatias. Como tal, o nosso grupo pretendeu produzir uma pequena contribuição 
para a área de estudo destas proteínas, uma contribuição que esperamos que seja 
útil, em particular nas áreas de saúde e indústria, já que a estrutura da RuvBL2 
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humana determinada durante esta tese é um potencial alvo de compostos 
farmacológicos amplamente reconhecido. 
O caminho para a compreensão do funcionamento de qualquer proteína 
passa pela análise da sua estrutura, e foi este o principal objectivo deste trabalho: a 
obtenção da estrutura de resolução atómica remanescente da família das RuvBLs, 
a RuvBL2 humana (hsRuvBL2). Aqui apresentamos a estrutura atómica da RuvBL2 
humana suficientemente completa para providenciar nova informação quanto à 
sua biologia. A estrutura da hsRuvBL2 resolve o domínio II, um domínio móvel 
responsável por interacções proteína-proteína e regulação da actividade ATPase. 
Neste trabalho tentamos demonstrar de que forma a ligação de ATP pode levar à 
movimentação do domínio II através de interacções com o loop N-terminal, e 
demonstramos ainda que as tags de afinidade afectam a oligomerização e 
estabilidade da hsRuvBL2 em solução. Uma comparação com a homóloga 
hsRuvBL1 demonstra diferenças na distribuição de cargas superficiais que podem 
justificar algumas diferenças de regulação entre as duas proteínas. Finalmente, 
dados obtidos por microscopia electrónica revelam que a presença de ADN de 
cadeia simples promove a oligomerização de hsRuvBL2 monomérica. A 
informação estrutural recolhida neste trabalho demonstra que a hsRuvBL2 
apresenta motivos específicos na sua superfície que permitem que seja distinguida 
da hsRuvBL1 no contexto de uma via de sinalização. Adicionalmente, esta foi a 
primeira estrutura apo obtida para uma RuvBL2 de um organismo eucariota. Uma 
comparação da estrutura aqui obtida com a estrutura da hsRuvBL2 truncada ligada 
a ADP, e com a estrutura da RuvBL2 de Chaetomium thermophilum, também ligada 
a ADP, sugere um potencial modo de acção que conecta a entrada de ATP com um 
movimento mecânico do domínio II que poderá ser a base de actividades 
dependentes de ATP. Visto que a cristalografia de raios-X providencia um modelo 
estrutural detalhado, porém algo estático, recorremos à microscopia electrónica 
para obter informação acerca da plasticidade do complexo hsRuvBL2. Observámos 
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que esta proteína é capaz de formar heptâmeros, um facto curioso mas de 
relevância biológica ainda indeterminada. 
Combinámos o conhecimento estrutural obtido com ensaios de ligação ao 
ADN, já que o modo de ligação ao ADN das RuvBLs é ainda um foco de discussão, 
e pouco caracterizado. Os nossos resultados demonstram que a hsRuvBL2 tem de 
estar no estado monomérico no início da reacção, por forma a estabelecer ligação 
com o ADN, visto que não observámos variação na distância percorrida pelo ADN 
em gel na presença de hsRuvBL2 hexamérica, quando comparada com a distância 
percorrida pelo ADN isoladamente. Tendo em conta que as concentrações às quais 
a hsRuvBL2 é monomérica são demasiado baixas para permitir a observação de 
ligação por ensaios de variação de mobilidade electroforética em gel (EMSA), 
utilizámos microscopia electrónica para observar que a hsRuvBL2 monomérica se 
reorganiza em anéis na presença de ADN de cadeia simples. Os ensaios por EMSA 
mostraram ainda que monómeros de hsRuvBL1 são também capazes de se ligar ao 
ADN de cadeia simples, e parecem conferir à hsRuvBL2 hexamérica a capacidade 
de se ligar ao ADN, ou alternativamente podem actuar como pontes de ligação 
entre o ADN e o hexâmero de hsRuvBL2. 
Uma análise das formas oligoméricas de hsRuvBL2 com e sem tags de 
afinidade demonstrou que a presença e posição das tags interferem com o estado 
de oligomerização. Observámos também que há uma influência na variação de 
estado oligomérico conforme a concentração de proteína: a hsRuvBL2 com tag C-
terminal é sempre hexamérica, enquanto que a hsRuvBL2 com tag na extremidade 
N-terminal adquire diferentes estados oligomérico conforme a concentração a que 
se encontra. 
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This introduction aims to integrate relevant information presently 
available on RuvB-Like proteins with knowledge of the eukaryotic cell. The 
elucidation of the human RuvBL2 structure, determined in this work, will 
contribute to a better understanding of this protein family, which contains 
proteins that function both separately and in complex. Since they are deeply 
involved in such fundamental processes as development, chromatin remodelling 
and disease, including multiple cancer types, it is fundamental to understand 
their roles in the cell. In that way, one can follow the next step in regulating their 
activity with a better defined strategy in mind: the design of chemical compounds 
that will affect a particular activity, without interfering with their parallel 
workings inside the cell, a risk when targeting such a ubiquitous protein. 
Fortunately, this protein comprises discrete areas, targetable by multiple 
regulators, which may provide some clues as to where to begin, as long as it is 
possible to correlate the effect of targeting such areas to the outcome in the cell, 
and at the organism level. 
 
1.1 A SIMPLIFIED VIEW OF THE EUKARYOTIC CELL 
 
The crowded cell 
 
The eukaryotic cell environment is based on an aqueous moiety, with a 
high concentration of macromolecules (50-400 mg/mL), leading to 
macromolecular crowding effects, such as volume exclusion of reactants and 
reduced diffusion coefficients of macromolecules1. Such an overcrowded 
environment precludes random movements and chance collisions as the basis for 
the protein-protein contacts needed for catalytic activities to occur. In fact, 
overcrowding promotes protein association and self-association of monomers2,3. 
Therefore, the formation of multi-subunit assemblies is facilitated by the 
Introduction 
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environment, and improves catalytic efficiency, through the formation of multi-
subunit complexes composed of the enzymes that are part of a catalytic pathway. 
Many different proteins have been identified so far in such supramolecular 
assemblies, with varying degrees of binding affinities and complexity. RuvBL1 
and RuvBL2 are two of those proteins that take part in various assemblies, either 
individually4–7 or as a heteromeric complex8–13. 
 
Eukaryotic cell compartmentalization 
 
The function of a protein is strongly dictated by its sub-cellular location 
and by interactions with binding partners, which may also be correlated with the 
deposition of post-translational modifications (epigenetic markers). Additionally, 
the cell proteome distribution varies during the cell cycle, and a few genes are 
only transcribed for specific cell types. Furthermore, about one-third of its 
proteins are found in multiple organelles, which suggests roles in diverse and 
multiple pathways, such as is the case for RuvB-Like proteins. This wide 
distribution justified a brief description of the eukaryotic cell, for visual aid (Fig. 
1.1). 
The eukaryotic cell is highly compartmentalized, which confers 
functional segregation. It contains a true nucleus, delimited by a nuclear 
membrane. The inner membrane serves as an anchoring site for chromatin, and 
the outer membrane is continuous with the endoplasmic reticulum. Nuclear pores 
distributed across the membrane allow the exchange of macromolecules between 
the nucleus and the cytoplasm. The nucleoplasm supports the chromosomes and 
the nucleoli, and it is the place where transcription and replication events take 
place. The nucleoli are structures not bound by membranes, where ribosomes are 
synthesized, processed and assembled, a complex process controlled by nucleolar 
Chapter 1 
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substructures such as the fibrillar centre. The nucleoli also comprise proteins 
involved in stress responses and cell cycle regulation. 
The cytoskeleton is composed of three types of fibres. The microtubules 
are the stiffest of the three, and are responsible for spindle formation during 
mitosis. Actin filaments are polarized, dynamic filaments with the ability to 
quickly assemble and disassemble, making them essential in the response to 
outside stimuli and in cell motility. As such, they are in direct contact with 
membrane-bound proteins and focal adhesions. The latter, also known as force-
sensing and transducing complexes, are multi-subunit assemblies constructed by 
layers connecting actin filaments to the extracellular matrix. Functions of the 
different constituents of the focal adhesions start from receptor-matrix binding, 
linkage to actin and force transduction, intracellular signal transduction and actin 
 
 
Figure 1.1 – Representation of the eukaryotic cell. Highlighted are the most relevant 
organelles and cellular structures. Depicted from http://www.carolguze.com/text/102-7-
eukaryoticcells.shtml. 
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polymerization and regulation. Two examples of components of focal adhesions 
are PI3Ks (phosphatidylinositol kinases) and Arp2/3 (actin related proteins 2 and 
3). The Arp2/3 complex binds to the pointed ends of actin filaments, nucleating 
them, and facilitating the formation of actin-based protrusions, essential for 
motility. Finally, the intermediate filaments provide support to the cell and 
resistance to mechanical stress, and anchor the chromosomes to the inner part of 
the nuclear membrane, the lamina. 
The cytoplasm comprises the cytosol, a semifluid liquid that contains 
mostly proteins, amino acids and ions, plus all non-nuclear organelles. The 
endoplasmic reticulum (ER) is a membrane-bound organelle, and the first step in 
the secretory pathway, together with the Golgi apparatus (GA)14. Vesicles are 
small, enclosed organelles that are formed to create a dedicated environment to 
perform a variety of specialized functions, such as specialized metabolic 
reactions, transport, degradation of biomolecules and secretion. The centrosome 
is an organelle responsible for microtubule organization in the cell. It is composed 
of two centrioles, embedded in the pericentriolar matrix, and it is the microtubule 
organising centre (MTOC) of the cell during G1 and G2 phases of the cell cycle 
(see section 1.1.1). During mitosis the centrosome will mature into the spindle 
pole, and may form cilia by elongating microtubules15. The mitochondria are 
involved in the production of energy in the form of ATP, are involved in cell 
death, signalling and differentiation, and are the only organelles to possess their 
own genome (in animals). Interestingly, it was recently shown that RuvBL2 
possesses a mitochondrial targeting signal in one of it isoforms (isoform 3, 
Accession: NP_001308120.1), and indeed RuvBL2 and RuvBL1 were identified in 
mitochondria-enriched fractions. It has been suggested that, either by alternative 
splicing or alternative translation initiation, a form of RuvBL2 could be produced 
starting only at M46, thus activating this mitochondrial targeting signal. The 
Chapter 1 
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function of mitochondrial RuvBL2 isoform 3 is not yet clear, but it was shown to 
interact with the mitochondrial DNA polymerase gamma16. 
Each cell is delimited by the plasma membrane, which provides a 
selective barrier with the outside environment. Proteins located in the membrane 
are responsible for cell to cell contacts, signal transduction, transport and 
adhesion to other cells or the extracellular matrix. Some proteins possess a signal 
peptide that promotes active transport out of the cell, and are thus secreted via 
the secretory pathway. 
 
DNA packing and organization 
 
Human chromosome sizes range between 50,000,000 and 300,000,000 bp. 
 
 
 
Figure 1.2 – A) Structural organisation of genomic DNA. In order for the processing machinery to 
access the DNA, a section of the genome has to be unconstrained (uncoiled), for which the 
surrounding will become supercoiled, up to a limit. From17. B) Crystallographic structure of the 
nucleosome. Depicted from18. 
 
A B 
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In each cell, the DNA fibre is more than 2 meters long and can only be 
accommodated in the cell nucleus by iterative folding (Fig. 1.2A) into a 
condensed structure, the chromosome. Linear arrays of nucleosomes are coiled 
into a 30 nm fibre19, linked and stabilised by linker histone H1. The basic folding 
unit - the nucleosome - is composed of 146 base pairs supercoiled in two turns 
around a histone octamer, composed of two H2A-H2B heterodimers and a H3-H4 
tetramer  (Fig. 1.2B), forming the fundamental unit of chromatin8,18,20. 
Histones not only help in DNA packing, but can also be interchanged 
between different forms that bind more or less tightly to DNA, aiding in 
transcription regulation, together with DNA sequence and remodelling 
machinery. Histone post-translational modifications (PTMs) mark locations of 
double strand breaks and replication fork stalling, for further processing by the 
cellular repair machinery. After a DNA strand break or replication fork stall, 
canonical forms of H2A are replaced at the site of the break by H2AX, which 
contains a conserved SQ(E,D)(I,L,F,Y) motif at the carboxyl terminus, a common 
PI3K kinase (PIKK) phosphorylation motif. The serine residue is phosphorylated 
immediately after a double strand break, by PIKKs DNA-PKcs (DNA-dependent 
protein kinase catalytic subunit) and ATM (ataxia-telangiectasia mutated), 
forming a number of γ-H2AX foci that approximates the number of DSBs. H2AX 
phosphorylation triggers a series of molecular events that activate DNA repair 
response, and proteins such as BRCA1, Nbs1, Rad50 and Rad51 have been found 
to form foci that co-localize with γ-H2AX foci21,22. The consequence is an extensive 
change in local chromatin composition, including acetylation, ubiquitination, 
potential H2A.Z deposition and eventually histone eviction, concomitant with 
end resection8. For example, the RuvBL-containing INO80 chromatin remodelling 
complex is recruited by γ-H2AX to sites of replication fork stalling as cells enter 
the S-phase, and promotes efficient progression of replication by stabilising 
stalled replisomes. INO80 also functions in collaboration with SRCAP to replace 
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γ-H2AX with the H2AZ variant in case of DSBs23. This facilitates nucleosome 
eviction prior to DNA strand repair, since H2AZ nucleosome structure and 
biochemical studies suggest that its association with DNA may be weaker than 
that of H2AX22. In yeast, Htz1 (homolog of human H2AZ) promotes deposition of 
Gcn5 histone acetyltransferase, which acetylates histone H3 in response to UV 
stress, in Htz1-containing nucleosomes. Htz1 subsequently stabilises the 
interaction of Rad14 with damaged DNA, promoting nucleotide excision repair 
(NER) after UV irradiation24. 
The mobility of a chromosomal locus varies with cell cycle stage and with 
chromatin status. DNA mobility, particularly at sites of double strand breaks 
(DSB), is not simply caused by Brownian motion, but is a controlled and 
regulated cellular process, promoted by enzymes. With about 53 different types 
of Snf2-type ATPases (enzymes that catalyse the hydrolysis of ATP to ADP with 
concomitant DNA/RNA remodelling) in humans, it is expected that each one will 
have different, even if maybe partially redundant, impacts on chromatin 
composition, mobility and structure which may, at least in the case of INO80, 
impact on  chromatin dynamics. However, the activity of the DNA damage 
response (DDR) system and chromatin remodellers is not restricted to damaged 
sites, as checkpoint activation leads to an increase in chromatin mobility that is 
dependent on the INO80-dependent ATR (ataxia telangiectasia Rad3-related) 
kinase Mec1 and its downstream target kinase Rad538. In case of difficult-to-
repair DSBs and collapsed replication forks, DNA is relocalized from the 
nucleoplasm to the nuclear pore, an event that is dependent on the presence of 
histone H2A.Z, which implies an involvement of the RuvBL-containing SWR1 
complex. In fact, depending on the DSB cause, chromatin re-localization may 
occur towards the nuclear pore or the membrane protein Mps3. This is dependent 
on the cell cycle stage, such that association of persistent DSBs with Mps3 (which 
suppresses recombination) requires Rad51 and end resection, which occurs only 
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in the S phase, while DSB association with the nuclear pore (which favours non-
canonical recombination) occurs also in G1 phase8.  
 
1.1.3 AAA+ PROTEINS 
 
ATPases associated with various cellular activities (AAA+ ATPases) are 
present in all domains of life, and eukaryotic genomes typically encode 50 – 100 
different proteins belonging to this family25. The AAA+ ATPases fall within the 
second major group of the P-loop NTPases, the ASCE (additional strand catalytic 
E, for the characteristic catalytic glutamate residue within the Walker B motif). 
Proteins of this superfamily use the energy obtained from ATP binding and 
hydrolysis to perform a variety of biochemical activities. Members of this 
superfamily include helicases, chaperones and regulatory components of 
proteolytic machines, which usually assemble into hexameric rings or helical 
structures (although pentameric, heptameric and octameric examples also exist)25. 
As such, this superfamily comprises members involved in the normal 
maintenance of the cell, but also in stress response. The defining feature of the 
numerous members of this group is an ATP-binding module, which associates 
into arrays to originate a functional complex. ATP binding and hydrolysis events 
at the interface of neighbouring subunits lead to conformational changes within 
the AAA+ assembly that are responsible for the enzymatic activity of the 
complex26,27. The interface between protomers thus undergoes adjustments 
according to the bound nucleotide state, while maintaining integrity of the 
complex. Interestingly, it was observed that of all the AAA+ ATPases analysed, 
RuvBL1 protomers had the largest surface contact area. In fact, the ATP binding 
pocket in RuvBL1 is so tightly occluded that it seemed to render impossible the 
exchange of the bound ADP, which could justify the observed low ATPase and 
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lack of helicase activities. It was suggested that a co-factor may be necessary to 
enable these activities, similarly to other members of this family25,28. 
This large superfamily is characterized by the heterogeneity of its 
members’ structures and functions. However, there are some common structural 
features: all possess a core αβα nucleotide-binding domain and an adjacent α-
helical domain, composed of two helical hairpins associated to form a left-handed 
superhelical structure (Fig. 1.3). The latter is a smaller domain, poorly conserved 
at the primary sequence level, but highly conserved structurally, such that it is a 
hallmark of the AAA+ ATPase superfamily. In these multimeric complexes, the 
ATP-binding site is located at the interface between neighbouring subunits: one 
protomer provides the main nucleotide binding pocket, composed of Walker A,  
 
 
 
Figure 1.3– General structural features of the AAA+ ATPase core. A) The ATPase core is subdivided 
into an αβα subdomain and a superhelical subdomain. B) Distribution of the canonical AAA+ 
motifs. C) Top and side views of the HsIU from Haemophilus influenzae. The superhelical “lid” 
domain (purple), locates to the outside of the ring structure. Additional helices (orange) form the I-
domain, characteristic of HsIU-family proteins. From29. 
Superhelical domain 
αβα subdomain 
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Walker B, sensor I and sensor II motifs; the adjacent protomer contributes a 
conserved arginine (box VII, Second Region of Homology – SRH – or SRC 
motif)30. These conserved motifs all map to the AAA+ core αβα nucleotide fold, 
except for sensor II, which is located in the helical subdomain, known as the 
AAA+ “lid”. An arginine “finger”, extending from one monomer to the adjacent 
one, completes the ATP binding pocket, and polarises the γ phosphate to 
facilitate hydrolysis. This important residue has also been shown to be 
responsible for oligomerization of hexameric ATPases, since its mutation 
abolished oligomerization, as well as ATP binding and hydrolysis and DNA 
translocation. Addition of wild-type monomers to the mutated ones resulted in 
dimer formation, since only part of the population was able to provide this 
residue to promote the interaction31,32. The sensor I motif is typically an Asn, but 
can also be another polar residue, such as Ser, Thr or Asp; this motif participates 
in hydrolysis by coordinating the attacking water nucleophile, together with the 
Walker B residues. The Walker A motif has a consensus sequence 
GXXXXGK[T/S] (X represents any amino acid), in which the Lysine present on the 
P-loop (phosphate-binding loop) contacts directly the β and γ phosphates of ATP, 
making it critical for ATP binding. The Walker B motif consensus sequence is 
hhhhDE (h represents a hydrophobic amino acid). In this motif, the glutamate 
polarises a water molecule for in-line attack of the γ phosphate during ATP 
hydrolysis, and its mutation to glutamine or alanine abolishes this activity25,31. 
These mutants can nevertheless be useful in order to obtain a “trapped” structure 
that may allow the observation of transient conformational states25,27,33,34. This 
glutamate residue has a pivotal role in translation of nucleotide state to enzyme 
activation state. Indeed, analysis of several ADP and ATP bound AAA+ ATPases 
shows that two major conformational changes occur between the ATP and ADP 
complexes. The first major movement occurs in the glutamate sidechain itself, 
which rotates by approximately 100° in the ATP complex relative to its position in 
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the ADP complex, and forms a hydrogen bond with an asparagine residue in an 
adjacent strand. This “glutamate switch” thus traps the ATP-bound complex in a 
higher energy and inactive form, in contrast to the ADP-bound “active” form. The 
second major movement occurs in an area farther from the active site, and may 
involve loops that interact directly with the Glu-Asn pair, providing 
communication between the ATPase and ligand-binding sites. The known 
exceptions to date are the HslUV/Clp family proteases and the RuvB-Like 
helicases, in which the glutamate contacts a conserved threonine or serine residue 
instead of the Asn residue. This switch pair formation requirement upon ATP 
binding is suggested to be a way of repressing ATPase activity until there is 
ligand binding (a mechanism which is reversed in the cases where the ligand 
represses instead of activating)31.  
Although AAA+ ATPases require ATP to perform activities that other 
enzymes can perform without, their ATP turnover is frequently poor in 
comparison with other ATPases such as hexokinase or even DNA helicases 
(turnover numbers are typically 0.1 to a few per second for AAA+ enzymes, 
versus several hundred per second for the “simpler” metabolic ATPases). 
Furthermore, the ATPase activity is often positively or negatively regulated by a 
ligand, and sometimes the same ligand can have opposite effects on different 
proteins. For instance, DNA binding leads to an increase in the ATPase activity of 
Replication Factor C, and yet represses ATPase activity of the Origin Recognition 
Complex. ATP hydrolysis suppression is necessary in complex enzymatic 
systems, with complex assembly pathways and multiple intermediate steps. 
ATPase activity is enabled at the point when ATP turnover is necessary for 
completion of the reaction or recycling of components. In this way, ATP binds 
during complex assembly, but its hydrolysis is suppressed until the complex is 
fully assembled31. 
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Sequence and structure comparisons show that AAA+ ATPases went 
through significant divergent events both before and after the emergence of the 
last common ancestor between bacteria, archaea and eukarya. Members of this 
superfamily can be subdivided into groups, clades and families, where the clade 
is defined by the distinct structural elements located within and around the 
AAA+ core. The five groups described are: Classic AAA ATPases (classical AAA 
clade or extended AAA group); helicases and clamp loaders (HEC); protease, 
chelatase, transcriptional activators and transport (PACTT); ExeA (type II 
secretory pathway ATPase); and signal transduction ATPases with numerous 
domains (STAND). RuvB-Like/Rvb proteins belong to the classical AAA group, 
which also includes NSF, CDC48, Pex, Bcs, proteasomal ATPase, katanin, Vps4, 
FtsH and Clp Domain 1 (d1) families. The last two families, as well as RuvBL, 
diverge from the others25,29. However, topological analysis of the ATP binding 
pocket revealed RuvBL1 to have closer structural similarities with the HEC group 
(DnaA, Orc, CDC6 clade)25. 
The great functional diversity of AAA+ proteins is a reflex of their 
diversity of accessory domains and co-factors, the diversity of their oligomeric 
assemblies and heterogeneity of residues that define key nucleotide-binding 
features. These variations define the specificity of AAA+ assemblies for different 
substrates and the mechanisms responsible for coupling conformational changes 
within the assembly. Interestingly, adaptor proteins have been identified which 
interact with the ATPase module to regulate its activity by increasing its target 
specificity, without necessarily compromising other activities of the ATPase. 
These adaptor proteins are an elegant way for the cell to strictly regulate the 
activity of AAA+ proteins by regulation of the adaptor proteins themselves. An 
example of an adaptor protein in higher eukaryotes is p47, which interacts with 
the AAA+ ATPase p97, regulating the p97-mediated fusion of Golgi and 
transitional endoplasmic reticulum membranes, as well as the growth of the 
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nuclear envelope. Interestingly, many adaptor proteins identified so far, despite 
their sequence variability, use the N-terminus of the ATPase as the interaction 
platform for binding and regulating the ATPase activity26. 
 
1.1.4 HELICASES  
 
Nucleic acid helicases are molecular motor proteins that couple the 
chemical hydrolysis of a triphosphate nucleotide with the unwinding of the 
energetically stable DNA or RNA duplexes. This process allows access to single 
stranded templates for proteins involved in transcription, replication, 
recombination and repair machineries. The mode of unwinding of each helicase 
depends on the structure and type of nucleic acid substrate. Helicases can thus be 
classified as DNA-DNA, DNA-RNA or RNA-RNA dependent NTPases. The 
interaction of helicases with each nucleic acid substrate may be regulated by other 
proteins that modulate their access to the substrate. Such regulatory mechanisms 
ensure that in vivo each helicase will be active only in the pathway and at the 
moment when they are required35. The first helicase was discovered in 1976 in 
Escherichia coli, and two years later another was found in an eukaryotic organism, 
the lily flower. Since then, helicases have been found to be ubiquitous to all living 
organisms and many viruses36,37. 
Most helicases share a few common biochemical features, namely nucleic 
acid binding, NTP binding and nucleic acid-stimulated hydrolysis of NTP. 
Helicases do not necessarily unwind nucleic acids, and those that do may or may 
not translocate along the strand. Most commonly, helicases bind preferentially to 
a ssDNA strand in a sequence-independent way, and from there they start to 
unwind the DNA double helix unidirectionally. A few exceptions preferentially 
bind dsDNA, such as RecBCD, simian virus 40 (SV40) large antigen and, notably, 
RuvB helicases36. 
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Helicase classification is made difficult by the complexity of existing 
systems, the variability of oligomerization states, nucleic acid specificity, 
translocation polarity, preference for single or double stranded DNA/RNA, and 
the addition of regulatory modules. The most recent classification system has 
been proposed by Singleton et al in 200738, which divides helicases into 6 
superfamilies according to their most prevalent functional motifs and 
characteristics. All superfamilies have common motifs that mark them as 
helicases: the Walker A (G(x)4GKT) and Walker B (DExD/H) motifs, and the 
“arginine finger”, that is involved in energy coupling. Superfamily 1 includes 
only bona fide monomeric ssDNA helicases, i.e., proteins that translocate along 
single stranded nucleic acids and catalyse the separation of double strands39. 
Superfamily 2 is the largest, encompassing 10 intensively studied families, 
including DEAD-box RNA helicases, the RecQ-like and the Swi/Snf family (where 
the complexes SWR1, INO80 and RAD54 are included). Swi/Snf complexes are 
involved in several processes in the cell that are correlated with chromatin 
remodelling, such as replication, DNA repair, RNA polymerase regulation, cell 
cycle progression and tumour progression. The mechanisms employed by these 
large supramolecular complexes involve mostly histone manipulation, i.e., 
altering the structure of nucleosomes in order to change DNA accessibility. 
Chromatin remodelling complexes are composed of multiple subunits, including 
one member of the Swi/Snf family, and other accessory proteins. The INO80 
complex, for instance, not only includes the SF2 helicase Ino80, but also the 
RuvBL1/2 dodecameric complex, and 12 other proteins40,41 (see section 1.3.2 for 
more information on chromatin remodelling complexes containing RuvBL 
proteins as one of the components). Superfamilies 3-6 include helicases that form 
hexamers and double hexamers: SF3 is composed entirely of viral helicases42, and 
includes AAA+ proteins with multiple enzymatic activities, a 3’ to 5‘ processivity 
and the ability to form both hexamers and dodecamers38. SF3 helicases possess an 
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origin binding domain, which allows viruses to bypass the host-cell regulatory 
mechanisms, and a characteristic C motif43 (Fig. 1.4); SF4 includes only helicases 
with 5’ to 3’ polarity; SF5 is composed of Rho5, which while being closely related 
to SF4 helicases, was attributed to a different superfamily on the basis of 
differences in sequence (Fig. 1.4). It functions as transcription terminator, 
unwinding RNA:DNA duplexes and releasing newly-formed RNA transcripts44. 
SF6 comprises only DNA helicases, unlike SF1-5, which contain both DNA and 
RNA helicases36. As in the case of SF3, members of this family have many 
characteristics of AAA+ proteins (see section 1.1.3). However, SF6 members 
display also characteristic sensor 1 and 2 motifs (Fig. 1.4). Representative SF6 
members include the mini chromosome maintenance (MCM) protein complex, 
which is the helicase component of the eukaryotic replicative holo-helicase 
CMG45, and prokaryotic RuvB (see section 1.1.6). 
 
 
 
 
 
Figure 1.4 - Representative helicases from Superfamilies 3 to 6. Of notice is the general trend 
towards a ring-shaped structure. From 38. 
Introduction 
 19 
Although the prokaryotic RuvB has been included into SF6, RuvB-Like 
proteins have not been allocated to any particular superfamily. Their structural 
characteristics support their inclusion in SF6, considering the presence of SF6-
specific motifs Walker A and B, and sensor 1 and 2, as well as some of the 
biochemical characteristics known so far, namely their classification as AAA+ 
ATPase with multiple cellular functions and ssDNA specificity. Like MCM, 
RuvBLs interact with binding partners through the outer part of the ATPase core, 
in the latter case through the accessory domain II module46. Curiously, the Rho 
helicase, the constituent member of SF5, was observed by EM to have an open 
“notched” conformation (Fig. 1.4), which is proposed to correspond to an open 
ring or absence of one subunit. This conformation was also observed by EM for 
RuvBL2 (unpublished result, see chapter 2, section 2.5.2). This diversity of 
characteristics among superfamilies creates a vast and complex number of 
systems, adapted to the particular needs of the cell. 
Some proteins have been classified as helicases with basis on their 
sequence, displaying the characteristic helicase motifs, but do not perform the 
biochemical helicase activity. This is the case of SWI/SNF family, from SF2 (see 
section 1.2), which couples ATP binding and hydrolysis with chromatin 
remodelling through nucleosome rearrangements that alter chromatin 
accessibility47. 
A genome-wide analysis of human helicases48 identified 64 RNA helicases 
and 31 DNA helicases, including 5 RecQ members, KU70, 9 MCM 
(minichromosome maintenance) proteins, nucleolin, 2 chromodomain helicases, 2 
DNA repair helicases, lymphoid-specific helicases, RuvB-Like 1 and 2, Pif1, 
Twinkle, BACH1, RecQ5 isoforms alpha, beta and gamma and regulator of 
telomere elongation helicase (RTEL1). 
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1.1.5 CHAPERONES 
 
Most major processes that take place in the cell are performed by multi-
component complexes, usually through energy-dependent conformational 
changes. Examples include complexes involved in chromatin remodelling, 
proteasomes and ribosomes. The complexity of such structures foretells the need 
for specific support in the assembly process. The help of “molecular 
matchmakers”, able to use the energy gained from ATP hydrolysis to induce 
conformational changes in one or both elements of a molecular pair, was initially 
described for protein-DNA complex formation49. However, since then this 
concept has been expanded to include other types of complexes, such as multi-
protein complexes50. Chaperones can thus be ascribed the function of promoting 
the non-covalent assembly of other proteins or protein complexes. Chaperones 
may also interact with other proteins to prevent aggregation and/or promote 
proper folding, many times in an ATP-dependent manner. Many evolutionarily 
related chaperones belong to the AAA+ family, and use ATP-dependent 
conformational alterations in the ATPase core to perform their functions. Some 
AAA+ proteins still specialise in disassembly, remodelling or disaggregation, 
acting either in concert with a proteasomal machine for further target 
degradation, or by themselves51. Many of these proteins share a hexameric 
structure and a conserved protein-processing pore. However, it has been 
observed that they do not necessarily exert their disassembling/remodelling 
functions through translocation-dependent unfolding, but may do so through 
other ATP-dependent interactions with the target protein (e. g. the σ54-activating 
enzymes)51. 
RuvBL proteins are fundamentally involved in various mechanisms that 
implicate a chaperone function. They are involved in the assembly of chromatin 
remodelling complexes INO80, SWR/SRCAP and TIP60, but not as the catalytic 
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subunit. In all cases the RuvBL1/2 complex seems to have a scaffolding function12. 
However, as part of the larger SWR/SRCAP complexes, responsible for histone 
exchange, the RuvBL1/2 complex was found to have not only a scaffolding 
function, but also to be able to perform in vitro by itself the exchange of canonical 
histone H2A for the more labile H2A.Z52, another function added to the panoply 
of activities already identified for these versatile proteins. 
As part of the R2TP complex, RuvBL1/2 participates in the assembly of 
box C/D and box H/ACA snoRNPs. R2TP is involved in the assembly of core 
factors in both snoRNPs, but recruits specific factors in each family. These factors 
chaperone the core components as they are assembled, regulate the assembly and 
disassembly of pre-snoRNP intermediates and regulate the activity of 
intermediate subcomplexes53,54. In eukaryotes and archaea, box C/D snoRNAs 
modify rRNAs and possibly mRNAs, and box H/ACA snoRNAs have motifs 
included in the RNA sequence of telomerase, a complex that works in the 
synthesis of telomeric DNA54. As a chaperone in snoRNPs assembly, the R2TP 
complex regulates ribosome biogenesis and consequently controls cell 
proliferation. 
In mammalian cells, R2TP interacts through RuvBL1/2 with intermediate 
H/ACA snoRNP core components and their co-chaperones, namely SHQ1 and 
dyskerin/NAP57, dissociating them for subsequent assembly in the holo-complex. 
The dyskerin interaction is suggested to make use of the RuvBL1/2 central 
channel, which seems fit to thread the unstructured dyskerin C-terminus. This tail 
is not necessary for binding to RuvBL1/2, but it is necessary for separation of 
dyskerin from SHQ1, which further suggests a mechanism of action whereby the 
complex “grabs” both proteins and follows with a rotational movement of the 
barrel-like structure, which could be responsible for the forceful separation of 
both proteins. This possibility may be supported by the fact that point mutations 
in the Walker A and Walker B motifs of RuvBL2 lead to severe defects in snoRNA 
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accumulation55. This model seems to be applicable also to C/D core proteins, since 
some of their components possess similarly unstructured, highly charged tails, 
which are essential for yeast survival and for mammalian nucleolus 
maturation11,12. The biogenesis of box C/D snoRNPs is mediated by the 
R2TP/HSP90 complex and other assembly factors. These assembly factors are as 
of yet uncharacterized, although pull-down assays performed in yeast have 
identified TAF9, NOP17 and BCD1 as intermediate factors, which are not present 
in the mature snoRNP. Of these, NOP17 and BCD1 have been shown to interact 
directly with RuvBL1 and RuvBL2, respectively56.   Interestingly, interaction of 
R2TP with box C/D snoRNPs was shown to decrease in poorly growing cells, as 
R2TP re-localizes from the nucleus to the cytoplasm, depending on the cell 
growth phase and nutrient condition57.  
All core components of H/ACA snoRNPs also assemble with TERC 
(Telomerase RNA component) to form TERC-containing RNP, in a process 
involving the RuvBL1/2:dyskerin complex and dependent on the ATPase activity 
of RuvBL1. In addition to TERC, the Telomerase complex includes TERT 
(Telomerase reverse transcriptase) and the TERC-binding protein dyskerin. As 
part of the RuvBL1/2 complex, RuvBL1 was shown to interact directly both with 
TERT and with dyskerin. Telomerase holoenzyme adds DNA repeats to 
telomeres, nucleoprotein structures that protect the termini of chromosomes. In 
cancer cells, Telomerase activity is upregulated, conferring immortality by 
protecting chromosome ends indefinitely, contrary to the gradual loss of activity 
observed in normal cells. Both RuvBL1 and RuvBL2 were shown to be essential 
for Telomerase activity and for the accumulation of TERC and dyskerin, as 
depletion of RuvBL1, RuvBL2 or dyskerin leads to loss of TERC. Furthermore, the 
low-activity TERT:RuvBL1/2 complex seems to be highly abundant relative to the 
highly active TERT:TERC:dyskerin complex, which suggests that the former may 
also be a target for regulation, or that its assembly may require some time. 
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Interestingly, the TERT:RuvBL1/2 complex is especially abundant during S phase, 
a time-dependent association that may justify the cell cycle-dependence of 
Telomerase formation58. Additionally, since RuvBL1 and RuvBL2 are involved in 
maintenance of dyskerin levels, they could also be targets of interest in congenital 
diskeratosis, a disease caused by low activity of dyskerin and decreased TERC 
levels, which results in low telomerase activity and much shorter telomere 
length59. It is further suggested that epigenetic modifications of RuvBL1 and 
RuvBL2 may be an interesting venue of study in the context of Telomerase 
activity regulation, since it has been observed that, e. g., SUMOylation of RuvBL1 
and RuvBL2 modifies their transcriptional activity and protein-protein 
interaction59–61. 
Still as components of R2TP, RuvBL1 and RuvBL2 are involved in the 
assembly and stability of PIKKs, via the concerted interaction of the 
R2TP:HSP90/Prefoldin-Like complex, the TTT complex and the PIKKs12. 
The RuvBL1/2 complex was also recently shown to have chaperone 
functions in protein homeostasis, under stress conditions as yet unidentified 
(other than heat shock or proteasome inhibition, which did not induce RuvBL 
expression). In this role, RuvBL1/2 complex was shown to promote the formation 
of an organelle, the aggresome, which functions as storage compartment for 
aggregated proteins, and possibly also in their proteasomal or autophagic 
degradation62. This organelle is formed as an alternative to the ubiquitin-
proteasome degradation pathway, when the accumulation of aggregates becomes 
too extensive63, and indeed overexpression of RuvBL1 and RuvBL2 protected 
yeast cells exposed to proteotoxic heat stress. Furthermore, depletion of either 
RuvBL1 or RuvBL2 suppressed aggresome formation in mammalian cells 
expressing aggregate-forming synphilin – a substrate of the aggresome. To help 
elucidate the role of RuvBL1/2 complex in this process, we collaborated with the 
group of Michael Sherman, by providing RuvBL1/2 full-length complex, which 
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was used for interaction assays with synphilin (since this was the total of our 
contribution to this study, and occupied only a small portion of the total duration 
of my PhD, the RuvBL1/2 complex purification protocol is only briefly described 
in the discussion section). It was thus assessed that RuvBL chaperone activity was 
independent of R2TP complex (see sections 1.1.7 and 1.2), and that neither 
RuvBL1 nor RuvBL2 had the ability to promote aggresome formation by 
themselves, but that the RuvBL1/2 complex formation was necessary for this 
function. This is consistent with their dodecameric, barrel-like structure, as well 
as their inner channel charge distribution, which as a mix of positive and negative 
charges from both types of monomers, supports a possible association with a 
polypeptide chain. Co-immunoprecipitation followed by mass spectrometry 
identified both RuvBL1 and RuvBL2 as interacting with synphilin. Interestingly, 
this interaction occurs between the ankyrin repeat domain of synphilin, which is 
the domain responsible for its aggregation, and K372 of RuvBL1, which is located 
on the surface of the ATPase core and in close proximity to the central channel. 
This interaction is critical for assembly of the aggresome. In line with this, while 
in naïve cells, RuvBLs are distributed throughout the cytoplasm and nucleus, 
after proteasome inhibition they were recruited to protein aggregates and then 
transported to the aggresome. Interestingly, ATPase activity was significantly 
stimulated also by other amyloid-forming proteins, namely insulin and casein 
fibrils, an increase more noticeable in the domain II-truncated complex. In fact, 
even denatured BSA potently enhanced this activity, in contrast to the native 
form, which had no effect. Finally, it was concluded that the main effect of 
RuvBLs is actually on disaggregation, rather than recruitment of aggregates to the 
aggresome, since disassembly of aggresomes is strongly suppressed by RuvBL1 
depletion62. 
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1.1.6 RUVB AND RUVB-LIKE PROTEINS 
 
RuvBL1/Pontin/Rvb1/Tip49 was initially discovered in 1997 in rat, in 
association with the TATA-binding box protein (TBP), by Masato Kanemaki, from 
the group of Taka-Aki Tamura64,65. TBP is a general transcription factor that works 
at the core of multiprotein transcription factors, necessary for recruitment of all 
classes of RNA polymerases, which binds at the TATA box promoter element66. In 
1998 RuvBL1 was found as part of a complex with RuvBL2/Reptin/Rvb2/Tip48, 
associated with the RNA polymerase II holoenzyme, and later in 1999 RuvBL2 
was found as part of a complex with RuvBL1 alone in human cells67. 
 
RuvB-Like proteins are eukaryotic proteins with partial structural 
homology to bacterial RuvB (Resistance to UV) proteins (Fig. 1.5), the ATP-
dependent motors of the RuvAB complex that drive branch migration of Holliday 
junctions formed during homologous recombination77. The RuvA, RuvB and 
Table 1.1 – Different RuvBL names and their origins. 
RuvBL1 RuvBL2 Name origin 
TIP49 TIP48 TATA-binding protein (TBP)-interacting protein68,69 
TIP49a TIP49b TBP-interacting protein67 
Pontin52 Reptin52 Repressing Pontin526 
TAP54α TAP54β TIP60-associated protein70 
TIH1 TIH2 TIP49a/b homolog71 
ECP54 ECP51 erythrocyte cytosolic protein72 
NMP238 --- nuclear matrix protein73 
Rvb1 Rvb2 RuvB homolog74 
p50 p47 protein75 
RuvBL1 RuvBL2 Ruv (Resistance to UV) B-Like (RuvB homolog)76 
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RuvC proteins are necessary for normal levels of cellular resistance to UV or 
ionizing radiation, or of mitomycin. Based on this partial homology, these 
proteins were immediately assumed to be ATP-dependent DNA helicases, and 
indeed they were shown to have helicase as well as ATPase activities in vitro67,78. 
Interestingly, RuvB-Like amino acid sequences are highly conserved not only in 
eukaryotes but also in Archaea, highlighting them as some of the most conserved 
nuclear dynamics-related proteins. Phylogenetic analyses further showed that the 
analysed archaea possess only one RuvBL copy, belonging to the RuvBL2 branch. 
Moreover, bacterial RuvB was shown to be closest to RuvBL2 than RuvBL1. 
Together, these facts suggest that RuvBL2 is the common ancestor of the RuvBL 
family, from which RuvBL1 would diverge after the emergence of eukaryotes.67  
 
 
Figure 1.5 – Main structural features of RuvB-Like proteins. A - Structural alignment of human 
RuvBL2 (yellow) and bacterial RuvB (blue). The red circle highlights the extra domain II in RuvBL 
proteins. B – Bottom view of the RuvBL1 hexamer. The central ATPase core (green) is formed by 
domains 1 and 3, and displays a central channel. The extra domain II from each monomer (blue) 
protrudes outwards, producing 6 mobile arms. C – Side view of RuvBL1 hexamer. ATPase core in 
green, with bound nucleotide in red. Domains 2 in blue. 
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This raises the question for the need for two highly similar proteins, 
which often work together. It is possible that this need arose as organisms became 
more complex, in order to fine-tune more complex pathways, such as the Wnt/β-
catenin signalling pathway, or pathways responsible for cell adherence (possibly 
during the transition to multicellularity), as can be observed in their antagonistic 
regulation of metastization processes by controlling the expression of metastasis 
Suppressor gene KAI161,79. 
RuvB hexamers contain only an ATPase core, and associate to form 
double rings through the mediation of RuvA octamers previously primed 
through interaction with a Holliday junction80. Compared to prokaryotic RuvB, 
RuvB-Like proteins comprise an extra domain II, located between domains I and 
III, encircled in fig. 1.5A (interestingly, domain II of RuvBL proteins locates 
spatially to roughly the same position occupied by RuvA in relation to RuvB80, 
such that a double RuvB ring acquires conformation similar to a RuvBL1/2 double 
ring81–83). Domains I and III form an ATPase core, responsible for nucleotide 
binding and hydrolysis (in green in figs. 1.5B and 1.5C) whereas domain II forms 
a mobile arm that protrudes from the more rigid core, such that in a ring the 
ATPase core faces a central channel and six mobile domains protrude outwards. 
RuvBLs are usually found in the cell as single or double hexameric rings, with a 
1:1 proportion of each9,84. Whether each ring is constituted of a mixture of RuvBL1 
and RuvBL2 or homomeric still under debate, since the resolution of the 
structures obtained by cryo-electron microscopy (cryo-EM) does not yet allow a 
clear distinction between RuvBL1 and RuvBL2. It is also not always clear whether 
the contact between rings occurs between the ATPase cores or through the 
domains II. However, it is now mostly accepted that the latter interaction is 
probably the most frequent, since both EM and crystallographic structures of 
dodecamers obtained to date show double hexamers interacting through the 
domains DII, as well as alternating RuvBL1 and RuvBL2 monomers in the 
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hexameric rings. Nevertheless, both proteins are able to form homohexamers in 
vitro28,85. Oligomer formation was shown to be dependent on the presence of the 
Walker A and Walker B motifs. However, these were not necessary for binding to  
other proteins through domain II7. 
RuvBL1 is encoded in chromosome location 3q21, a region of frequent 
rearrangements in leukaemia and solid tumours86,87. RuvBL2 is encoded in 
location 19q13.33 of chromosome 19, and is physically linked with the breast 
cancer-related CGB/LHB gene cluster88. This chromosome has more than double 
 
 
Figure 1.6 - RuvBL2 protein expression data, identified by specific antibody CAB012432, from 
Abcam (product 36569). Top: Expression levels in several organs. Bottom: expression levels in 
cancer vs. normal cells. Dark blue: high expression levels; light blue: medium expression levels. The 
bars indicate the proportion of high vs. normal levels of RuvBL2 identified in a total number of 
analysed samples, for each cancer type. From the protein atlas annotation project. 
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the gene density in comparison to the genome-wide average89. RuvBL2 is 
ubiquitously expressed, and high protein levels have been identified in many 
organs and tissues (Fig. 1.6), but are especially high in the testis and thymus67, a 
pattern closely repeated by the eukaryotic recombination factor Rad51; mRNA 
levels are conversely highest in the testis but relatively low otherwise90. 
A variety of functions and seemingly unrelated roles have been attributed 
to RuvBL2, which has been identified mostly in the nucleus, but also in the 
cytoplasm and associated with the cytoplasmic membrane. Together with 
RuvBL1, it has been implicated in regulation of gene transcription, chromatin 
remodelling, DNA damage sensing and repair and in the assembly of protein and 
ribonucleoprotein complexes (Fig. 1.7). Both exert their roles as part of signalling 
pathways that are involved in nutrient sensing, RNA metabolism, DNA damage 
repair and pathophysiology, such as cancer, ciliary biology and disease. In fact, 
they have been shown to be overexpressed in many tumours, and to be directly 
involved in tumour biology, hypoxia and metastization4,5,60,91–96. RuvBLs perform a 
variety of functions. Regarding mechanisms of transcriptional regulation, RuvBLs 
are reported to be required for the induction of interferon-stimulated genes in 
response to interferon alpha, independently of their ATPase activity. They also 
have a role in the regulation of nuclear hormone receptors, such that both 
proteins can bind to oestrogen and glucocorticoid receptors, with agonistic 
effects97. Conversely, RuvBLs antagonistically regulate transcription during heart 
development98, are differently methylated in hypoxic cells, and genome-wide 
analyses show that they don’t share many common targets in hypoxia signalling 
pathways4,5. Further studies are required to elucidate how these two proteins, 
which function as part of the same complex, can also achieve transcriptional 
specificity. 
The answer may lie partly in the regulation of their oligomerization state, 
such that when they are working alone, they recognize different 
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promoters/regulators of expression, as suggested by Rowe and colleagues in 
200899. Here, using ChIP/re-ChIP assays, they show that the addition of phorbol 
ester induces the recruitment of RuvBL1/Tip60 activator complex to the promoter 
of the anti-metastatic KAI1 gene, in a way that mutually excludes the recruitment 
of RuvBL2/β-catenin complex. How their oligomerization state is regulated is still 
a matter of debate, but one of the mechanisms may rely upon interaction with 
binding partners, as has been demonstrated for the histone H3. Acetylation and 
methylation of histone H3 N-terminus regulates the activity and oligomerization 
state of RuvBL1 and RuvBL2. In fact, RuvBL2 association with the progesterone 
receptor gene promoter is related to the H3 marks of the surrounding histones100. 
Another mechanism which may direct the transcriptional specificity of RuvBL1 
and 2 may be related with specific post-transcriptional modifications (PTMs). As 
an example, SUMO-conjugated RuvBL2 is recruited to the nucleus, where 
together with β-catenin, it binds to the promoter of the metastasis suppressor 
gene KAI1, leading to metastasis60,61. 
 
Figure 1.7 – RuvL1 and 2 are involved in several pathways in the cell. Adapted from101 
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1.1.7 ROLES OF RUVBLS IN THE CELL AND CELL CYCLE  
 
RuvB-Like proteins are ubiquitous in the eukaryotic cell, and as such 
have a widespread influence in various pathways and cellular functions. The 
mechanisms that regulate their roles in each case are not completely understood. 
Their action is likely regulated by their oligomeric state and post-transcriptional 
modifications that will direct them towards interaction with specific partners or 
multi-subunit complexes, in response to the metabolic state of the cell, other 
external factors or even disease states4,60. A wide array of functions performed by 
RuvBLs is achieved through the activity of R2TP complex, and by their 
participation in other supramolecular assemblies, in a seemingly dynamic way, 
adapted to the needs of the cell (Fig. 1.8). 
 
 
Figure 1.8 – RuvBL complex functions mostly as part of larger supramolecular assemblies. 
R2TP complex functions vs RuvBL complex functions. From57. 
 
Checkpoint pathways 
Checkpoint pathways are activated upon DNA damage, blocking 
progression of the cell cycle until the damage is repaired, before allowing the 
cycle to resume and transit to the next phase. The signalling cascade activates p53, 
leading to inactivation of cyclin dependent kinases, and preventing cell cycle 
progression from G1 to S (G1/S checkpoint), DNA replication (intra S checkpoint) 
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or G2 to mitosis (G2/M checkpoint)102. RuvBLs play roles in checkpoint 
regulation, usually as part of supramolecular assemblies, such as the INO80, 
SWR1 or TIP60 complexes. 
In yeast, Mec1/ATR and Tel1/ATM phosphorylate subunits of the INO80 
complex (Ies4 and Ino80) during DNA damage response, affecting DNA damage 
checkpoint response, but not the DNA repair pathway. Checkpoint activation 
also leads to phosphorylation of subunits of the SWR1 complex (Bdf1 and Swr1). 
Both complexes, which include RuvBL1 and RuvBL2 as components, thus 
participate in the process of checkpoint adaptation, by helping overcome an 
extended checkpoint arrest and re-enter the cell cycle with an unrepaired DSB. 
INO80 and SWR1 seem to have antagonistic activities in yeast, since cells 
deficient in Ino80 are unable to overcome checkpoint arrest, an effect which is 
counteracted by the additional deletion of Swr18,103. 
Human TIP60 complex was observed to be recruited to chromatin after 
mitogenic stimulation, in an E2F-dependent manner, during late G1, resulting in 
acetylation of histone H3 and H4, and subsequent transition to S-phase104. TIP60 is 
also involved in activation of ATM, thus regulating the ATM-Chk2-Cdc25 and 
ATM-Chk2-p53 pathways. These are responsible for inhibition of DNA synthesis 
in response to DNA damage, and inhibition of Cdk activity, respectively103. 
RuvBL2 was also found to form a complex with activating transcription 
factor 2 (ATF2), a member of the ATF-CREB family of transcription factors 
involved in cell cycle progression and differentiation105. 
 
The subcellular distribution of RuvBLs is very cell-cycle-dependent, and 
undergoes particularly major changes during M phase. RuvBL1, which mostly 
localizes in the nucleus, was found to co-localize with α- and β-tubulin in the 
mitotic spindle. In anaphase-to-telophase transition, RuvBL1 co-localizes with 
PLK1 (polo-like kinase 1)106, which interestingly has the ability to phosphorylate 
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RuvBL1 but not RuvBL2. Like RuvBL1, RuvBL2 was found to be excluded from 
the chromosomes in early mitosis, and a small population associated with the 
centrosome and mitotic spindle. However, unlike RuvBL1, it localizes to the 
midzone during telophase and to the midbody during cytokinesis. Despite the 
fact that RuvBL1 and RuvBL2 usually function together as a complex, the 
protomers separate during cytokinesis. Together with the fact that PLK1 
associates with RuvBL1 in vivo, this suggests an unknown mechanism of 
differential regulation of RuvBLs during mitosis. Regardless, both RuvBLs are 
necessary for efficient chromosome alignment and segregation107–109. 
 
Transcription regulation 
As illustrated thus far, transcription of genes requires the coordinated 
action of many different factors, starting with the action of a) ATP-dependent 
chromatin remodelling complexes, which both mobilise nucleosomes and 
exchange histones from the DNA; and b) enzymes capable of adding or removing 
covalent modifications on histones, other proteins, or DNA, such as acetylation, 
methylation or ubiquitylation, which results in the recruitment of various protein 
complexes that recognize these modifications. RuvBLs are part of chromatin 
remodellers INO80 and SRCAP, which are involved in alterations in nucleosome 
mobility at the promoter region of a large subset of genes, and are also part of the 
TIP60 complex, responsible for nucleosomal H4/H2A HAT activity, as well as for 
acetylation of several non-histone proteins. 
 RuvBL1 and RuvBL2 may function together or independently, and have 
even been shown to work antagonistically in the regulation of transcription of 
several target genes, notably anti-metastatic KAI161, and show antagonistic effects 
during early development in zebrafish embryos98 (see sections on cancer and 
development). In Drosophila, RuvBL1 and RuvBL2 function antagonistically to 
regulate the expression patterns of Hox proteins: while RuvBL1 associates with 
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Trithorax group Brahma (Brm) complex, RuvBL2 associates with Polycomb group 
Polycomb Repressive Complex 1110, thus regulating expression of homeotic 
genes111,112. 
When working in concert, RuvBL1 and RuvBL2 are usually found as 
members of larger supramolecular assemblies, although there is no indication so 
far that they may antagonistically regulate those complexes’ activities in these 
cases. However, when demonstrated to work antagonistically, so far they have 
always been found to work in association with different complexes, such as Tip60 
and β-catenin4,60,61,113. 
 
PIKK signaling 
RuvBL1 and RuvBL2 regulate all PIKK members. PIKKs are serine-
threonine protein kinases that regulate DNA damage responses, nutrient-
dependent signalling and nonsense-mediated mRNA decay (NMD). They 
phosphorylate proteins involved in cell cycle progression, DNA repair, apoptosis 
and cellular senescence12. 
The PIKK family consists of 6 kinases. ATM is responsible for cellular 
response to DNA double strand breaks, by phosphorylating histone variant 
H2AX in response to DNA double strand break caused by environmental stresses 
such as UV light21. ATR phosphorylates histone H2AX in response to accidental 
DSBs caused by metabolic stresses21, and mutations in this protein lead to growth 
retardation and microcephaly. DNA-PKcs is involved in DSB repair by non-
homologous end joining. SMG1 (suppressor with morphological effect on 
genitalia 1) regulates nonsense-mediated decay of aberrant mRNA. mTOR 
(mammalian target of rapamycin) controls cell growth in response to 
environmental cues, mitogenic signals and nutrient availability. TRRAP 
(transformation/transcription domain-associated protein) is a regulator of gene 
expression via association with histone acetyltransferase complexes. All 6 PIKKs 
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require the HSP90 co-chaperone Tel2 (as part of the TTT complex) to associate to 
R2TP, through the PIH1D1 subunit12,114. 
DNA damage response involves the concerted action of sensors, 
transducers and effectors. Sensors detect the damage, and activate PIKKs ATM, 
ATR and DNA-PKcs, which transmit the signal to the effector proteins. In fact, 
more than 900 phosphorylation sites have been identified that contain a 
consensus ATM or ATR phosphorylation motifs, in 700 proteins that are 
phosphorylated in response to ionizing radiation (IR)115.  Depending on the 
severity of the damage, the effector proteins (which include transcription factor 
p53) activate the checkpoints which will arrest the cell cycle and either proceed to 
DNA repair or initiate the pathways which will lead to apoptosis or cell 
senescence. R2TP regulates DNA damage response of ATM, ATR and DNA-PKcs 
by affecting their stability, and by regulation of ATR activity, leading to 
decreased activation of p53114. Knockdown of RuvBL1 or RuvBL2 leads to 
decreased mRNA levels of ATM, ATR, DNA-PKcs, mTOR and TRRAP, but does 
not affect the abundance of other kinases. The RuvBL1/2 complex is also 
responsible for the phosphorylation and activation of direct downstream effectors 
of ATM, ATR, mTOR and SMG1, respectively Chk2, Chk1, p70 S6K and Upf1116, 
and interacts directly with the Fanconi Anemia complex, involved in DNA 
crosslink repair115,117. Human RuvBL2 was also found to be a potential target of 
ATM/ATR, as it includes putative phosphorylation sites118. The RuvBL1/2 
complex further interacts with the URI prefoldin complex through 
Monad/WDR92. The URI complex is involved in nutrient sensing responses 
through regulation of gene responses and cell survival signalling downstream of 
mTOR118. 
Protein kinases function as switches that coordinate the pathways by 
which a given signal transduction pathway is achieved, phosphorylating multiple 
components of particular pathways, sometimes even components of the same 
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multi-protein complex. The human genome encodes 518 kinases, and they are 
critical regulators of signal transduction pathways related to metabolism, 
transcription, cell cycle progression, cytoskeletal rearrangement and cell 
movement, apoptosis and differentiation. In eukaryotes, PIKKs initiate the 
cellular stress response in situations which may compromise genome integrity, 
mRNA translation or nutrient availability119. Overall, DNA damage signalling is 
known to regulate initiation of origins, fork stability, the intra-S phase checkpoint, 
and fork resumption after damage115. 
 
1.2 RUVBL1 AND RUVBL2 IN HIGHER-ORDER 
COMPLEXES 
 
As mentioned above, during transcription, replication and DNA repair, 
chromatin accessibility is dynamically altered by two main classes of chromatin 
remodellers: the first class includes ATP-dependent complexes that mobilize 
nucleosomes and alter accessibility to underlying DNA. The second class includes 
acetylases, deacetylases, methylases and demethylases, responsible for the 
addition or removal of covalent modifications on histone tails, thus altering the 
local compaction state of chromatin. 
RuvBLs are frequently found associated with larger complexes as 
chaperones, or as activity regulators. Notably, the RuvBL1/2 complex is part of 
the R2TP complex, and is essential for INO80 complex activity due to its role in 
the incorporation of actin-related protein 5 (Arp5). Yeast RuvBLs also increase the 
stability of TIP60 complex, by increasing its histone acetyltransferase activity in 
vitro and protecting the catalytic subunit, Tip60, from heat inactivation. RuvBLs 
further contribute to TIP60 complex activation by preventing its p400-mediated 
inhibition, a role achieved through the interaction of RuvBLs with the SNF2 
domain of p400120.  
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 This section focuses on relevant RuvBL-containing complexes known to 
date. RuvBLs are commonly found associated with chromatin remodelling 
complexes, which highlights their importance at the transcription regulation level 
in various cellular settings, from development to disease and metabolic response 
to nutrient availability. 
 
R2TP and snoRNPs 
The R2TP complex, highly conserved among eukaryotes, together with 
its co-chaperone HSP90, is involved in the biogenesis of small nucleolar 
ribonucleoprotein (snoRNP, required for biogenesis of ribosomal, small nuclear 
and transfer RNA) and pre-ribosomal RNA processing, and plays crucial roles in 
apoptosis, PIKK signalling and RNA polymerase I, II and III assembly (Fig. 1.9). 
R2TP-HSP90 complex also takes part in the assembly of ribonucleoprotein 
particles, such as Telomerase and spliceosomal U4 snRNA. 
 
 
Figure 1.9 - R2TP complex functions. Adapted from116. 
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The human/yeast R2TP complex comprises RuvBL1/Rvb1, RuvBL2/Rvb2, 
RPAP3/Tah1/Spag and PIH1D1/Pih1, of which PIH1D1 targets R2TP to dyskerin 
(a central module in box H/ACA snoRNP), Rpb1 (a core subunit of RNA 
polymerase II) and Tel2 (a core subunit of the Tel2:Tti1:Tti2 complex, which is a 
central regulator of PIKK abundance and DNA damage response signalling 
pathways). The structure of the yeast homologue of R2TP has been recently 
determined by cryo-EM (Fig. 1.10)121. It shows that the complex is composed of 
one heterohexamer of RuvBL1/RuvBL2, with one Tah1p-Pih1p (RPAP3-PIH1D1) 
copy sitting at the bottom of the complex, bound to multiple DII domains. RPAP3 
is the interaction bridge with the ubiquitous molecular chaperone HSP90, 
forming a complex essential in the assembly of box C/D snoRNPs53,114,116,122–124. The 
cryo-EM structure provides insights into the general mode of interaction between 
the RuvBL1-RuvBL2 and the Tah1-Pih1 subcomplexes. However, additional 
crystallographic information still needs to be gathered, so that the specific 
interactions of each complex can be characterised. Only then can some 
understanding be derived into the function and mode of regulation of each 
protein. 
 RuvBL2 binding to ATP, ADP and ATPS (but not hydrolysis) led to 
R2TP disassembly and abolished binding to Nop58, a subunit of C/D snoRNPs. 
Since Walker A/B motifs were shown to be crucial for C/D snoRNPs, ATPase 
activity may play a role at a different stage of snoRNP assembly. RuvBL1/2 makes 
ATP-dependent contacts with R2TP components and box C/D core proteins, in an 
intermediary step during box C/D snoRNP assembly: they bind 15.5K when 
loaded with ATP and PIH1D1/RPAP3 otherwise. This intermediary assembly 
complex is further composed and stabilized by NOP58, NUFIP, ZNHIT3 and 
ZNHIT6 (BCD1), of which the latter also has ATP-dependent interactions with 
RuvBL1/2. Interestingly, many HIT-proteins seem to be specific interactors of 
RuvBL1/2, although some of these interactions are still to be characterized125.  
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Point mutations in Walker A/B of yeast RuvBL2 led to temperature-
sensitive or lethal phenotypes. RuvBL2 depletion and mutation analyses revealed 
a crucial role in both C/D and H/ACA snoRNA accumulation, and depletion 
caused core subunits of each snoRNP family to accumulate in the nucleoplasm55. 
Finally, in situations of poor nutrient availability, R2TP is relocalized into the 
cytoplasm, decreasing interaction with snoRNP and consequently affecting pre- 
rRNA maturation57. 
 
RNA polymerase holoenzyme assembly 
There are three different RNA polymerases in eukaryotic cells: RNA pol I, 
which produces ribosomal RNA; RNA pol II, responsible for transcription of 
small nuclear RNAs and messenger RNAs; and RNA pol III, which synthetizes a 
range of small RNAs, including tRNAs. RNA pol II consists of 12 subunits, of 
which Rpb1 and Rpb2 form the active cleft. 
R2TP and HSP90 together with the prefoldin-like complex, are involved 
in assembly of RNA polymerase II in the cytoplasm and subsequent transport to 
 
Figure 1.10 – Structure of the yeast R2TP complex. Left: cryo-EM volume. For the 
RuvBL complex, the ATPase core is depicted in grey, and the DII domains are depicted in pink. 
The Tah1p-Pih1p complex is depicted in yellow. Right:  Schematic representation of the R2TP 
complex and a possible mode of interaction with Hsp90 and Tel2p. Adapted from121. 
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the nucleus. Intermediate steps in the assembly of RNA pol II include interaction 
of HSP90 and its co-chaperone RPAP3/hSpagh/Tah1 with RNA pol II subunits 
Rpb1 (the largest RNA pol II subunit) and Rpb8. RPAP3, also interacts with the  
large subunits of RNA polymerases I and III, which suggests it may have a part in 
their assembly as well114,126 (Fig. 1.9). The same interactions have been 
demonstrated in Drosophila as for yeast. In conclusion, R2TP is involved in the 
assembly of snoRNPs and all three RNA polymerases, and is thus deeply 
involved in the assembly of the machineries that produce tRNAs, mRNAs and 
ribosomes127.  
 
INO80, SRCAP/SWR1 and p400 
INO80 and SRCAP (Snf2-related CREBBP activator protein complex, 
known as Swi/Snf2-related [SWR1] in yeast) both belong to the Swi/Snf2-related 
INO80 family. The INO80 complex works with other complexes to remodel 
chromatin at the promoter sites and sites of DNA double strand break (DSB), 
increasing accessibility to the DNA strand, by promoting sliding, positioning and 
eviction of nucleosomes, allowing the efficient recruitment of DNA transcription 
and repair machinery. In yeast, it was observed that after phosphorylation of 
H2A, histones H2B and H3 were lost, in a process that depended on INO80 ATP-
dependent nucleosome sliding activity. This process rendered chromatin sensitive 
to nuclease activity, and allowed recruitment of RAD51 to DSBs128.  
INO80 promotes both efficient progression and stabilization of the 
replication fork, as well as resumption of DNA synthesis under replication stress 
conditions, increasing tolerance to DNA damage. This complex is also involved in 
telomere maintenance, centrosome stability and chromosome segregation. The 
mechanisms of action involve eviction of H2AZ histone variant in favour of the 
canonical H2A, particularly at non-promoter sites. SRCAP catalyses the inverse 
reaction, depositing the H2AZ-H2B dimer in exchange for H2A-H2B129. Thus, 
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while sharing many similarities in subunit composition (Table 1.2), INO80 and 
SRCAP have opposing catalytic activities, and together contribute to H2A.Z 
genomic distribution. Besides the exchange activity shared with SRCAP, the 
INO80 complex is additionally able to mobilise other nucleosomes, regulating 
access to DNA, and thus contributing to transcription regulation of a large 
number of genes whose promoters are dependent on the Ino80 subunit (though 
not on RuvBL1 or RuvBL2)8,12,41,130–132. To sum up, INO80 and SRCAP seem to 
work together to exchange γH2AX and H2AZ with free H2AX, thus dynamically 
renewing the substrates for phosphorylation and DNA repair responses23. 
 
Table 1.2 – Subunit composition of INO80 and SRCAP. From133. 
Subunit 
type 
INO80 complex SWR1 (yeast) and SRCAP 
(human) complexes 
  Saccharomyces 
cerevisiae 
Homo 
sapiens 
Drosophila 
melanogaster 
Saccharomyces 
cerevisiae 
Homo 
sapiens 
ATPase Ino80 INO80 INO80 Swr1 SRCAP 
RuvB-like Rvb1 and Rvb2 RUVBL1 and 
RUVBL2 
Reptin and 
Pontin 
Rvb1 and Rvb2 RUVBL1 
and 
RUVBL2 
Actin Act1 β-Actin Actin Act1 β-Actin 
Actin-
related 
protein 
Arp4, Arp5 and 
Arp8 
BAF53A, 
ARP5 and 
ARP8 
ARP5 and ARP8 Arp4 and Arp6 BAF53A 
and ARP6 
YEATS 
protein 
Taf14 Not known Not known Yaf9 GAS41 
Non-
conserved 
subunits* 
Ies1, Ies2, Ies3, 
Ies4, Ies5, Ies6 
and Nhp10 
Amida, 
CCDC95, 
FLJ20309, 
IES2, IES6, 
MCRS1, 
NFRKB, 
UCH37 and 
YY1 
Pleiohomeotic Bdf1, Swc2, 
Swc3, Swc4, 
Swc5, Swc6 and 
Swc7 
DMAP1, 
GAS41, 
tubulin, 
XPG, YL1 
and ZnF-
HIT1 
*Subunits in all other rows of this table are conserved. Act, actin; Arp, actin-related protein; 
BAF53A, BRG1-associated factor 53A; Bdf1, bromodomain factor; CCDC95, coiled-coil domain-
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containing 95; DMAP1, DNA methyltransferase 1-associated protein 1; GAS41, glioma amplified 
sequence 41; Ies, INO80 subunit; MCRS1, microspherule protein 1; NFRKB, nuclear factor related 
to B-binding protein; Nhp10, non-histone protein 10; Rvb, RuvB-like; RUVBL, RuvB-like; 
SRCAP, SNF2-related CBP activator protein; Swc, SWR1 complex; Taf14, TBP-associated factor 14; 
UCH37, ubiquitin C-terminal hydrolase 37; XPG, xeroderma pigmentosa group G; Yaf9, yeast AF9; 
YEATS, Yaf9, ENL, AF9, Taf14, Sas5; YY1, yin yang 1; Znf-HIT1, zinc finger-His triad protein 1. 
 
In each complex, the catalytic subunit that engages the nucleosomes is 
either the Ino80 or the Swr1 ATPase. In the SWR1 complex the RuvBL1/2 
subcomplex has a scaffolding function, assembling all functional subcomplexes in 
an ATP-dependent manner, where the insertion domains of RuvBLs (domain II) 
face the core of the SWR1 complex. Despite this orientation, observed by electron 
microscopy, crosslinking was found between residues of the ATPase core domain 
of the RuvBL complex and the Swr1, Swc2 and Arp4 subunits (Fig. 1.11). This 
observation, together with the fact that the complex is composed of a discrete 
assembly of functional modules, suggests some flexibility within the complex. 
This led to the suggestion (supported by EM structures that also show high 
 
 
 
Figure 1.11 – Cryo-EM structure of the SWR1 complex. The RuvBL1/2 hexamer is located at the 
bottom, and seems to interact through the domain II arms, forming a scaffold (A). B) diagram 
representation of the subunits in the complex. From134 
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flexibility of RuvBL1/2 complexes), that potential substrate- or nucleotide-
dependent conformational changes of Swr1 or RuvBL1/2 could form the basis for 
histone dimer exchange activity9. 
In INO80, the RuvBL1/2 has been observed to be present as a 
dodecameric double ring, located at the periphery of the elongated complex (Fig. 
1.12), although some doubts remain as to the interpretation of the EM envelope, 
and the possibility remains that it may be a hexamer135. RuvBLs are essential for 
the complete assembly of the INO80 complex and, as in the SWR1 complex, are 
responsible for the recruitment of the catalytic Swr1-like subunit Ino80, through 
subunit Arp512,84. Cross-linking coupled to mass spectrometry supports a ring 
structure composed of alternating RuvBL1 and RuvBL2 monomers, as observed 
in the existing RuvBL1/2 crystallographic structures46,84,85.  Recent results suggest 
that the RuvBL1/2 complex may have a chaperoning function during the 
assembly of INO80: binding of an insert of the subunit Ino80 to a RuvBL1/2 
hexamer leads to dodecamer formation, and maintains the natural conformational 
flexibility of the DII domains. Subsequent RuvBL1/2 binding to ATP leads to 
dodecamer disassembly, which is thought to be the final step in the cycle135.  
SRCAP/SWR1 and INO80, and consequently RuvBL1 and RuvBL2, are 
involved in the regulation of chromatin mobility and association of DNA damage 
with perinuclear sites. These two chromatin remodellers are also relevant for 
 
Figure 1.12 – Cryo-EM structure of the INO80 complex (A). The RuvBL1/2 dodecamer sits at 
the head of the complex (B). From46. 
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chromatin dynamics in terms of nucleosome composition, chromatin compaction 
and the precise locus position within the nuclear sphere. In summary, despite 
their many similarities in subunit composition, while SRCAP has been shown to 
incorporate the H2A.Z variant into nucleosomes, INO80 evicts unacetylated 
H2A.Z shortly after its incorporation at damaged sites136, and also remodels, 
spaces or removes entire nucleosomes. 
An additional role for the INO80 complex is the interaction with the 
Cdc48 component of the Ubiquitin Proteasome System, during the degradation of 
RNA Polymerase II, as a result of genotoxic effects and stalling. It is also 
suggested that INO80 promotes the removal of ubiquitinated Rpb1 (the largest 
subunit of RNA pol II) from chromatin, thus keeping genome integrity137. 
 
TRRAP-TIP60 histone acetyltransferase 
TIP60 (human nomenclature, homologous to yeast NuA4 [nucleosome 
acetyltransferase of histone 4], which does not possess RuvBLs) is a histone 
acetyltransferase (HAT), which means that it remodels chromatin by transferring 
an acetyl group to histones, therefore converting chromatin into the more relaxed 
and accessible euchromatin (thus rendering the DNA transcriptionally active). 
Like other Arp4-containing complexes (INO80 and SWR1), NuA4 is recruited by 
γH2AX8. This complex has also been shown to acetylate ATM protein kinase after 
DNA damage, thus activating ATM. TIP60 shares some subunits with the SWR1 
complex and others with the NuA4 complex, suggesting that TIP60 may be a 
fusion of these two complexes12. 
The acetyl-transferase activity of TIP60 is essential for accumulation of 
repair machinery at the site of DNA damage and removal of H2AX from 
chromatin12. In fact, histone acetylation (H3K56Ac) promotes deposition of the 
SRCAP/SWR1 complex, and consequent nucleosome exchange129,138,139, increasing 
chromatin dynamics140. HAT activity of TIP60 is also required for H4 acetylation 
Introduction 
 45 
prior to phosphor-H2AX remodelling and dephosphorylation, during DNA 
damage response12. Interestingly, in mammalian cells exposed to ionizing 
radiation, it was shown that RuvBL1 silencing led to a 50% decrease in RAD51 
foci formation, which was shown to be caused by impaired TRRAP-TIP60 
function. INO80 and SRCAP/SWR1 activities did not seem to be affected, nor did 
the DNA damage signalling cascade effected by PIKKs, since the number of γ-
H2AX foci was the same in RuvBL1-silenced and control cells141. Recently, the 
group of Claire Davies (2017) demonstrated that RuvBL1 is methylated by the 
PRMT5 arginine methyltransferase. This is shown to be critical for the 
acetyltransferase activity of TIP60, and leads to H4K16 acetylation. This facilitates 
53BP1 displacement from DSBs, thus regulating homologous recombination142. 
The TIP60 complex is mostly found associated with genes that have 
increased expression levels, where RNA Polymerase II is co-localized143. TIP60 is 
also responsible for p53 acetylation, necessary for its binding to promoters of pro-
apoptotic genes12. 
The TRRAP protein associates with several histone acetyltransferase 
complexes, such as SAGA, GCN5, PCAF and TIP60, working as a scaffold in their 
assembly, and as an intermediary for their regulation. Transcription regulator c-
MYC binds to TRRAP in the HAT complexes, and induces acetylation of histones 
in target genes, in response to mitogenic signals. ChIP assays show that c-MYC 
recruits at least five subunits of this complex: TIP60, TRRAP, p400, BAF53, actin, 
RuvBL1 and RuvBL2103,144. The TIP60 complex is co-bound at about 50-60% of 
Myc/Max binding sites in mouse embryonic stem cells, and this seems to be 
directly involved in regulating the c-Myc-dependent transcriptional network143. 
The activity of the mammalian TIP60 complex seems to be a combination 
of the activities of yeast NuA4 and SWR1 chromatin remodelling complexes. In 
fact, a heterogeneous population of TIP60 complexes has been found to date, 
suggesting a dynamic assembly, with a few varying subunits, among them 
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p400143. Like the human protein SRCAP, p400 is a human homologue of yeast 
Swr1 that is found in the human TIP60 complex and which also promotes the 
H2A.Z exchange into the promoter regions of p53 target genes. However, p400 
and SRCAP seem to be mutually exclusive, and are usually found in different 
chromatin regions during specific cellular processes52, suggesting a plasticity in 
complex formation according to the needs of the cell. 
RuvBL1 and RuvBL2 are common subunits of the TIP60 and SRCAP/p400 
complexes, and were found in both small and large versions of the latter. The 
RuvBL1/2 complex was interestingly found to have the catalytic activity 
responsible for the H2A to H2A.Z exchange capabilities of the small SRCAP/p400 
complex. This did not apply to the incorporation of H2A or H2A.X, suggesting 
H2A.Z-specific activity of the RuvBL1/2 complex. The mechanisms are as yet 
unknown, but these findings suggest yet another function for RuvBL complexes, 
in the targeted incorporation of H2A.Z histone variants, namely in the p21 
promoter, at the p53 response element52 (Fig. 1.13). 
 
Figure 1.13 – Part of the Homo sapiens p53 signalling pathway. Based on the KEGG pathway 
database145.  
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Interaction with Yin Yang 1 
Yin Yang 1 (YY1) is a transcription factor belonging to the Polycomb 
group which regulates a myriad of important cellular events. López-Perrote and 
colleagues found that the RuvBL1/2 complex interacts with YY1 during DNA 
damage repair, and that this interaction is important for the formation of Rad51 
filaments foci, during homologous recombination. YY1 were shown to interact 
preferentially with RuvBL1, and Rad51 foci formation was shown to be 
dependent on RuvBL2 ATPase activity146. 
  
1.3 RUVBLS IN DEVELOPMENT AND DISEASE 
 
RuvBLs have been associated with several diseases, although little is still 
known about their mechanisms of action and regulation. The group of Bernhard 
Schermer has identified both proteins as interactors of NPHP1, a protein involved 
in the pathogenesis of nephronophthisis (cystic kidney disease), and of other 
ciliopathy proteins. Depletion of RuvBL1 in kidney tubular epithelial cells of a 
mouse model led to perinatal mortality due to severe cystic kidney disease, 
supporting their role in the molecular pathogenesis of cystic kidney disease and 
related ciliopathies97. In the zebrafish model, a mutation leading to RuvBL2 loss of 
function leads to kidney cyst formation and ventral body curvature, two 
phenotypes related to ciliary defects, and lead to Primary (genetic) Ciliary 
Dyskinesia. Further investigation showed that RuvBL2 interacts with cilia-related 
genes, and is essential for normal ciliary functions147. Curiously, ruvbl2 
transcription is up-regulated in Chlamydomonas during flagellum regeneration148. 
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1.3.1 DEVELOPMENT 
 
RuvBLs are intimately linked to developmental processes, and their 
importance is felt at the onset of foetal development, as demonstrated by the fact 
that RuvBL1 and RuvBL2 null mice mutants are not viable. In fact, RuvBLs are 
essential for viability in all organisms analysed to date, including Drosophila 
melanogaster6 and Caenorhabditis elegans. In zebrafish and Xenopus, knockdown 
with antisense morpholino oligonucleotides led to embryonic lethality149. Dutta 
and colleagues have also demonstrated that the ATPase activities of RuvBL1 and 
RuvBL2 were equally and independently essential for viability in Saccharomyces 
cerevisiae76; furthermore, a RuvBL1 plasmid could not rescue a RuvBL2-defficient 
strain of S. cerevisiae, further supporting that the two genes have non-redundant 
functions7. In early embryonic development, RuvBL2 interacts with Oct4, a key 
regulator for the development of the inner cell mass and for the self-renewal of 
embryonic stem cells (ESCs), to regulate pluripotency in ESCs and iPSCs (induced 
pluripotent stem cells)150,151. 
Gain-of-function studies in Xenopus show that xRuvBL1 and xRuvBL2 
overexpression lead to increased cell proliferation, and consequent convexity at 
the injection site. Contrariwise, knockdown led to reduced mitoses. Further 
studies showed that xRuvBL1 and xRuvBL2 act through interaction with c-
Myc/Miz-1 to control cell proliferation during development. More specifically, the 
N-termini of both RuvBLs were shown to be essential for interaction with c-Myc, 
p21 repression and mitogenic function149. 
In zebrafish embryos, RuvBL1 and RuvBL2 were found to have 
antagonistic roles in heart development, and a reduction in RuvBL1 leads to heart 
hyperplasia. Concordantly, the liebeskummer (lik) mutation in RuvBL2, which 
increases its ATPase activity and renders it DNA-independent, has the same 
effect. This mutation (which consists of an insertion of the amino acid residues 
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Phe, Cys and Arg within the OB fold) enhances the repressing function of the β-
catenin/TCF-dependent siamois promoter. Thus, the balance of RuvBL1 and 
RuvBL2 regulates cardiac (and gut) growth in the early embryo98,152. 
Some parasites such as Plasmodium vivax, P. falciparum, P. knowlesi, 
Trypanosoma cruzi and Schistosoma mansoni possess 3 RuvB-Like proteins. In the 
case of P. falciparum, a phylogenetic analysis revealed that pfRuvBL1 and 
pfRuvBL2 share more similarities to human and yeast RuvBL1, while pfRuvBL3 
was more similar to RuvBL2153. It is interesting to note this apparent exclusivity to 
human parasites. In the case of P. falciparum, RuvBL2 and 3 seem to interact at the 
intraerythrocytic mitosis, serving only to increase appreciably the helicase activity 
of RuvBL2154. 
 
1.3.2 CANCER 
 
It is clear at this point that chromatin remodellers play a vital role in 
maintaining the integrity of the genome. 
RuvBL2 overexpression has been found to be a marker of poor prognosis, 
and it was found to be overexpressed in hepatocellular carcinoma (HCC, both 
RuvBL1 and RuvBL2), stomach, kidney, colon cancer, melanoma and bladder 
carcinoma, and involved in others. In HCC cells, RuvBL2 overexpression was not 
associated with changes in sequence in the cases analysed, and led to an increased 
presence in the cytoplasm. Silencing RuvBL2 in these cells led to an increase in 
the expression of several pro-apoptotic genes and reduced cell growth155. More 
recently, it was found that in HCC, RuvBL2 silencing led to a decrease in H2AX 
phosphorylation, in parallel with a decrease in protein expression of ATM and 
DNA-PKcs kinases (the major H2AX kinases), as well as a decrease in the number 
of BRCA1 and 53BP1 foci. It is suggested that RuvBL2 overexpression in HCC 
may be a factor of resistance to treatment, as it has been observed in subgroups 
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of chemo-resistant breast and ovarian cancers94. Later, it was determined that 
depletion of RuvBL1 led to similar effects, and in fact, the stability of one 
depended on the presence of the other, supporting a collaborative role, probably 
at the level of protein translation, when heteromers may likely be formed. 
Interestingly, these effects were observed in other cell types and species, 
suggesting that RuvBL1/2 co-depletion may be widespread93. 
In E2f-dependent HCC, the E2f1 transcription factor recruits the 
RuvBL1/2 complex to E2f1 target genes, enhancing the transcriptional response. It 
is suggested that the mechanism involved relies on the ability of RuvBL1/2 
complex to exchange H2A/H2AZ by itself52,156. 
Additionally, RuvBL1 has been identified as a key modulator of apoptosis 
and oncogenesis through c-MYC and E2f1 interactions157, and was also shown to 
have a role in neoplastic transformation mediated by β-catenin (inhibition of 
RuvBL1 was linked to inhibition of histone acetylation of β-catenin target genes, 
which in turn led to an arrest in expression of β-catenin/TCF (T-cell factor) target 
genes)158. RuvBL2 was found to have an antagonistic activity6. In colon cancer 
cells that contain wild type p53, overexpression of EHF transcription factor leads 
to RuvBL1 upregulation, with a concomitant repression of p53 and consequent 
repression of apoptosis159. 
RuvBL2 silencing also proved to have an anti-proliferative effect in cells 
from gastric and kidney cancer (RCC). In RCC, in fact, RuvBL2 displayed a 
behaviour similar to that in HCC, and further promoted cell migration and 
invasion, with RuvBL2 depletion leading to the same physiological effects as in 
HCC160. In gastric cancer cells, RuvBL2 was found to have a dual role in the 
transcription of htert gene: the RuvBL2/c-MYC complex-dependent association to 
the promoter, and regulation of hTERT mRNA, which decreased with silencing of 
both RuvBL1 and RuvBL2. Targeting of RuvBL2 is thus suggested as a 
therapeutic means to regulate Telomerase161. In colon cancer cells, RuvBL2 was 
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also found to be essential for hTERT full transcriptional activation, but dependent 
on the growth factor EGF162. In mammary HC11 cells, RuvBL1 and RuvBL2 were 
able to increase the oncogenic effect of c-MYC, by increasing its ability to repress 
the C/EBPδ promoter, an effect which was further increased when both proteins 
were coexpressed163. In HEK 293 cells, RuvBL1 was found to interact directly with 
c-MYC, through the MBII domain of the latter and the domain II of the former7. 
RuvBL2 was further found to act independently of the p53 pathway, by 
repressing the ARF (alternate reading frame, p14) tumour suppressor164. In 
paediatric acute myeloid leukaemia, chromosomal translocations frequently 
originate the fusion gene MLL-AF9. In immortalized human cord blood-derived 
hematopoietic progenitor cells, this led to an increased expression of RuvBL2, on 
which the cells depended for proliferation and survival165. In neuroblastoma cells, 
drug-induced apoptosis was shown to occur in a RuvBL2-dependent way. The 
end result was accumulation of acetylated H3, cell cycle arrest in G2/M phase and 
 
Figure 1.14 – RuvBL1 (Pontin) and RuvBL2 (Reptin) work antagonistically to regulate expression 
of anti-metastatic protein KAI1. From61.  
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activation of 
apoptosis cell signalling pathways166.  
 In prostate cancer cells, a subpopulation of RuvBL2 is SUMOylated, 
which results in its recruitment to the nucleus (Fig. 1.14). There, it forms a 
complex with the Wnt-signalling component β-catenin which represses the 
expression of anti-metastatic gene KAI1. This repressing function is abrogated 
with de-SUMOylation of RuvBL2, as well as by the expression of K456R mutant, 
which precludes SUMO-binding, and thus prevents nuclear re-localization. 
Hence, RuvBL2 SUMOylation seems to be an active control mechanism for the 
transcriptional repressive function of RuvBL2, by recruiting it to the nucleus. It 
follows that levels of Ubc9 and SENP1, the proteins responsible for RuvBL2 
SUMOylation, seem to affect the KAI1-mediated metastatic potential, at least 
partly by altering the SUMOylation state of RuvBL2. De-SUMOylation of RuvBL2 
in turn leads to recruitment of coactivator Tip60 to the promoter, activating the 
expression of KAI1. RuvBL1, as part of the TIP60 complex, acetylates histones at 
the promoter of the KAI1 gene, leading to KAI1 expression. It is thus suggested 
that RuvBL2 SUMOylation state may affect binding affinity of proteins for 
promoters12,60,167. 
 
1.3.3 HYPOXIA 
 
Hypoxia is a common feature in solid tumours due to decreased 
vasculature formation and deficient oxygen perfusion. Hypoxic cells have thus 
developed adaptations to hypoxic microenvironments, through expression of 
hypoxia-inducible transcription factor (HIF)-dependent genes. In particular, 
when under low oxygen concentrations, the oxygen-sensitive HIF-1α subunit is 
stabilised and binds to oxygen-insensitive HIF-1β subunit. The HIF-1αβ 
heterodimer then binds to hypoxia-responsive elements located in enhancer 
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regions, activating the transcription of target genes involved in metabolic 
pathways responsible for increasing adaptation to microaerobic environments, 
chemotherapeutic resistance, genomic instability, cell proliferation and 
metastasis4,168,169 (Fig. 1.15). 
Besides low oxygen levels, other factors may modulate HIF-1 activity, 
such as the presence of other oncogenes and tumour suppressors169. RuvBL1 and 
RuvBL2 have both been identified as two such factors, where RuvBL2 acts as a 
repressor of transcription and RuvBL1 as a co-activator, an example of the 
antagonistic roles played by these homologs. 
During hypoxia, RuvBL1 is methylated by G9a and GLP 
methyltransferases, which promotes the formation of a complex with p300 and 
HIF-1α. Concomitantly, binding of HIF-1αβ complex to the promoter is 
hyperactivated, increasing the expression levels of proteins involved in cell 
survival and proliferation, tumour growth and invasive properties, such as Ets1 
(ETS proto-oncogene 1, a transcription factor involved in stem cell development, 
cell senescence and death and tumorigenesis), KDM4B lysine demethylase and 
 
 
Figure 1.15 - Part of the Homo sapiens HIF-1 signalling pathway. From the KEGG pathway 
database145. 
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IGFBP3 (insulin growth factor binding protein 3)4. RuvBL1 methylation is 
dynamic, and reversed as soon as cells return to normoxic levels.  
RuvBL2 negatively regulates expression of HIF-1 target genes involved in 
metabolism, cell death and survival. The mechanism involved relies on the 
association of RuvBL2 with HIF-1α in hypoxic conditions, in a methylation 
dependent manner: under hypoxic conditions, Lys67 of RuvBL2 is methylated by 
G9a methyltransferase, which leads to increased binding to HIF-1α, negatively 
regulating expression of hypoxia target genes VEGF (Vascular Endothelial 
Growth Factor), PGK1 (Phosphoglycerate Kinase 1) and BNIP3 (BCL2 interacting 
Protein 3). In vitro results show that substitution with a RuvBL2 K67A mutant 
abolished this effect, and supported an interaction with a methylated K67-
containing peptide. The RuvBL2-HIF-1α complex binds to promoters 
concomitantly with a decrease in RNAseII recruitment. Reptin methylation thus 
accounts for a negative feedback loop, fine-tuning the expression of a subset of 
hypoxia target genes. At the cell level, RuvBL2 methylation led to a significant 
reduction in motility of a breast cancer cell line, implying it is involved in 
inhibition of cell migration. Knockdown of RuvBL2 or expression of a K67A 
mutant in the same cells under hypoxic conditions also led to a 2-fold increase in 
migratory potential, whereas expression of WT RuvBL2 reduced invasion. These 
results were recapitulated in a mouse model, and suggest that RuvBL2 hypoxia-
induced methylation may affect tumour growth and invasive properties by 
inhibition of genes such as VEGF5. 
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INTRODUCTION TO SSDNA-BINDING PROTEINS 
 
In order to copy or repair DNA strand breaks, the double helix must be 
opened to expose the two complementary strands. The need to process single 
stranded DNA (ssDNA) led to the onset of a specialized group of proteins. To 
understand how they act, and to be able to predict whether a protein may bind ss 
or dsDNA, the characteristics of the DNA substrate must be known. The single 
DNA strand is composed of repeating nucleotide units. Each nucleotide is in turn 
composed of a phosphate backbone, a sugar and a nucleoside base. ssDNA-binding 
proteins (SSBPs) make use of all of these features to recognise and bind to ssDNA. 
Since one of the non-bridging oxygens in each phosphate group is negatively 
charged, the DNA single strand can be considered a negatively charged polymer, 
with positive charges from some exposed bases. Thus, SSBPs frequently line their 
DNA-binding surfaces with the positively charged amino acid residues Lysine and 
Arginine1. In fact, since negative charges attract proteins, and the dsDNA is 
composed of two strands bound via the bases, such that the phosphate backbones 
protrude outwards, most DNA in the cell is associated with proteins, such as 
histones 2.  
SSBPs are known to form electrostatic interactions via the positively-
charged guanidinium group of their arginine residues with the negatively charged 
delocalised -cloud of the aromatic nucleoside base. SSBPs can also make stacking 
interactions between the aromatic planar side chains of tyrosine and phenylalanine 
residues and the planar nucleoside bases in ssDNA. This additional strategy 
provides an alternative binding surface that can be used in conjunction with 
binding to the backbone phosphodiester group. SSBPs may further interact in a 
non-sequence specific way with the ssDNA via hydrogen bonds from the amino 
acid side chains, or even the amide or carbonyl groups. More rarely, the sugar 
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moiety is also sometimes involved in interactions with SSBPs. DNA and RNA 
sugar groups differ by an extra 2’ hydroxyl group in the sugar rings of the RNA 
bases. This allows for steric exclusion of 2’ hydroxyls in ssDNA-binding proteins, 
or affinity adjustment in proteins that can bind both, but make use of the 2' 
hydroxyl group to increase their affinity towards RNA1. The single DNA strand is 
much more labile and susceptible to chemical and nucleolytic attacks than dsDNA, 
and many SSBPs have been identified as part of larger complexes with other 
genome maintenance proteins. These facts suggest that DNA metabolic processes 
are likely to occur upon a ssDNA/SSB nucleoprotein filament, instead of on naked 
ssDNA3. 
One of the main features that allows surface recognition of ds vs. ssDNA 
is their flexibility: dsDNA is constrained by base pairing, which promotes the 
formation of a double helix with a rigid spacing of 0.34 nm between each 
phosphate, and 10 base pairs per turn (in B-from DNA). On the other hand, in 
ssDNA the internucleotide spacing can vary quite widely1. 
The OB-fold, so named after its initially identified 
oligonucleotide/oligosaccharide binding properties, is commonly found in SSBPs. 
According to the SCOP (Structural Classification of Proteins) database, the OB-fold 
is present in sixteen different superfamilies. This fold consists of two three-
stranded, anti-parallel β-sheets, with an α-helix frequently found packed between 
strands 3 and 4, forming a cleft. Despite their rather constant ‘Greek key’ structure 
and ubiquity, the primary sequence of the OB-fold is not well conserved in SSBPs, 
and varies between 70 and 150 amino acids. The tertiary structure can vary quite 
widely in the length of each element, particularly in loop length. OB-folds are 
frequently found as recognition domains in larger macromolecular complexes. 
Although the majority of OB-folds is related to ssDNA recognition, they have also 
been described at the interface of protein-protein interactions3,4. Finally, the 
association constant of an individual OB-fold for ssDNA is relatively low (around 
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105-106 M-1s-1), but their modular nature allows them to work together in order to 
raise the affinity1. 
SSBPs do not unwind dsDNA. Rather, they bind and stabilise the single 
DNA strand as it is produced by the action of a helicase, ssDNA bubbles or 
transiently available 5’ or 3’ ends. Their function is to protect the exposed single 
DNA strand prior to the action of the subsequent enzyme in the pathway, which 
may be a DNA polymerase or another protein involved in DNA recombination and 
repair1. 
The primary sequence of RuvBL2 provides some clues as to its helicase 
nature, namely by its sequence similarity to bacterial RuvB helicase. Furthermore, 
it has been described to bind ssDNA and unwind upstream duplexes in vitro, under 
two conditions: that the protein should be in the monomeric state at the onset of 
activity5; and that the DNA single stranded portion should be at least 30 
nucleotides long5. ATP hydrolysis was found to increase in the presence of DNA, 
and helicase activity was shown to be dependent on the presence of ATP, 
suggesting that ATP binding is at least necessary for this processive activity to 
occur5. Since ATP binding should only occur when at least two monomers associate 
to form a dimer – and thus a complete nucleotide binding pocket, with the addition 
of the trans-arginine finger, this suggests that DNA single strands may act as 
scaffolds for RuvBL2 oligomerization. Interaction with histone tails has also been 
shown to promote formation of RuvBL2 rings. Although DNA-binding and 
helicase activities have also been reported for RuvBL1, they are not as well 
described as for RuvBL26–9. However, while RuvBL2 has 3’  5’ processivity, 
RuvBL1 has occasionally been described to work in the opposite direction, 
although few advances have been made to establish the details of RuvBL1 helicase 
activity7. However, the notion that DNA processivity increases for the heteromeric 
complex, suggesting a synergistic or complementary mode of action, appears to be 
consensual6,9. The ablation of domain 2 from both the individual proteins and the 
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RuvBL1/RuvBL2 complex also greatly increases ATPase and helicase activities, 
hinting at a regulatory function for this domain6. Interestingly, some groups have 
shown that, in the RuvBL1/RuvBL2 dodecameric complex (which occurs naturally 
when expressed without the use of tags), not only do the rings interact through the 
domains 2, but they do so in a flexible way. As such, two conformations were 
observed: a compact one, in which the external regions of the D2 domains are 
intimately connected, and an extended one, in which these domains rotate and 
stretch, pushing the rings apart, and putatively exposing the DNA-binding region 
of domain 2 (see table 3.1)10. 
 
2.1 hsRuvBL2 stability, oligomerization and DNA 
binding  
 
2.1.1 METHODS   
 
   Protein expression and purification  
 
The codon-optimized sequence of hsRuvBL2 with a C-terminus-His6 tag 
including a 3C protease cleavage site was obtained from Genscript. The vector 
pET49b_ruvbl2_Cter_His was transformed into E. coli B834 and gene expression was 
induced by the addition of 100 µM IPTG at 30°C for 19 h. The dry cells were 
resuspended in lysis buffer (50 mM phosphate buffer pH 7, 500 mM NaCl, 50 mM 
imidazole, 100 µM ADP, 1 mM MgCl2) supplemented with EDTA-free protease 
inhibitor tablet (Roche) and benzonase (Novagen), thoroughly homogenised using 
an ULTRA-TURRAX (IKA T18 basic) and passed twice through a Z basic cell 
disruptor (Constant Systems) at 15000 psi. The cell lysate was separated by 
centrifugation at 35000 g for 35 min, filtered through a 0.22 µm filter, injected 
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through a 5 mL HisTrap HP column (GE Healthcare) and eluted with a gradient of 
buffer B (50 mM phosphate buffer pH 7, 500 mM NaCl, 1 M imidazole, 100 µM 
ADP). Fractions containing hsRuvBL2 were pooled and desalted to remove 
imidazole by exchanging into a buffer containing 50 mM Na/KPO4 pH 7.0, 500 mM 
NaCl, 100 µM ADP and 1 mM MgCl2. A fraction of tagged hsRuvBL2 was kept 
aside at this point, for analyses of the tagged form of hsRuvBL2. The remaining 
fraction was incubated overnight at 4°C with HRV3C protease in a 1:100 ratio. The 
mix of untagged hsRuvBL2, free tags, uncleaved hsRuvBL2 and 3C protease was 
applied to GST and HisTrap columns set in tandem, and the flow through of 
untagged hsRuvBL2 was collected. Finally, both tagged and untagged protein 
were in turn injected on a HiLoad 16/60 Superdex 200 pg column (GE Healthcare), 
previously equilibrated with 50 mM phosphate buffer pH 7, 500 mM NaCl, 100 µM 
ADP, 1 mM MgCl2. Thermal shift assays (TSA) were performed at several stages, 
to determine the best sample buffer and to assess stability of hsRuvBL2 in the 
presence and absence of different nucleotides. Prior to the final concentration step, 
ADP was added to a concentration of 4 mM. 
 
   Differential scanning fluorimetry  
 
The protein melting temperature (Tm) determination was performed by 
monitoring protein unfolding with the fluoroprobe SYPRO Orange dye (Molecular 
Probes), which although completely quenched in an aqueous environment, emits 
fluorescence upon binding to the exposed hydrophobic patches during   protein 
unfolding. This increase in fluorescence can be measured as a function of 
temperature. The assays were performed in an iCycle iQ5 Real Time PCR Detection 
System (Bio-Rad), equipped with a charge-coupled device (CCD) camera and a Cy3 
filter with excitation and emission wavelengths of 490 and 575 nm, respectively. 
This equipment can detect the fluorescence changes in 96-well plates 
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simultaneously (low profile plate, Bio-Rad) and thus can be used for parallel 
differential scanning fluorimetry (DSF) assays. The 96-well plates were sealed with 
optical quality sealing tape (Bio-Rad) and centrifuged at 2500 g for 30 seconds 
immediately prior to the assay, to remove possible air bubbles. The plates were 
subsequently heated from 20 to 90°C with stepwise increments of 0.5°C with a 60-
second equilibration time, followed by the fluorescence read out. In a typical assay 
with a total volume of 20 µl, a protein concentration of 0.125 mg/ml and a 5-fold 
dye concentration (stock is 5000 fold) were used to guarantee the best signal to 
noise ratio. The assay was prepared by adding protein to the mix of dye-buffer 
solution. 
An initial sample buffer screening was performed using a screen of 96 
buffers with varying buffer molecules, pH and salt concentrations. For buffer 
screenings, the dye dilution buffer used was HEPES pH 7.5 at 50 mM, since HEPES 
has the lowest pH variation with temperature. The assay was prepared by adding 
2 µl of protein and dye mix to 18 µl of new buffer (100 mM), in this way testing the 
protein behaviour in a set of 96 different buffers. When the effect of nucleotides 
was tested, all assays were prepared in previously determined optimal protein 
buffer (50 mM Na/K phosphate, 500 mM NaCl, 4 mM MgCl2). In this case, prior to 
the assays the protein was incubated with nucleotides with a molar excess higher 
than 10-fold (4 mM of nucleotide to ca. 300 µM hsRuvBL2). All assays were 
performed with pure protein, from the peak corresponding to a hexameric 
oligomer, collected after the last size exclusion purification step. Fluorescence 
intensities versus temperature were used to calculate the protein melting 
temperature (Tm) by determining the first derivative (d(Rfu)/dT) to extract the 
minima, which corresponds to the exact transition as the inflection point of the 
melting curve. The higher the Tm, the more stable the protein. 
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   Size exclusion chromatography coupled to multi-angle laser 
light scattering  
 
SEC-MALLS was performed by Christine Ebel at the Institut de Biologie 
Structurale (IBS) in Grenoble. This technique was used to determine, for each 
sample, the hydrodynamic radius and molecular weight, in order to analyse the 
influence of tags and nucleotides in the oligomerization state of hsRuvBL2. 
The protein sample was thawed on ice for 1 hour, centrifuged at 96500 x g 
just prior to the experiment and injected into a WTC050N5 (Wyatt) column 
equilibrated at 20°C in sample buffer (50 mM Na/K PO4 pH 7, 500 mM NaCl, 1 mM 
MgCl2, 500µM ATP or ADP). Coupled to the chromatographic system were: a 
multi-wavelength absorbance detector (Shimadzu SPD-M20A), which measures 
the absorbance of the eluate between 190 and 700 nm; a static light scattering 
detector (WYATT mini DAWN TREOS), which measures scattering at three 
different angles from a sample illuminated by a 658 nm laser beam and makes it 
possible to determine the molecular weight (MW) from the intensity of the 
scattered light; a dynamic light scattering (Quasi Elastic Light Scattering – QELS) 
detector (WYATT DynaPro Nanostar), which measures the fluctuation of the 
scattered light intensity at 90°, from which the hydrodynamic radius (Rh) can be 
calculated. MALLS analyses the time averaged (1s) scattered light intensity I, and 
allows for the determination of MW (and radius of gyration Rg if greater than 20 
nm). QELS analyses the fluctuations of the scattered light intensity, I, as a function 
of time, and allows the determination of the diffusion coefficient Dt, and thus 
hydrodynamic radius Rh. The analysis was performed using the ASTRA software 
version 5.4.3.18.  
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hsRuvBL2 without tags and with tags on the N- and C-terminus were 
analyzed in buffer with ADP. Additionally, untagged hsRuvBL2 was analyzed 
after dialysis to buffer with ATP. 
 
   Analytical ultracentrifugation 
 
Analytical ultracentrifugation (AUC) analysis of sedimentation coefficients 
of hsRuvBL2 was also performed in collaboration with Christine Ebel, from the 
Institut de Biologie Structurale, in Grenoble. AUC is one of the most precise 
analytical techniques for the calculation of the oligomerization state of a complex. 
The aim was to determine differences in the oligomerization state of the different 
hsRuvBL2 samples in a buffer containing ADP: untagged and with tags on the C- 
or N-terminus. 
AUC is a powerful technique for the quantitative characterization of 
macromolecular associations in solution. Sedimentation velocity measures the 
rate at which the boundaries of molecules move during mass redistribution, as a 
consequence of exposure to high centrifugal fields. An equilibrium sedimentation 
experiment is performed to determine the concentration distribution after 
equilibrium is reached11. Sedimentation velocity (SV) was used in this work to 
determine the proportion of different oligomeric forms for each sample, as well as 
their molecular weight, and to observe whether the hsRuvBL2 complex undergoes 
concentration-dependent dissociation.  
Sedimentation velocity experiments were performed at 35000 revs per min 
and 20°C, in a XL-I analytical ultracentrifuge using an Anti-50 rotor (Beckman 
Coulter, USA), with 3 and 12 mm path length Ti double-sector centrepieces 
equipped with sapphire windows (Nanolytics GmbH, Germany), loaded with 110 
and 420 µL, respectively, depending on protein concentration, sample and 
reference solvent. Acquisitions were made using interference optics. Due to the 
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presence of 4 mM ADP, absorbance detection could not be used (for a 3 mm path 
length, A280 is higher than 1.5). HsRuvBL2 samples were stored at -80°C, in 50 mM 
Na/K phosphate, 500 mM NaCl, 1 mM MgCl2, and 4 mM ADP. Prior to the 
experiments, samples were thawed and diluted in the same buffer. The reference 
channels were filled with the buffer without ADP. 
The analyses were done with the Sedfit software12, v14.1. Partial specific 
volumes, , were calculated from composition with Sedfit. The program 
SEDNTERP (http://sednterp.unh.edu/), was used for the analysis, with buffer 
density,  = 1.025 g mL-1 and viscosity,  = 1.06 cP. 
Sedimentation velocity profiles were analysed in terms of continuous 
distribution c(s) of sedimentation coefficients, s13. Peak integration provides 
estimates of s and of the signals. The linear fit s=s0(1 - k’sc), where c is the protein 
concentration, was used to estimate the sedimentation coefficient at infinite 
dilution, s0. 
For homogeneous samples, the non-interacting species analysis provides 
independent estimates of s and of the diffusion coefficient, D, which was used in 
the Svedberg equation s0/D= M (1-v )/RT, to provide an experimental value for 
the molar mass, M, with R the gas constant and T the temperature. 
The value of s0 was also interpreted considering D=RT/NA6πηRH, leading 
to a modification of the Svedberg equation: s0=M(1-v ) ⁄ (NA6πηRH), where NA is 
the Avogadro’s number and RH=f/fminRmin is the hydrodynamic radius, with f/fmin the 
frictional coefficient and Rmin the radius of the anhydrous volume. 
 
   Small angle X-ray scattering  
 
SAS (small angle scattering) techniques detect the scattering of X-ray 
photons - SAXS (or neutrons - SANS), which occurs at very small angles from the 
v
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incident beam. SAS is useful for retrieving information from “disordered” systems, 
were the arrangement of molecules is random. 
SAXS was used to assess the oligomerization state of the samples in 
solution, as well as to detect variations in shape, such as different compaction states 
of the constituent domains. This technique provides only a low resolution 
envelope, so the main purpose in this work was to compare the results in solution 
with the structures obtained with cryo-EM and X-ray crystallography. The results 
obtained in solution should be closer to the protein behaviour in vivo, since there 
are no mobility constraints. This is thus a good complementary technique to gain 
additional insight into the size, shape and mobility of the constituent domains of 
the protein/complex. 
HsRuvBL2 was analysed at beamline B21 of the Diamond Light Source 
(Didcot, UK), both in solution using a sample changer and through in-line analysis 
of the sample applied to a size-exclusion chromatography column. Analysis in 
solution was performed by merging datasets from serial dilutions of a hsRuvBL2 
fraction from the centre of the S200 peak (in the final purification stage), from 0.6 
to 4.5 mg/mL. In-line analysis was performed by injection of a fraction at 5.5 
mg/mL, also of a sample from the middle of the S200 peak, in a Shodex 403kw 
column. Measurements were performed at several points during peak elution. All 
samples were filtered through a 1 MDa filter prior to analysis to eliminate larger 
aggregates.  
 
Electrophoretic mobility shift assays (EMSA)  
 
Electrophoretic mobility shift assays were performed to assess hsRuvBLs 
ability to bind DNA in native conditions. Since it has already been established that 
RuvBL2 binds only to single stranded DNA14, M13mp18 was used in these assays. 
M13mp18 is a large molecule (2.236 MDa, 7249 bases), and as such allows binding 
Oligomerization and DNA-binding of hsRuvBL2 
 
 
 
79 
of several RuvBL molecules, thus producing a weight variation large enough to be 
identified in the gel. Prior to the agarose gel separation, the protein was incubated 
with ssDNA in a reaction mixture with a total volume of 20 µL, of which 0.5 µL 
(1.12 nM) DNA, variable amounts of protein (50 or 25 µM) and completed with 
reaction buffer (25 mM HEPES/KOH pH 8, 2.5 mM Mg(CH3COO)2, 100 mM KCl, 
0.2 mM DTT)14 supplemented with 4 mM ATP and 2 mM MgCl2. Negative controls 
were performed by adding either only DNA or only protein to the reaction buffer. 
The reaction occurred for 1 h at 23°C, after which 1 µL of 50% glycerol was added, 
the reaction was loaded in a 0.6% agarose gel in TBE 1x and run for 2h30m at 80 V. 
The DNA bands in the gel were observed by staining with SYBR Gold 
DNA stain (S11494, ThermoFisher), which binds to ssDNA with a high quantum 
yield. Fluorescence was detected with a Fuji TLA-5100, using a 473 nm excitation 
wavelength (LPB filter, 700 V). 
 
Analysis of hsRuvBL2 binding to DNA by negative staining EM 
 
Immediately prior to EM data collection (protocol described in Chapter 3), 
hsRuvBL2 was incubated with M13mp18 circular ssDNA, in conditions previously 
observed to lead to binding to DNA14. DNA binding had not been observed for 
RuvBL2 hexamers, either in published data by other groups, or in our hands; 
however, after observing EM micrographs that showed hexamer dissociation of 
hsRuvBL2 into its individual components after a prolonged dilution time (more 
than 1 day), we hypothesized that the rings would be able to re-form around DNA, 
based on the known mechanisms of action of other helicases. To prove this 
hypothesis, hsRuvBL2 was incubated with M13mp18 DNA after hexamer 
disruption. A control incubation was prepared without DNA. After 30 minutes of 
incubation at room temperature (about 20°C) in buffer with ATP, both samples 
(with and without DNA) were adhered to the Rhodium/Copper EM grids (pre-
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treated with a carbon coating and rendered hydrophilic through an electrical glow 
discharge), washed with Tris-containing buffer, and incubated with uranyl acetate. 
 
 
2.1.2 RESULTS AND DISCUSSION 
  
  Purification tags and nucleotides affect hsRuvBL2 stability and 
oligomerization state 
 
In order to study hsRuvBL2, the problem of low stability in solution had to 
be overcome. To tackle this, differential scanning fluorimetry assays were 
performed, which allowed for the quantitative analysis of hsRuvBL2 stability in 
 
 
Figure 2.1 – Fluorescence intensity vs. temperature for the thermal unfolding of the 
hsRuvBL1ΔDII/hsRuvBL2ΔDII complex in the native (continuous line) and selenomethionine 
substituted (dotted line) forms. These initial assays show an increase in thermal stability of 8°C 
between the native and the selenomethionine-substituted truncated RuvBL1/2 complex. 
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solution under various conditions. We first started by analysing two samples of the 
DII-truncated RuvBL1/RuvBL2 complex previously studied by our group: 
hsRuvBL1ΔDII/RuvBL2ΔDII, in the native and selenomethionine-substituted 
(selenomet) forms (Fig. 2.1). This initial analysis clearly indicated that 
selenomethionine substitution led to an increase in the thermal stability of the 
complex, with a difference of 8°C in the melting temperature. These results 
prompted us to produce selenomethionine-substituted hsRuvBL2, with a view of 
increasing stability for crystallization purposes. Additionally, since tagged 
hsRuvBL2 has been used as a tool for in vivo assays, to enable the identification of 
binding partners (such as c-myc15), we further inquired whether tags also had an 
influence on RuvBL2 behaviour, knowing that affinity tags placed on the N-
terminus of scRuvBL1 (from Saccharomyces cerevisiae) and scRuvBL2 were shown to 
induce alternative oligomeric states in the yeast Rvb1:Rvb2 complex16. Specifically, 
Cheung and colleagues found that Histidine-tagged scRvb1 and scRvb2 form a 
dodecameric complex, which is reverted to a hexamer upon tag removal. Thus, to 
address the issue of whether the location of the affinity tags would also affect the 
assembly and stability of human hsRuvBL2, we expressed recombinant hsRuvBL2 
in E. coli, with affinity (FLAG and His) tags either at the N- or C-terminus, both in 
the native and selenomet form. It became clear during purification that the tags 
placed at the N-terminus greatly destabilized hsRuvBL2, as this sample, in the 
native form, was prone to aggregation during concentration steps. We analysed the 
thermal stability of the native and selenomet hsRuvBL2 by DSF, both with the 
affinity tags on the C- and on the N-terminus, and further produced untagged 
hsRuvBL2 by cleaving the tags on the C-terminus. DSF assays (Fig. 2.2) show that 
thermal stability of hsRuvBL2 is lowest for the N-terminal tagged forms (54 and 
58°C, for the native and selenomet forms, respectively), followed by the C-terminal 
tagged forms (55 and 59°C). Stability was maximized after cleaving the C-terminal 
tags (56 and 60°C). 
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Together, these results suggest that the insertion of affinity tags may be 
detrimental to hsRuvBL2 folding and stability. Such an influence may be better 
 
 
Figure 2.2 – HsRuvBL2 thermal stability in solution is affected by tags, as observed by differential 
scanning fluorimetry assays. An N-terminal tag decreases stability the most, followed by a C-
terminal tag. The untagged hsRuvBL2 (tag removed from the C-terminus) is the most stable. All 
constructs are further stabilized by selenomethionine substitution. However, this increased stability 
did not result in the successful crystallization of the SeMet variant (see chapter 3). 
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understood in the context of the overall structure of hsRuvBL2, which is discussed 
in the next chapter. Briefly, the N-terminus forms a long (ca. 40 residues) 
unstructured loop in the absence of a nucleotide in the binding pocket. In structures 
where RuvBL2 is bound to a nucleotide, this loop becomes organized, partly 
through interaction with the bound nucleotide. These observations suggest that the 
N-terminus may have a function related to ATP binding, and that the addition of 
affinity tags may interfere with this function. The C-terminal tags are less 
destabilizing. The C-terminus of human RuvBL2 is organized into an antenna-like 
helix, which protrudes outward from the top of the hexameric complex. Compared 
to that of hsRuvBL1, the C-terminal helix of hsRuvBL2 is longer, and in yeast, this 
motif may be involved in interactions with binding partners, such as scPih1p17. 
Altogether, these results suggest that the use of tags for in vivo studies may 
be disadvantageous, since it can compromise protein behaviour in different 
conditions, as well as generate non-physiological complexes. On the other hand, 
given the need for the use of tags in some studies, the use of both tagged forms of 
RuvBL2 should be analysed during complex formation studies in vivo, bearing in 
mind that the influence of tags in oligomerisation plasticity may produce results 
different from the in vivo reality. 
 Thermal stability of hsRuvBL2 was further tested in the presence and 
absence of nucleotides (Fig. 2.3), since ATP is the natural substrate of RuvBL2. The 
melting curve of apo hsRuvBL2 (full line) suggests a lack of structural integrity, 
denoted by the high initial fluorescence and lack of a defined melting transition. A 
DSF curve with such high initial fluorescence indicates the presence of exposed 
hydrophobic patches at the onset of the assay (20°C), and thus that the sample is 
not properly folded. This precludes the expected unfolding pathway, and hence 
the absence of a well-defined melting transition. Conversely, hsRuvBL2 pre-
incubated with nucleotides produced curves with lower initial fluorescence, and 
well defined melting transitions. These curve characteristics indicate that in the 
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presence of nucleotides there are no exposed hydrophobic patches in hsRuvBL2 at 
the beginning of the assay, and thus that the protein is properly folded. ADP 
provided the highest thermal stabilization effect to hsRuvBL2 in solution, and thus 
produced an optimal system for the subsequent analyses. 
 
Figure 2.3 – Thermal stability of hsRuvBL2 in the absence and presence of nucleotides, 
determined by differential scanning fluorimetry assays. Apo hsRuvBL2 (native untagged 
construct) shown as a full line versus thermal stability upon incubation with nucleotides (dotted 
lines). Pre-incubation of hsRuvBL2 with nucleotides leads to curves with a well-defined melting 
curve transition, and lower initial fluorescence, which is indicative of a proper 3-dimensional fold. 
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Having determined that hsRuvBL2 in the presence of ADP provides the 
most stable sample, we pursued the goal of clarifying whether affinity tags have 
any influence in human RuvBL2 oligomerization. For this purpose we used size-
exclusion chromatography. We produced hsRuvBL2 expressed with affinity tags 
either on the C- or N-terminus. We also analysed both samples after tag removal. 
Analytical SEC results showed that hsRuvBL2 expressed with an N-terminal tag 
assembles into a mixture of dodecamers and hexamers (Fig. 2.4 top), as had been 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 – SEC profiles of hsRuvBL2 with tags on the N- and C-terminus, before and after tag 
removal. Oligomeric behaviour seems to be maintained after tag removal. Top: When hsRuvBL2 
is expressed with a tag on the N-terminus, it forms both hexamers and dodecamers, both with 
(solid line) and without (dashed line) tag. However, when the tag is placed on the C-terminus 
(bottom), hsRuvBL2 forms mostly hexamers (tagged hsRuvBL2 - solid line), an oligomeric state 
also maintained after tag removal (dashed line). 
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previously observed by our group by SAXS6. We further observed that these 
oligomeric forms are still assembled after the tag is removed. On the other hand, 
when the tags were inserted in the C- terminus, hsRuvBL2 assembled mostly as a 
hexamer, again without modifications after tag removal (Fig. 2.4 bottom). These 
results suggest that, in hsRuvBL2, the oligomeric behaviour of hsRuvBL2 may be 
determined during protein biogenesis, and that this behaviour is maintained after 
tag cleavage.  
 
  Stability of hsRuvBL2 oligomers varies with concentration 
 
Having observed that tags influence the oligomers formed by hsRuvBL2, 
we further asked whether the tag position may also affect the oligomeric plasticity 
depending on hsRuvBL2 concentration. For this, we analysed hsRuvBL2 with tags 
on the C-terminus, on the N-terminus, and an untagged form, obtained by tag 
cleavage from the C-terminus. 
Initial oligomerization state analyses at different concentrations were 
performed using classical analytical SEC studies using a Superdex 200 10/300 
column, in a buffer containing 500 mM and 1 M NaCl (Fig. 2.5). At these high ionic 
strengths, the observed oligomer is consistently a hexamer. As the protein 
concentration is lowered ca. 10-fold from 2.5 mg/mL to 0.2 mg/mL, the apparent 
molecular weight slightly decreases. Additionally, we have observed by electron 
microscopy that at low concentrations the hexameric rings start to acquire an open 
conformation, which may lead to a lower apparent molecular weight (Fig. 2.6). We 
further attempted to obtain more accurate values for the molecular weight of the 
observed oligomer using SEC-MALLS. However, this analysis was not successful, 
as no peaks were observed for the tagged samples, suggesting adherence to the 
guard column. The analysis of untagged hexameric hsRuvBL2 in presence of ATP 
and ADP provided an equivalent molecular weight, roughly corresponding to a 
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hexamer. However, these results are inconclusive regarding the influence of 
nucleotides on oligomeric state, since it cannot be demonstrated that there was 
nucleotide exchange. 
 
Figure 2.5 – Oligomerization state of untagged hsRuvBL2 at different protein concentrations, in 
buffer with 500 mM NaCl and 1 M NaCl.  At the tested protein and salt concentrations, the 
observed oligomeric species corresponds to a hexamer. However, as protein concentration 
decreases, there is a slight shift towards a lower apparent molecular weight. This may indicate 
partial subunit loss or a change in conformation, such as partial ring opening. 
 
Figure 2.6 – Open ring conformations were observed in hsRuvBL2 samples after they had been 
diluted to about 100 µg/mL for a few hours. The arrow indicates an open (notched) ring. 
Micrograph of a sample observed by negative staining EM. 
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Analytical ultracentrifugation analyses (Fig. 2.7) were performed to 
compare sedimentation velocity (SV) profiles. These were analysed as a continuous 
distribution of sedimentation coefficients, c(s), which allowed the analysis of 
homogeneity and concentration effects. Using this technique, we observed that C-
terminally tagged hsRuvBL2 forms a mostly homogeneous complex at all 
concentrations tested, with a major oligomer at about 10 S, which corresponds to a 
hexamer – ca. 90% of the signal (Fig. 2.7a and c). 
 
 
 
 
Figure 2.7 – Analytical ultracentrifugation profiles of hsRuvBL2 constructs. Tags affect the 
oligomerisation equilibrium of hsRuvBL2: while hsRuvBL2 with C-terminal affinity tags is 
hexameric at all concentrations tested, N-terminally tagged hsRuvBL2 assembles into higher MW 
oligomers as protein concentration is increased. 
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The N-terminal tagged hsRuvBL2 at low concentrations (0.6 mg/mL) forms 
a mixture of hexamers (77%) and dodecamers (14%), while at higher concentrations 
(1.9 mg/mL), the hexamer population decreases to 17% concomitant with an 
increase in dodecamer population to 45% (Fig. 2.7b). The expected value for a 
globular compact species with the same mass of the hsRuvBL2 dodecamer is 18.3 
S, and the observed value was 17±1 S. It can thus be concluded that for this 
construct there is an equilibrium between hexamer and dodecamer formation, with 
a higher percentage of dodecamer being assembled as concentrations increase. In 
addition, larger oligomers/aggregates were detected between 18 and 45 S (6% at 0.6 
mg/mL and 27% at 1.9 mg/mL), which are not detected in significant amounts for 
the other construct (Fig. 2.7). It is possible, considering the absence of evidence in 
the literature for the formation of such high molecular weight species in RuvBLs, 
that the N-terminal tag promotes the formation of aberrant, or non-physiological, 
complexes. 
Sedimentation (s) and diffusion (D) coefficients were obtained from data 
acquired for C-terminal tagged and untagged hsRuvBL2. The mean of the D values 
were used to calculate masses in solution, providing molecular weights of 288 and 
354 KDa (for comparison, the corresponding theoretical molecular weights are 323 
and 307 KDa), close to the expected value for an association state of 6 ± 1. The 
sedimentation coefficient was combined with the theoretical molar mass of the 
hexamer, to obtain an estimated hydrodynamic radius (RH) of 6.8 ± 0.2 nm, and 
frictional ratio of 1.5 ± 0.06, corresponding to slightly elongated shapes (the typical 
value for a globular compact shape is 1.25). 
In all constructs there is also a minor population of free monomer, at 3.5 S 
(1-5%). Curiously, in the N-terminally tagged construct, this population increases 
concomitantly with the increase in protein concentration (Fig. 2.7b). 
In conclusion, AUC analyses show that expression of hsRuvBL2 with tags 
on the C-terminus produces a homogenously hexameric sample, before and after 
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tag removal, in the conditions used. Despite the fact that this construct was also 
shown to be the most stable by TSA, the presence of tags may negatively affect 
some experiments, as observed by the absence of curves when SEC/MALLS was 
attempted using these samples, which may be caused by protein adhesion to the 
guard column. The presence of tags in this position also precluded the formation 
of crystals, which form after about 6 h when using untagged hsRuvBL2. On the 
other hand, N-terminally tagged hsRuvBL2 is heterogeneous, with a mixed 
population of hexamers and dodecamers, larger aggregates and dissociated 
species. 
Combining the observations from this section and the previous one, it 
becomes apparent that the position of affinity tags affects both the stability and 
oligomer formation in hsRuvBL2 in response to variations in protein concentration. 
Furthermore, the oligomeric behaviour in each case is maintained after tag 
removal, which suggests that either oligomeric behaviour is determined during 
protein biogenesis, or that the two residues that remain after tag cleavage (Gly and 
Pro) may still have some influence (which seems less likely). 
This difference in behaviour of the differently tagged hsRuvBL2 constructs 
suggests that tag placement may interfere with other analyses, namely interactions 
with other partners and with specific activities. As demonstrated by TSA, the N-
terminally tagged construct of hsRuvBL2 is slightly more unstable, suggesting that 
tag placement in the N-terminus may be more detrimental. However, both the N-
terminal loop and the C-terminal helix have putative functions, namely in 
interaction with other proteins18,19, hence it might be better for interaction assays to 
analyse the results obtained using both constructs. Additionally, equilibrium 
dynamics is affected by tag position: C-terminally tagged hsRuvBL2 is consistently 
hexameric, while N-terminally tagged hsRuvBL2 forms oligomers in a 
concentration-dependent manner. 
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SEC/MALLS was performed to assess the MW of hsRuvBL2 in buffers with 
ADP and ATP. The latter was obtained by dialysis of the ADP-purified sample to 
a buffer with ATP. The observed peaks correspond to a MW of 303 KDa and 296 
KDa, of hsRuvBL2 in buffer with ADP and ATP, respectively. These values are 
within the error margins for a hexamer in both cases. Whether there was nucleotide 
exchange upon dialysis cannot be determined; however, from observation of the 
existing structures and activities6,14,20, nucleotide exchange is precluded in the 
hexameric form, due to the very occluded entrance to the nucleotide binding site. 
Only in the DII-truncated complex was nucleotide exchange observed. The 
observed hydrodynamic radii (7.0 ± 0.1 and 7.15 ± 0.1 nm) are also within the error 
margins, as compared to the values obtained by AUC. Since we cannot be sure of 
nucleotide exchange in the binding pocket, no conclusion can be drawn from these 
results regarding the influence of nucleotides. Notwithstanding, they support the 
results obtained by AUC. 
 
 Insights into hsRuvBL1 and hsRuvBL2 binding to DNA 
 
RuvBL2 binding to DNA is independent of nucleotide sequence, and 
restricted to single-stranded DNA6,14. Papin and colleagues have also clearly shown 
that only monomeric RuvBL2 (yeast and human) can bind the polynucleotide 
chain, which suggests a mechanism of action whereby RuvBL2 oligomerizes 
around a single chain overhang, and only then starts to perform the upstream 
unwinding of the remaining double helix, in an ATP-dependent process14. 
Here, we aimed to expand the current knowledge on the DNA-binding 
mode of hsRuvBL2, and gain further insight into hsRuvBL1 and hsRuvBL2 binding 
to DNA. In our hands, hsRuvBL2 binding to DNA was first observed while 
purifying the N-terminally tagged, selenomethionine-substituted hsRuvBL2. The 
elution peaks (Absorbance at 280 nm) obtained by size-exclusion chromatography 
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were applied into an agarose gel and stained with SYBR green (Fig. 2.8). A 
coommassie-stained acrylamide gel confirmed the presence of protein in the peak 
corresponding to the putative dodecamer, albeit in much lower amounts than in 
the hexameric peak. The fact that the peak corresponding to the dodecamer is the 
more intense is due to the contribution of DNA in the sample. DNA presence was 
identified exclusively in the peak corresponding to the dodecameric complex, 
which prompts the question of whether DNA promotes the formation of 
dodecamers or if previously formed dodecamers have a tendency to bind DNA. 
 
 
Figure 2.8 – Initial observations of DNA bound to hsRuvBL2 (N-terminally tagged). Both the 
“dodecamer” and the “hexamer” peaks of a size-exclusion chromatography purification step were 
observed in an agarose gel. SYBR green staining indicates the presence of DNA exclusively in the 
“dodecamer” peak. N - Native samples; D – Heat denatured samples. 
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Papin and colleagues have observed that RuvBL2 is required to be in the 
monomeric form at the onset of DNA binding, and also that RuvBL2 activity and 
oligomerization are modulated by interaction with binding partners, such as 
histones5,21. These observations suggest that DNA binding may also be a driver of 
oligomerization, a hypothesis we addressed using single-particle electron 
microscopy. During the EM experiments, we observed the dissociation of 
hsRuvBL2 hexamers into monomers (Fig. 2.9a) after dilution to the very low 
concentration of about 100 µg/mL, a concentration which limits the techniques that 
allow the observation of the structural changes taking place upon interaction 
between hsRuvBL2 and DNA. When monomeric hsRuvBL2 was incubated with 
single-stranded DNA, the previously disassembled rings were re-formed (Fig. 
2.9b). Although the circular M13mp18 DNA strand could not be observed at the 
resolution obtained by negative - staining EM, it can be assumed that, if the rings 
assembled around the DNA chain, the latter would remain associated with the 
protein complex. 
    
Figure 2.9 – Monomeric hsRuvBL2 assembles into rings in the presence of ssDNA. a) At a 
concentration of 100 µg/mL, hsRuvBL2 slowly dissociates into monomers (and possibly dimers). 
This dissociation can be observed by EM, since the monomers are too small to be clearly identified. 
Conversely, hexamers (and possibly heptamers) are large enough to be observed by EM. Thus, it 
was possible to observe their formation as a consequence of incubation with M13mp18 ssDNA (b). 
 
a b 
hsRuvBL2 monomers hsRuvBL2 after incubation with DNA 
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Alternatively, DNA binding may occur through the external region of 
domain 2, as suggested for hsRuvBL120, since both proteins display an OB-fold 
within this region. However, if binding occurred only through domain 2, it 
probably would also be observed in the hexameric forms. Furthermore, helicase 
activity – for which prior binding to the DNA strand is required - was shown in 
complexes where the external region of domain 2 was deleted22. 
 
 
Figure 2.10 – Electrophoretic mobility shift assay with hexameric hsRuvBL2, monomeric 
hsRuvBL1 and M13mp18 ssDNA shows an interplay between the two proteins that enables 
hexameric hsRuvBL2 to bind DNA. HsRuvBL2 is not able to bind ssDNA when in the hexameric 
form (lane 6). However, when co-incubated with ssDNA and monomeric hsRuvBL1 (lanes 2 and 4), 
a shift in the DNA running distance is observed which indicates binding of both hsRuvBL1 and 
hsRuvBL2 to DNA (as compared to the shifts in lanes 1 and 3, in which the total molar amount of 
protein is the same as in lane 2). Parallel experiments done with AMP-PNP (lanes 5 and 6) support 
the ATP-dependence of binding to DNA. Agarose gel stained with SYBR gold DNA stain. 
 
1     2     3     4    5     6    7     8    9    10 
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We confirmed the lack of binding of hexameric hsRuvBL2 to M13mp18 by 
EMSA (Fig. 2.10, lanes 5 and 6), as the shift displayed by DNA alone (lane 5) or in 
presence of hexameric hsRuvBL2 (lane 6) was the same in both lanes. Interestingly, 
hexameric hsRuvBL2 was able to bind DNA when co-incubated with monomeric 
hsRuvBL1 (lanes 2 and 4): in these lanes, the shift in DNA running distance 
corresponds to a DNA which is bound to the total number of hsRuvBL1 and 
hsRuvBL2 molecules in the reaction.  Lane 3 contains 25 µM of hsRuvBL1, and lane 
4 contains 12.5 µM each of hsRuvBL1 and hsRuvBL2. Binding to DNA is shown to  
be dependent on ATP hydrolysis, since prior co-incubation of monomeric 
hsRuvBL1 with the non-hydrolysable ATP analogue AMP-PNP precludes the 
binding of any hsRuvBL to the DNA (lanes 7 - 10), and as such the running distance 
of DNA in the gel is the same as the one observed for free M13mp18. 
The question remains whether hsRuvBL2 returns to a monomeric state or 
open ring conformation upon DNA release. Our observation of open (notched) 
rings by EM (Fig. 2.6), shows that hsRuvBL2 may acquire that conformation, and it 
may be one way through which the rings are released from DNA. A second 
possibility would be a total ring fragmentation, in a way similar to what happens 
with the CMG helicase at the end of DNA replication23. 
Finally, despite presenting an OB-fold, it is possible that the functions of 
the external region of domain 2 may be more related to its indirect interaction with 
the nucleotide in the binding pocket (through a mechanism explored in the third 
chapter), than to a direct interaction with DNA. It is also worth noting that while 
the OB-fold is mostly present in nucleic acid-binding proteins, they can also occur 
in larger proteins as recognition domains, and have even been found at protein-
protein interfaces4. Thus, although an interaction of the domain II with DNA was 
observed for hsRuvBL120, it is possible that the OB-fold in hsRuvBL2 may also be 
important for its interaction with other proteins in a supramolecular assembly, 
such as within the Ino80 complex, where cross-linking/mass spectrometry analysis 
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shows a strong interaction profile between the OB-folds of ctRuvBLs and Ies224. 
Interestingly, EM micrographs showed hsRuvBL2 hexamers to be frequently found 
in direct lateral contact (not shown), forming continuous strings, which is also 
suggestive of a tendency of domain 2 to act as a mediator in protein-protein 
interactions. 
 
2.2 Preliminary study of RuvBL-interacting protein c-Myc 
 
c-Myc is an oncogenic transcription regulator, for which a full-length 
structure has never been determined. To date, the only known structure is that of 
the C-terminal domain, responsible for interaction with DNA, in complex with the 
C-terminal domain of Max protein. The N-terminal portion of c-Myc, the 
Transcription Activation Domain (TAD), is responsible for interaction and 
regulation of other proteins, including RuvBL1. It has been known for some time 
that the interaction between RuvBL1 and c-Myc occurs between Myc Box II (MBII) 
and the domain DII of RuvBL1. This interaction, when de-regulated, most often 
leads to oncogenesis25. Fig. 2.11 depicts some oncogenic pathways in which RuvBLs 
are involved. Considering this, and the importance of c-Myc as a pharmaceutical 
target, our proposal was accepted by the Oxford Protein Production Facility for the 
cloning, high-throughput expression and solubility screening of an assembly of 
constructs of human c-Myc (hsc-Myc, henceforth referred to as c-Myc). The main 
objective was to find a combination of factors leading to the attainment of soluble 
protein constructs, with emphasis on the segment responsible for the interaction 
with RuvBL1. On the long term, the expression of c-Myc MBII, together with the 
existing knowledge on the expression, purification and crystallization of hsRuvBL1 
and 2, will enable us to follow the next rational step: the study of the interaction 
between hsRuvBL1, hsRuvBL2 and c-Myc. The main goal of that study will be to 
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understand how the interaction between c-Myc and hsRuvBLs occurs on a 
structural level. This knowledge may lead to the development of a strategy to 
modulate this interaction. 
The present work was developed at the Research Complex at Harwell (part 
of the Oxford Protein Production Facility), under the supervision of Dr. Louise 
Bird. 
 
2.2.1 METHODS   
 
   Construct design 
 
c-Myc is an intrinsically disordered protein, according to Disorpred and 
PsiPred26 (Fig. 2.12). Wood and colleagues determined, through specific deletions, 
 
 
Figure 2.11 – Involvement of hsRuvBL1 and 2 in cancer pathways. The hsRuvBL1-c-Myc cancer 
progression pathway is dependent on the ATPase activity of RuvBL1. 
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that c-Myc binds to RuvBL1 through amino acids 118-152 of c-Myc25. Thus, 
constructs were selected in order to include this region, while also trying to 
maintain secondary structure-containing domains and avoiding the more 
disordered regions, which tend to decrease solubility and crystallization. Table 2.1 
enumerates the constructs and vectors selected for expression. 47 constructs were  
designed, based on their functional significance and disorder probability. One 
positive control (GFP) was included, for visual assessment of the success of the 
expression tests. 
 
A 
B 
 
Figure 2.12 – c-MYC secondary structure prediction. A) PsiPred secondary structure prediction shows 
most of c-Myc as being disordered. B) Disorpred indicates the regions with highest probability of being 
disordered. 
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Tags were chosen on the basis of their records as solubility enhancing. All 
vectors include also a 6xHis tag and a cleavage site for HRV 3C protease. The latter 
feature is indispensable, for the presence of tags, being very large and mobile 
elements, may hinder crystallization of the target protein. 
 
Table 2.1. Constructs tested at the OPPF. MBI – Myc Box I; MBII – Myc Box II; TAD – Transcription 
Activation Domain. SUMO – Small Ubiquitin-like Modifier; GST – Glutathione-S-transferase; HALO – 
Halotag (Promega); MBP – Maltose Binding Protein; TF – Trigger Factor; NusA – E. coli NusA; GFP - 
Green Fluorescent Protein (positive control for expression). 
                                          Constructs   
Tags 
(vector) 
1-439 
(FL) 
15-158 (MBI 
+ II) 
1-160 
(MBI + II) 
1-262 
(TAD) 
36-160 
(MBI + II) 
91-158 
(MBII) 
96-155 
(MBII) 
48-158 
(MBII) 
SUMO 
(pOPINS3C) 
X X X X X X X X 
GST 
(pOPINJ) 
GFP  X X X X X X X 
HALO 
(pOPINHALO) 
X X X X X X X X 
MBP 
(pOPINM) 
X X X X X X X X 
TF 
(pOPINTF) 
X X X X X X X X 
NusA 
(pOPINNUSA) 
X X X X X X X X 
  
   Cloning procedures 
 
Template DNA (pET49-b_c-Myc) was obtained from GenScript, codon-
optimized for expression in E. coli. PCR products of our target constructs were 
obtained using Phusion Flash polymerase, from Thermo. PCR products were 
cleaned using magnetic beads (Azincourt AMPure XP, from Beckman Coulter), 
after treatment with DpnI restriction enzyme to remove the methylated template 
DNA. Cloning was achieved using In-Fusion technology, from Clontech. For this, 
the linearized vectors were mixed with our PCR products, and the In-Fusion 
polymerase creates regions of homology at the ends. After 30 minutes at 42°C, the 
reaction was stopped by adding EDTA and the ligation was transformed in highly 
Chapter 2 
 
 
 
100 
competent OmniMAX cells, from Invitrogen. Cells were plated in 24 well plates, in 
LB mixed with 50 µg/mL carbenicillin, X-gal and IPTG. Individual white colonies 
were picked and grown overnight in Power Broth mixed with 50 µg/mL 
carbenicillin. Glycerol stocks and minipreps were prepared for each clone, using 
the Theonyx Liquid Performer Robot and the Wizard SV96 kit from Promega. A 
PCR was performed to confirm the presence of the tagged insert, using as forward 
primer pOPINF (similar to T7 but larger, since annealing temperature of the T7 
primer is too low), and the reverse primer specific for each insert. Insert and tag 
sizes were verified by agarose gel using SYBR Safe gel stain. The high efficiency 
observed in our PCRs is most likely a consequence of the high quality of the 
template, since it was optimized for codon usage in E. coli and also in order to 
abolish any secondary structures that the template might form, which would 
diminish the efficiency of primer binding. 
 
 Protein expression and purification 
  
Each vector was transformed in E. coli Lemo21 and Rosetta 2 competent 
cells. Lemo21 cells are adequate for the expression of membrane, toxic or difficult 
soluble proteins, and by adding L-rhamnose to the growth medium, levels of 
expression can be tightly tuned by modulating the level of lysozime (lysY), the 
inhibitor of T7 RNA polymerase. Rosetta 2 cells contain the pRARE2 plasmid, 
which allows for the translation of 7 codons mostly used by eukaryotes, by 
supplying the respective tRNAs. However, since the gene contained in our 
expression vector had been codon optimized, this strain worked as simple BL21 
strain. One colony of each was grown overnight at 600 rpm, in 600µL of Power 
Broth supplemented with 30 µg/mL chloramphenicol and 50 µg/mL carbenicillin. 
150 µL of the overnight culture was inoculated into 3 mL (5%) of Power 
Broth or auto-induction medium supplemented with carbenicillin and 
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chloramphenicol. For Lemo21 cells, media were additionally supplemented with 
250 µM Rhamnose. (Levels of expression may be optimized later by varying the 
concentration of Rhamnose - no Rhamnose will produce the same effect as if we 
were inducing in a BL21 strain). Growth occurred at 37°C, 600 rpm. For cells 
growing in Power Broth medium, induction was achieved by adding 1 mM IPTG 
after 5 – 6 h of growth. After the addition of IPTG, growth proceeded at 20°C 
overnight. Cells in auto-induction medium were transferred to 25°C after 5 hours, 
and left to grow overnight. The Rosetta strain cells took longer to achieve induction 
OD, which is very likely due to the toxicity caused by basal levels of protein 
expression. A positive control was used for immediate visual assessment of 
induction efficiency, by inducing expression of GFP under the same conditions as 
the constructs. 
Purification of 1 mL induced cells was performed on the Qiagen Bio Robot 
8000 or Theonyx Robot, using GE His Mag sepharose magnetic beads. The cell 
pellet was first lysed, by freezing at -80°C for 20 minutes and then adding lysis 
buffer (Na Phosphate pH 8, 10 mM Imidazole, DNAse I, Lysozyme and a small 
percentage of detergent – this small percentage is abolished when physically 
disrupting cells, on a large-scale). The protein was purified from the supernatant 
after centrifuging 30 minutes at 5000 x g with the magnetic beads, washed with 
buffer containing 20 mM Imidazole and eluted with 60 µL of buffer containing 250 
mM Imidazole. 10 µL of each sample were mixed with 10 µL 2x loading buffer and 
10 µL of this mix were applied in a 24 well 10% BT gel. The gel run was performed 
at 200 V for 39 minutes and stained directly using Generon Quick Coommassie 
stain. 
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2.2.2 RESULTS AND DISCUSSION 
 
Of the 192 tested conditions, 5 produced promising results, both in PB and 
auto-induction medium, all of which using the Lemo21 cells. In many cases, cells 
failed to grow even before induction, mainly in Rosetta, which indicates toxicity 
caused by basal levels of protein expression. Purified protein also suffered 
proteolysis in the vast majority of cases, which resulted in the production of only 
the tags, or smaller portions of the expressed construct. 
 
The best results were obtained for c-Myc constructs 91 – 158 and 96 – 155 
(Table 2.2), which are the minimal constructs that still include MBII. These start on 
a region predicted as not unstructured and end after a helix, which may contribute 
to their increased stability (Fig. 2.13). Several solubility tags were tested. The tag 
that produced the most stable protein was TF (Trigger Factor), which is a 
prokaryotic ribosome-associated chaperone protein. 
 
 
Table 2.2. Results of c-Myc constructs expression tests. Green squares indicate successful 
expression and presence of non-degraded protein after the final purification tests. The darker 
squares indicate higher levels of protein at the end of the purification step. The two darker constructs 
were successfully produced in PB and auto-induction medium.  
 Constructs 
Tags 
(vector) 
1-439 
(FL) 
15-158 
(MBI + II) 
1-160 
(MBI + II) 
1-262 
(TAD) 
36-160 
(MBI + II) 
91-158 
(MBII) 
96-155 
(MBII) 
48-158 
(MBII) 
SUMO 
(pOPINS3C) 
X X X X X X X X 
GST 
(pOPINJ) 
GFP  X X X X X X X 
HALO 
(pOPINHALO) 
X X X X X X X X 
MBP 
(pOPINM) 
X X X X X X X X 
TF 
(pOPINTF) 
X X X X X X X X 
NusA 
(pOPINNUSA) 
X X X X X X X X 
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The optimization of the MBII purification protocol is ongoing. So far, 
thermal shift assays have not yielded a conclusive result for an improved 
purification buffer, as initial fluorescence is high and overall signal intensity very 
low, due most likely to its intrinsically disordered nature and small size (6 KDa). 
Additionally, preliminary NMR analyses indicate a disordered tridimensional 
structure, and low stability, at a concentration of 1 mg/mL. As a consequence of its 
lack of an ordered structure, MBII has yielded no crystals to date (either with or 
without tag, although in the former case, it may be due to the high solubility 
provided by the tag), and co-crystallization with hsRuvBL1 has likewise failed to 
provide crystals to date. Future optimization procedures will include co-expression 
with hsRuvBL1, both of the MBII domain, and the full-length c-Myc. 
 
 
Figure 2.13 – Successfully expressed constructs of c-Myc. HT purification of c-MYC constructs was 
most successful with the two constructs indicated, possibly because they contain helices at the 
boundaries, and are relatively small constructs. 
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3.1 Current structural knowledge on RuvB-Like proteins 
 
RuvB-Like proteins are widespread in Archaea and eukaryotes. To date, 
structural studies have been mostly based on electron microscopy (EM) and X-ray 
crystallography, with a few SAXS analyses to correlate with the overall protein 
shape in solution. The first structure of the human RuvBL1/RuvBL2 complex was 
published in 20071, followed by the yeast Rvb1/Rvb2 complex in 20082, both by 
negative staining EM. In 2005, RuvBL1 crystals had already been produced3, and 
in 2006 the first crystallographic structure of RuvBL1 alone was published4.  
RuvBL1 and RuvBL2 are homologous proteins that share 43% sequence 
identity and 65% sequence similarity, and are composed of three domains, I, II and 
III (Fig. 3.1). The Rossman-like αβα fold (domain I) and the canonical all-α 
subdomain (domain III) form the ATPase core. The smaller domain III forms a 
“lid” located near the P-loop (phosphate-binding loop), which covers the 
 
Figure 3.1 – Cartoon model of the human RuvBL1 monomer. Domain I is depicted in orange, 
domain II in cyan and domain III in red. ADP atoms are shown as spheres. The OB-fold is located at 
the outermost part of domain II (highlighted). 
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nucleotide-binding pocket at the interface of domain I and domain III. Between the 
canonical Walker A and Walker B motifs of domain I there is an insertion domain  
(domain II), that bears no significant sequence similarity to other known domains, 
except for residues 131-227 (RuvBL1), which organise into an OB-fold. Domain II 
is unique to RuvB-Like proteins. Like all AAA+ ATPases, RuvBLs assemble into a 
 
 
 
 
 
Figure 3.2 – Cartoon model of the hsRuvBL1 hexamer (PDB ID 2c9o). The ATPase core is depicted 
in green (light for domain I and dark for domain III), and the domain II in blue. ADP is represented 
as red sticks. Top: side view; bottom: bottom view. 
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Chapter 3 
 110 
hexameric torus-shaped complex (Fig. 3.2). The interfaces form a complete 
nucleotide binding pocket, which includes a trans-arginine finger from the adjacent 
monomer (Fig. 3.3). 
Structural studies show that, when mixed, RuvBLs form complexes 
composed of alternating RuvBL1 and RuvBL2 monomers, assembling as 
hexamers5,6 or dodecamers2,5–15, both in humans, yeast and Chaetomium 
thermophilum. However, only structures of RuvBL1/2 dodecamers have been 
reported (Table 3.1). These proteins are also able to form homomeric complexes, of 
  
 
 
Figure 3.3 – Interface between two monomers of RuvBL1. The interfaces are formed by contacts 
between domains I and III. The two adjacent monomers are represented respectively in shades of 
green and in shades of pink, each shade defining a domain. The ATP molecule from the left 
monomer is depicted in red spheres. The trans-Arginine finger from the right-side monomer, that 
completes the nucleotide binding pocked, is depicted in blue sticks. 
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which thus far only the crystallographic structure of hexameric RuvBL1 has been 
determined (Fig. 3.2)4,16. 
 
Table 3.1 – Structures of RuvBL1/RuvBL2 complex determined to date by electron microscopy. 
Some differences between the different studies are described, in what refers to expression, tags 
used and type of complex obtained. Differences in the purification buffers used may also have an 
important contribution to the observed structures. When the type of complex obtained is not 
described as hetero or homododecamer/hexamer, it is due to the fact that the resolution attained 
in that work did not allow for that distinction.  
EM structure Complex production Remarks 
 
 
 
 
Puri et al 2007 
Separately expressed in 
E. coli. 
Complex assembly by 
co-incubation of 
partially purified 
RuvBL1 and 
RuvBL2_His6. 
Human. Forms 
asymmetric dodecamers 
with equimolar RuvBL1 
and RuvBL2 amounts. 
RuvBL1/RuvBL2-His6. 
Gribun et al 2008 
Separately expressed in 
E. coli with N-terminal 
tags. Tags were cleaved 
prior to co-incubation.  
Yeast. Forms 
heterohexamer, 6-fold 
symmetric. Mixed in 
presence of ADP. 
 
Torreira et al 2008 
Co-expression in 
recombinant 
baculovirus (insect 
cells). 
 
Yeast. 
Rvb1/His-Rvb2. 
Negative staining-EM. 
1. 
2. 
3. 
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Table 3.1 – Structures of RuvBL1/RuvBL2 complex determined to date by electron microscopy. 
Some differences between the different studies are described, in what refers to expression, tags 
used and type of complex obtained. Differences in the purification buffers used may also have an 
important contribution to the observed structures. When the type of complex obtained is not 
described as hetero or homododecamer/hexamer, it is due to the fact that the resolution attained 
in that work did not allow for that distinction.  
EM structure Complex production Remarks 
Torreira et al 2008 
 
Yeast. 
Rvb1/His-Rvb2. 
Forms asymmetric 
dodecamers with 
equimolar amounts of 
RuvBL1 and RuvBL2. 
Cryo-EM. 
Cheung et al 2010 
Purified endogenous 
Rvb1/Rvb2 from 
Saccharomyces cerevisiae. 
Yeast. 
N-terminal tagged Rvb1 
and Rvb2 form 
dodecamers, and the 
untagged proteins form 
hexamers. 
Expression system and 
mode of complex 
assembly do not affect 
oligomeric state. 
Lopéz-Perrote et al 2012 
Co-transformation of 
His-RuvBL1 and RuvBL2 
in E. coli. 
Human. 
Untagged 
RuvBL1/RuvBL2 (negative 
staining) and His-
RuvBL1/RuvBL2 (cryo-
EM). 
Dodecameric assembly 
maintained after tag 
removal. 
Compact and stretched 
conformations 
independent of nucleotide 
present. 
4. 
5. 
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Table 3.1 – Structures of RuvBL1/RuvBL2 complex determined to date by electron microscopy. 
Some differences between the different studies are described, in what refers to expression, tags 
used and type of complex obtained. Differences in the purification buffers used may also have an 
important contribution to the observed structures. When the type of complex obtained is not 
described as hetero or homododecamer/hexamer, it is due to the fact that the resolution attained 
in that work did not allow for that distinction.  
EM structure Complex production Remarks 
 
Jeganathan et al 2015 
Co-expression of His-
Rvb1 and Rvb2 in E. coli. 
Yeast. 
Structure of untagged 
complex by negative 
staining EM. 
8% of complex is 
dodecamer, with four 
levels of compaction.  
Silva-Martin et al 2016 
Expressed separately in 
E. coli and subsequently 
co-incubated as 
monomers. 
Chaetomium thermophilum 
(fungus). 
Cryo-EM of untagged 
dodecamer. 
Stretched and compact 
conformations. 
Asymmetric features. 
Ewens et al 2016 
Co-expression of His-
Rvb1 and Rvb2 in E. coli. 
Yeast. 
Cryo-EM of untagged 
Rvb1/Rvb2. 
Nucleotide-dependent 
bent and straight 
conformations. Rotation of 
one hexamer relative to 
the other in a degree 
dependent on nucleotide. 
6. 
8. 
7. 
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Table 3.1 – Structures of RuvBL1/RuvBL2 complex determined to date by electron microscopy. 
Some differences between the different studies are described, in what refers to expression, tags 
used and type of complex obtained. Differences in the purification buffers used may also have an 
important contribution to the observed structures. When the type of complex obtained is not 
described as hetero or homododecamer/hexamer, it is due to the fact that the resolution attained 
in that work did not allow for that distinction.  
EM structure Complex production Remarks 
Rivera-Calzada et al 2017 
Co-expression of Myc-
RuvBL1 and His-RuvBL2 
in E. coli. 
Yeast. 
Cryo-EM of tagged 
heterohexamer. 
 
In the human proteins, the abscission of domain II led to preferential 
dodecamer formation (Fig. 3.4)12, while in yeast the dodecameric complex was 
shown to be formed due to the purification tags since, in their absence, hexamers 
preferentially formed6. Although this information should be taken into 
consideration (particularly when using tags for in vivo studies), it probably does 
not impair the validity of the structural information gathered from structures thus 
obtained, in particular considering that double ring formations have been observed 
to occur naturally17. The question of whether a dodecamer of homohexameric rings 
of RuvBL1 and RuvBL2 can exist is still unanswered. Some low resolution EM 
structures show an asymmetric dodecamer1,18, where one of the halves of the 
dodecamer is wider than the other (position 1 of table 3.1). Nevertheless, the 
possibility should be considered that this may be a transient conformational state, 
which has never been observed to date in the structures of double heterohexameric 
rings. Asymmetry caused by conformational states induced by nucleotide binding 
may also be considered. However, in structures where conformational differences 
7. 
9. 
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due to nucleotides have been observed, the diameter of both rings remained the 
same (position 7 of table 3.1). Alternatively, the asymmetric dodecamers could be 
composed of two distinct types of hexamers, or might be formed instead through 
contacts between domains II of the top ring and the ATPase core of the bottom ring 
(i.e., top-to-bottom, instead of the so far observed bottom-to-bottom). 
 
The highest resolution structures show that the interactions between 
hexamers occur between the domain II of RuvBL1 and RuvBL27–9,12 (Fig. 3.4, right). 
These domains are linked to the ATPase core by a flexible β-sheet link, which 
provides flexibility to the cage-like complex. The complex is thus able to acquire 
different conformations, depending on the nucleotide present in the binding 
pocket, and possibly on bound DNA or other proteins. The connection between 
ATP hydrolysis and mechanical movement remains a key missing link to our 
understanding of the biological functions of this complex, and a topic we aimed to 
address in this work. In the yeast dodecameric complex, ATP and ADP binding 
 
Figure 3.4 – Cartoon representations of the RuvBL1/RuvBL2 dodecamer. Left: human domain II-
truncated complex (PDB ID 2xsz). RuvBL1 monomers depicted in light green and RuvBL2 
monomers in blue-green. ADP represented in red sticks. Right: Chaetomium thermophilum complex. 
RuvBL1 monomers depicted in blue and RuvBL2 monomers depicted in pink. Side views. 
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lead, respectively, to the opposing movement of both hexamers14 by 29 and 32 
degrees, where the hinges are formed by the connections between the α/β tips of 
the domains II (OB folds) of RuvBL1 and RuvBL28. So far there are no comparative 
3D structures of apo vs. nucleotide-bound hexamers, but it has been suggested that 
the motion of domains II in a hexamer would be the same as in the dodecamer8. 
This motion leads to a compaction of the dodecamer height, from 145 Å to 130 Å, 
observed in a number of studies10,19 (Table 3.1). 
Interestingly, it has been observed in several instances that nucleotide 
binding leads to a rearrangement and stabilization of the N-terminal loop7,20,21, in 
addition to the already described movement of domain II. Molecular dynamics 
simulations of RuvBL hexamers and monomers in solution show that the major 
movements are associated with domain II and the C-terminal helix (domain III). In 
all cases, domain II acquires a wide variety of conformations, and its mobility is 
further enhanced by the addition of 3 residues (Phe-Cys-Arg) within the OB-fold, 
in the lik mutant22,23. Interestingly, the addition of these residues also increases the 
mobility of amino acid residues at the interface between domains I and III, where 
the nucleotide binding pocket is located, suggesting a connection between the 
motion of domain II and nucleotide exchange, supported by the results obtained 
with the domain II-truncated complex, which show an increase in ATPase activity 
12,24. 
The double rings observed by EM enclose a large central cavity. It has been 
suggested that this central channel could be used to pass DNA strands; both 
diameter and charge suggest that it would most likely be ssDNA, although a 
structure of a RuvBL-DNA complex has yet to be produced. The existing structures 
show side openings, suggestive of a possible extrusion mechanism similar to that 
of the archaean MCM25 or the simian virus 40 LTag26. On the other hand, the motion 
caused in the dodecamer by ATP and ADP binding exposes the OB-fold8, which 
could wrap DNA in a way reminiscent of a film reel. This type of function would 
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fit well in complexes such as the INO80, where the dodecamer sits at the DNA-
binding head, with the equatorial line between hexamers perpendicular to the 
“neck” of complex, exposing the external part of the domains II17 (see chapter 1). 
The issue of the physiologically relevant forms is still under debate, the 
reason for this being that ATPase and helicase activities have been observed in the 
heterohexamer, the truncated heterododecamer and in the RuvBL2 monomer but 
not in the RuvBL2 hexamer, and different results have been observed for the full-
length heterododecamer 2,18,21,27. However, this may not be the best way to assess 
the biological significance of the oligomer, since: a) oligomerization and activity are 
known to be regulated by cofactors present in the cell, such as the Histone H3 N-
terminal tail16; b) some functions, such as chaperone, may not require ATPase 
activity; and c) activity data has frequently been determined with undefined 
oligomeric forms16. 
Alternatively to working together, RuvBL1 and RuvBL2 also have 
independent activities27–29, and roles in the cell30,31. The oligomeric form in which 
they enact those roles is still a largely unexplored question. When working 
independently, their activities and association to binding partners are known to be 
regulated by markers such as SUMO or methyl groups30–34. 
Despite the many structural and biochemical publications, some 
fundamental questions remain unanswered, thwarted by the mobile nature of 
these proteins and the large size of their complex, which hinder the crystallization 
efforts. What is the mechanism and biological function of DNA binding? How are 
the different activities of RuvBLs regulated? How do they perform their activities 
when in complex vs in the monomeric form? How is the hydrolysis of ATP 
translated into movement with functional meaning? So far, structural studies have 
focused on the human and fungal proteins, both using X-ray crystallography and 
electron microscopy. With the exponential improvement the latter technique has 
experienced in recent years, more structures of the full-length dodecameric RuvBL  
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Figure 3.5 – Crystallographic model of an archaean RuvB-Like Holiday junction helicase from 
Sulfolobus islandicus. Top: Cartoon model of Sulfolobus islandicus RuvB-Like helicase (side view on 
the left and top view on the right). Bottom: Alignment of S. islandicus RuvBL (PDB ID 5F4H) with 
human RuvBL2 (PDB ID 5N7R). Alignment with EMBOSS Needle35. 
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complexes are being published, at increasingly higher resolutions. The 
supramolecular associations of RuvBLs with other proteins in high molecular 
weight complexes has been reviewed before (see chapter 1). Only two EM 
structures of such complexes have been determined to date; however, this is a fast-
growing field, and we should expect the next few years to bring larger multi-
complex structures. 
Recently, the crystallographic structure of an archaean RuvB-Like Holiday 
junction helicase has been determined to 2.7 Å resolution (Fig. 3.5, top, no 
publication available). However, despite being annotated as a RuvB-Like protein, 
the barrel-like complex does not have the outwards protruding domains 
characteristic of the (so far) known structures of eukaryotic RuvBLs. The sequence 
alignment (Fig. 3.5, bottom) also shows very limited conservation to the human 
RuvBL2 (17% identity and 32% similarity, calculated with BLAST, Needleman-
Wunsch alignment), and does not have the same domain distributions as 
hsRuvBLs. 
The three-dimensional structures of the human and fungal 
RuvBL1/RuvBL2 complexes are very similar to that of helicases, with which they 
also share function. However, they also bear similarities to known chaperones, 
such as HSP60/HSP10, and this function is perhaps the most commonly found so 
far in multi-complex assemblies, where RuvBLs are present as a dodecameric 
complex. The difficulty in discerning the true function of these proteins comes from 
the fact that they have multiple activities, and it is challenging to attribute a certain 
topological area to a specific function, especially when they may overlap. This may  
be the case of the OB-fold, which binds DNA - at least in RuvBL14, and proteins in 
both RuvBL1 and RuvBL217,36. 
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3.2 Crystallographic structure of hsRuvBL2 at 2.8 Å 
 
3.2.1 METHODS  
 
   Protein production 
 
hsRuvBL2 was produced for crystallization purposes using the same 
purification protocol described in the previous chapter. During optimization of 
protein stability and crystallization, different constructs of hsRuvBL2 were tested 
in order to improve the diffraction quality of the crystals: native and 
selenomethionine-substituted, with tags on the C- or N-terminus, and after tag 
removal from the C-terminus (the yield of untagged protein after tag removal from 
the N-terminus was too low for crystallization purposes). The native, N-terminus 
tagged form of hsRuvBL2 was the only construct not amenable to concentration to 
10 mg/mL or crystallization. Good quality-diffracting crystals were obtained from 
native, untagged hsRuvBL2. 
The following steps were added to the purification protocol in order to 
increase protein purity and homogeneity for crystallization purposes. After the tag 
cleavage and removal step, hsRuvBL2 was diluted in buffer to a final NaCl 
concentration of 50 mM and 500 µM ADP, injected into a Resource Q column and 
eluted with a gradient of buffer with 1 M NaCl. The resulting peaks were separately 
applied in the final S200 HiLoad 16/60 size-exclusion column, previously 
equilibrated in a buffer containing 20 mM phosphate pH 8, 200 mM NaCl, 3 mM 
MgCl2 and 500 µM ADP. hsRuvBL2 eluted as a hexamer at a concentration of 10 
mg/mL. 
hsRuvBL2 was dialysed to buffers at different pH values prior to 
crystallization. Crystals diffracting to 2.8 Å were obtained using protein dialysed 
to pH 6. 
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   Protein crystallization and crystal optimization 
 
Crystallization drops were set up with hsRuvBL2 tagged on the C- and N-
terminus, and with untagged hsRuvBL2. Native and selenomethionine-substituted 
forms of the constructs were tested. 
In order to find conditions promoting hsRuvBL2 crystallisation, initial 
crystallization screens were set up, with drops of 0.2 nL total volume in 96 well-
plates, using a Honeybee Cartesian Dispensing System, from Genomic Solutions. 
The crystallization screens performed are listed in table 3.2. Initial crystal hits 
obtained from the commercial screens were tentatively and continually optimized 
by varying combinations of the following factors: temperature; sitting/hanging-
drop; micro batch (under oil); capillary diffusion; streak-seeding; addition of 
compounds (3 screens of 96 different compounds – “additives” - were tested for 
the most promising crystallization conditions); ionic liquids (one screen of 24 
different ILs); precipitant concentration; buffer concentration; crystallization buffer 
pH; protein buffer pH; salt concentration; co-crystallization with nucleotides; 
proportion of protein/crystallization buffer (v/v) in the drop; addition of 
cryoprotectants; use of irregular surfaces to promote seeding. When crystal size 
was above 100 µm, the diffraction quality was tested at room temperature, either 
at the in-house source (Bruker AXS Proteum X8 diffractometer with a Pt135 CCD 
detector, coupled to a Microstar-I rotating anode X-ray generator with Montel 
mirrors) or at a synchrotron beamline. This allows the assessment of the crystal 
diffraction quality prior to addition of cryoprotectants. Additionally, in situ 
diffraction measurements were performed at a synchrotron beamline, with crystals 
still in the drops. For this, we used EMBL-designed plates with an X-ray permissive 
base. At the ESRF beamline BM-14, the plate was fitted in a support equivalent to 
the goniometer used for mounting loops with single crystals. 
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Since the crystal must be removed from the drop and flash-frozen to minimize 
radiation damage during data collection, different cryoprotectant solutions and 
freezing protocols were tested, followed by an analysis of the resolution of the 
crystal, as well as anisotropy. Several cryoprotectants were tested for each 
Table 3.2 – List of crystallization screens performed with hsRuvBL2. Most were used more than 
once for each construct, as changes in protein purification protocol may lead to a final sample with 
different characteristics. The additive screens were performed for each condition that produced 
promising crystals. The OPTI screens were designed in house by Ricardo Coelho, and test 
concentrations of four precipitants: PEG, NaCl, MPD and 2-propanol. These screens were also used 
only in the reservoir, by making drops with the crystallization condition. Commercial screens are 
from Qiagen, Jena Biosciences (JBS), Molecular Dimensions (MD) or Hampton Research (HR). 
Crystallization screens Additive screens 
Structure 1&2 (MD) Additive screen (Hampton) 
Index (HR) Silver bullets 1 and 2 (HR) 
Pact Premier (MD) Ionic liquids (HR) 
JCSG+ (MD)  
Morpheus (MD) Other screens 
Midas (MD) Crystal dehydration kit (JBS) 
Membgold (MD) Methylation kit (JBS) 
MembFac (MD)  
Nucleix (Qiagen)  
Nuc-Pro (JBS)  
Natrix (HR)  
Salt Rx (HR)  
Proplex (MD)  
Footprint + Macrosol (MD)  
Ammonium sulphate (Qiagen)  
OPTI 1 and 2 (handmade)  
PGA (MD)  
MPD (Qiagen)  
Cations (Qiagen)  
Anions (Qiagen)  
Cryos (Qiagen)  
Grid screen (sodium malonate, NaCl, sodium/potassium 
phosphate, ammonium sulfate) (HR) 
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crystallization condition: PEG200 and 400, Fomblin Y, Li2SO4, MPD, dioxane, 
ethylene glycol, glycerol, LiCl, TMAO, NaCl, sucrose, trehalose, xylitol, paraffin, 
paratone, LV cryo oil and malonate. Alternatively, in an attempt to avoid addition 
of cryoprotectants which might disrupt crystal packing, two additional strategies 
were performed with the most promising crystals: high-pressure cryocooling and 
dehydration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 – High-pressure cryocooling. a) High pressure cryocooling chamber, with connections 
to the liquid nitrogen pool below. b) Many crystals collapsed after exposure to high pressure 
levels. c) High pressure did not increase resolution, although diffraction spots became more 
defined. 
a 
b 
c 
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Using high-pressure cryocooling (HPC), crystals were harvested in 
specially designed loops (Fig. 3.6b), loaded into a high-pressure chamber where 
they were pressurized with Krypton gas at 2000 bar, and immediately cooled to 
liquid nitrogen temperature (Fig. 3.6a). The crystals were then transferred to 
regular cryocaps under liquid nitrogen, for data collection. HPC was performed in 
a pressure chamber coupled to a liquid nitrogen bath, handmade by Phillipe 
Charpentier (ESRF, Grenoble), and the crystals were measured at ESRF beamline 
BM14. During high pressure cryocooling, the water in the channels of the crystal 
lattice turns into high-density amorphous ice, instead of the more disruptive low-
density amorphous ice. This precludes the use of infiltratory chemical 
cryoprotectants37–39. 
Crystal dehydration takes into consideration the dynamic nature of 
crystals. The molecules that compose the crystal lattice have a degree of flexibility. 
Upon controlled dehydration of the surrounding environment of the crystal, there 
is a loss of water molecules that causes a lattice rearrangement. While this 
rearrangement is unpredictable and may decrease the quality of diffraction, in 
some cases, a tighter packing may lead to an increase in internal order40.  
Dehydrated crystals also dispense the addition of cryoprotectants. In this 
work, crystal dehydration was performed with two strategies: using saturated salt 
solutions or under controlled relative humidity conditions. 
Dehydration with salt solutions was performed by harvesting the crystals 
with mesh loops mounted on GB-B3S goniometer bases, and immediately covering 
them with MicroRT capillaries (Mitegen), which had been previously filled with a 
saturated salt solution. 12 solutions from the Crystal Dehydration and Salvage kit 
(Jena Bioscience) were tested, and the crystals were equilibrated for 2 minutes up 
to 2 hours, and then cryocooled in liquid nitrogen. 
Controlled dehydration was achieved at a synchrotron source, using a 
humidity control device (HC1) head, mounted at the BM14 beamline of the ESRF 
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(Fig. 3.7). The crystal was harvested using mounted mesh LithoLoops, and 
mounted on the goniometer. The relative humidity value (Rh) was first determined 
for the reservoir solution, and set up with the humidity controller nozzle for each 
crystal. The diffraction pattern of the crystal was analysed as humidity was 
decreased in 1-2% steps. Once the diffraction pattern attained the most satisfactory 
level achievable by that particular crystal, the HC1 head was quickly exchanged 
for the liquid nitrogen nozzle, the crystal was cryocooled and stored to collect a full  
dataset in a more intense beamline (ESRF ID29). 
In some cases, crystal annealing was performed at the synchrotron source, 
by briefly blocking the flow of cold nitrogen gas to allow the crystal to thaw and 
re-freeze. This may lead to a reordering of the crystal lattice, which is afterwards 
tested by observing the resulting diffraction pattern. 
 
Figure 3.7 – Controlled crystal dehydration was performed at BM14. a) Liquid nitrogen (1) and 
humidity control head (2) setup at BM14. b) and c) diffraction pattern collected at the indicated level 
of relative humidity (Rh).  
99% Rh 
8 Å 
95% Rh 
7 Å 
b a 
c 
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Crosslinking was performed by setting up simultaneously a 
glutaraldehyde hanging drop in the same well of a hsRuvBL2 sitting drop, such 
that by evaporation a mild crosslinking would occur. However, this led to protein 
aggregation in the drop. Lysine methylation was also attempted, in order to try to 
obtain a hsRuvBL2 form that could crystallize in a more ordered way, but this 
random addition of methyl groups led to a complete aggregation of hsRuvBL2. This 
may be due to the high amount of Lysines at the surface of hsRuvBL2. The N-
terminal residue is also a methylation target, which may have contributed to a 
decrease in stability. 
 
Production of hsRuvBL2 crystals diffracting to 2.8 Å 
 
Homogeneity of the hsRuvBL2 sample was assessed by size-exclusion 
chromatography, SDS PAGE gels, and by observing the sample in micrographs 
obtained by negative staining electron microscopy. This allowed us to observe 
whether the sample formed aggregates or included a large population of open 
rings, and directed the optimisation of the different purification steps to produce a 
more homogeneous sample, constituted mainly of closed rings. The observation of 
EM micrographs also showed that the rings started to acquire an open 
conformation and to become disrupted after a few freeze/thaw cycles. Finally, the 
purified hsRuvBL2 was dialysed to pH 6 immediately prior to crystallization. This 
pH is closer to the theoretical pI of hsRuvBL2 of 5.66, calculated with the 
Crystallization pH predictor41. 
Several commercial crystallization screens were tested initially (table 3.2). 
Of all the positive hits obtained, only a few were amenable to scale-up and 
optimisation. The crystallization drops were set up at 293 K, with a proportion of 
0.7 µL of protein to 0.3 µL of reservoir solution. 
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The majority of the tested cryoprotectants negatively affected diffraction 
quality, with the exception of glycerol and ethylene glycol (25% v/v). 
 
   Data collection 
 
An overview of the strategies used for crystal analysis and data collection 
 
In over 350 crystals that where tested, some techniques where used in order 
to optimize the collection of good quality data. The major problems observed with 
the crystals of hsRuvBL2 throughout this work were diffraction to very low 
resolution (no diffraction at all for many crystallization conditions), multiplicity 
and anisotropy. 
Initial assessments of crystal diffraction quality were performed with the 
in-house X-ray diffraction system, for crystals larger than 100 µm. Subsequent 
diffraction experiments were performed at high brilliance synchrotron radiation 
facilities (ALBA, Soleil, Petra III, Diamond and ESRF). 
Crystal screening in situ was performed, so as to discard the possibility 
that crystal removal from the drops was responsible for a decrease in diffraction 
quality due to a deformation of the crystal lattice.  
When the crystal size permitted, a grid analysis of the different areas of 
the crystal was performed prior to collection, in order to search for discrete areas 
of higher diffraction power by hitting the crystal briefly with the X-ray beam in one 
direction. The area that produced the most promising diffraction pattern was 
marked for data collection, which was performed in the cases were the first beam 
exposure did not cause radiation damage. 
Since we obtained mostly elongated prism-shaped crystals, helical 
collections were performed in cases when diffraction was of constant quality along 
the crystal - isotropic, so as to minimize radiation damage. 
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Ice coating of the loop surface was cleaned with a liquid nitrogen jet. 
Diffraction data from a crystal diffracting to 2.8 Å was collected at 293.15 
K at Proxima-I beamline, at the Soleil synchrotron source (St. Aubin, Paris, France), 
using a CCD detector (ADSC QUANTUM 315r). 
 
   Structure solution and refinement 
 
Data were indexed and integrated with XDS42, and the space group was 
determined with POINTLESS43 and scaled with AIMLESS44, all within the 
autoPROC data processing pipeline. At this stage, a test set comprising about 5% 
of the measured reflections of the data set was flagged for cross-validation 
calculations (Rfree flag). 
Four datasets were collected from the same crystal, in a total of 347 images. 
Since each image is 1° wide, this means that a 347° “wedge” was collected in total, 
yielding a data set with high multiplicity in space group P6. The total amount of 
collected images was used in a first “brute force” approach, where the high 
multiplicity was favoured in detriment of good statistics, in order to obtain an 
initial electron density map. The four datasets were processed individually and 
scaled together. 
The main data collection and processing statistics are listed in Table 3.3. 
Matthews coefficient calculations45 indicated the presence of one molecule per 
asymmetric unit. 
 
Table 3.3 - Data collection and refinement statistics 
Values in parenthesis refer to the highest resolution shell 
Data collection   
Beamline Proxima-1 (SOLEIL – Paris – France) 
Wavelength (Å) 0.9762 
Space group P 6 (168) 
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Table 3.3 - Data collection and refinement statistics 
Values in parenthesis refer to the highest resolution shell 
Data collection   
PDB entry - 5N7R 
 347o-wedge 40o-wedge 
Cell dimensions   
      a, b, c (Å) 122.97, 122.97, 60.84 122.5,   122.5,   60.65  
      α, β, γ (
o
) 90, 90, 120 90, 90, 120 
Resolution (Å) 106.5 – 2.80 (2.81 – 2.80) 40.25 – 2.87 (2.88 – 2.87) 
Rmerge (%) 38.6 (125.3) 10.5 (47.4) 
R
p.i.m.
 (%) 9.2 (44.1) 7.5 (34.0) 
<I/σ(I)> 14.4 (2.6) 10.2 (2.7) 
Completeness (%) 100 (100) 93.2 (93.8) 
Redundancy 16.4 (9.0) 2.7 (2.7) 
CC
½
 (%) 96.0 (74.3) 98.8 (88.5) 
Wilson B factor (Å
2
) 53.9 61.4 
Refinement   
Resolution (Å)  40.25-2.87 (2.88 – 2.87) 
No. Reflections  11413 
Rwork/Rfree (%)  17.6 / 25.6 
No. Atoms   
      Protein  2946 
      Water  59 
B factors (A
2
)   
      Average  53.1 
      Protein  53.3 
      Water  42.4 
r.m.s. deviations from ideal values   
      Bond lengths (Å)  0.01 
      Bond angles (
o
)  1.13 
Ramachandran plot   
      Favoured  96 
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Table 3.3 - Data collection and refinement statistics 
Values in parenthesis refer to the highest resolution shell 
Data collection   
      Outliers  0.3 
Rotamer outliers (%)  1.6 
Clashscore  0.0 
MolProbity score  0.92 
 
The 3D structure of hsRuvBL2 was solved by the molecular replacement 
method using Phaser46, with hsRuvBL1 domains I and III (cropped from the PDB 
ID 2C9O) as the phasing model. Since domain II corresponds to a very large portion 
of the total protein chain, the phasing power of the ATPase core was not enough to 
immediately provide electron density for that part of the chain, except for an alpha 
helix and part of the chain leading from the core to the mobile domain. For the 
iterative refinement of the electron density map, electron density was initially 
obtained with Buster47, and automated model building performed with 
Buccaneer48,49, in iterative cycles. The chain of domain II was built from the slowly 
emerging electron density, until the phases could no longer be improved with these 
programs. For the final refinement round with Buster, the input structure factor 
data were obtained from a 40° wedge of diffraction images, chosen for their better 
integration statistics, thus ensuring a higher accuracy of the final model. Manual 
model building/fitting was done in Coot50 against 2|Fo|-|Fc| and |Fo|-|Fc| 
electron density maps. Final molecule validation was performed with 
MolProbity51. 
 
Electrostatic surface calculations 
 
The software CHARMM was used to calculate the surface charges 
distribution in hsRuvBL1 and hsRuvBL2. For this, .pdb files of the hexamers were 
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generated, minus the water molecules and with added hydrogens. These files were 
input into the PDB2PQR software to generate .pqr files, which contain the charges 
and radii of the atoms. Topological visualization of the electrostatic potential was 
produced in Pymol with the plug-in APBS52. 
 
3.2.2 RESULTS AND DISCUSSION 
 
Purification of hsRuvBL2 
 
 hsRuvBL2 was first applied to a HisTrap and eluted with a 45% step of 
elution buffer (equivalent to about 500 mM imidazole) (SI Fig. 1). Immediately 
afterwards, the sample was exchanged into a buffer devoid of imidazole (SI Fig. 
2), and incubated overnight at 4°C with HRV 3C protease, in the presence of 1 mM 
TCEP. The mix of cleaved His6 tag, untagged hsRuvBL2, hsRuvBL2-His6 and 
protease was applied to a HisTrap column in tandem with a GSTrap. The collected 
flowthrough contained only untagged hsRuvBL2, and the chromatogram (SI Fig. 
3) indicates a high yield of cleaved sample. Untagged RuvBL2 was injected into a 
Resource Q column and eluted with a gradient of elution buffer containing 1M 
NaCl (SI Fig. 4). Four peaks were separately collected, with conductivity levels 
15.2, 20.2, 27.7 and 36 mS/cm, respectively. All four peaks were applied to the 
subsequent size-exclusion column, and all samples corresponded to hexameric 
hsRuvBL2 (as calculated from a standard curve). SI Fig. 5 corresponds to the 
elution curve of the sample collected in SI Fig. 4, eluted at 27.7 mS/cm conductivity, 
which produced the crystals that provided the hsRuvBL2 structure. The analytical 
SDS-PAGE gel with samples from each purification step is depicted in SI Fig. 6. 
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Crystallization of hsRuvBL2 
 
All constructs of hsRuvBL2 produced crystals. The selenomethionine-
substituted sample, initially expressed for the purpose of structure solution by the 
MAD (multi-wavelength anomalous dispersion) method, was actually more stable 
in solution, and allowed the purification of the N-terminally tagged construct. 
However, the native C-terminally tagged hsRuvBL2 was already quite stable, and 
SeMet substitution rendered that construct so stable that it precluded the formation 
of crystals. Table 3.4 describes the hsRuvBL2 crystal forms obtained, and their 
respective conditions. All crystalline forms were extensively optimized, and a few 
of them subjected to post-crystallization treatments in order to increase resolution. 
Crystals that were deemed too small for diffraction analysis are not included in the 
table. 
Of all the positive hits obtained, only a few were amenable to scale-up and 
optimisation. Condition B8 of the JCSG plus screen (0.2 M MgCl2, 0.1 M Tris pH 7, 
10% PEG 8000), which produced small thin needles, provided the most promising 
results (Fig. 3.8). This hit was reproduced on a larger scale using sitting drop 
vapour diffusion on a 24-well Linbro plate, with 500 µL reservoir solution and 1 
µL drop size. Needle size was increased by varying the crystallization condition 
components and concentrations, to obtain a final solution composed of 2-3% PEG 
3350 and 250 mM MgCl2. The crystallization drops were set up at 293 K, with a 
proportion of 0.7 µL of protein to 0.3 µL of mother liquor. The cryoprotectant 
solution used consisted of the mother liquor supplemented with 1% PEG 3350, 25% 
glycerol and 1 mM ADP. 
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Table 3.4 – The most representative crystals obtained with the different hsRuvBL2 constructs. 
Small non-optimisable crystallization hits are not represented. Untagged hsRuvBL2 was expressed 
with tag on the C-terminus. 
Crystal habit hsRuvBL2 
construct 
Crystallization 
conditions 
Typical 
crystal size 
(µm) 
Diffraction 
limit 
(Å) 
 
N-ter tag, 
SeMet 
 
 
50 mM cacodylate pH 
6.5, 18 mM CaCl2, 2.5 
mM spermine, 1.7% 
isopropanol 
20°C 
110x100 10 
 
N-ter tag, 
SeMet 
 
 
50 mM cacodylate pH 
7, 2.25 mM spermine, 
36 mM MgCl2 
20°C 
Small 27 
 
N-ter tag, 
SeMet 
 
 
20 mM MgCl2, 0.1 M 
MES pH 6, 3% 
isopropanol 
20°C 
Large 15 (multiple) 
 
N-ter tag, 
SeMet 
 
50 mM cacodylate pH 
6, 20 mM MgCl2, 1 
mM spermine, 6% 
ethanol, 25% MPD 
20°C 
200x100 
Very low 
diffraction 
 
N-ter tag, 
SeMet 
100 mM Bis-Tris pH 
5.5, 3.2 M NaCl 
30°C 
200x20 
6.5 
(multiple, 
anisotropic) 
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Table 3.4 – The most representative crystals obtained with the different hsRuvBL2 constructs. 
Small non-optimisable crystallization hits are not represented. Untagged hsRuvBL2 was expressed 
with tag on the C-terminus. 
Crystal habit hsRuvBL2 
construct 
Crystallization 
conditions 
Typical 
crystal size 
(µm) 
Diffraction 
limit 
(Å) 
 
N-ter tag, 
SeMet 
5 mM MgCl2, 2 mM 
CaCl2, 50 mM 
Cacodylate pH 6, 15% 
2-propanol, 1 mM 
spermine 
20°C 
50x50 
No 
diffraction 
 
N-ter tag, 
SeMet 
50 mM Cacodylate pH 
7, 1 mM spermidine, 5 
mM MgCl2, 10% tert-
butanol 
20°C 
small --- 
 
Untagged, 
native 
150 mM Mg Acetate, 
100 mM Ammonium 
Acetate, 5% PEG 4000 
20°C 
60x20 
No 
diffraction 
 
Untagged, 
SeMet 
10% PEG 4000, 150 
mM KCl 
20°C 
Plates ca. 5 
thick 
No 
diffraction 
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Table 3.4 – The most representative crystals obtained with the different hsRuvBL2 constructs. 
Small non-optimisable crystallization hits are not represented. Untagged hsRuvBL2 was expressed 
with tag on the C-terminus. 
Crystal habit hsRuvBL2 
construct 
Crystallization 
conditions 
Typical 
crystal size 
(µm) 
Diffraction 
limit 
(Å) 
 
Untagged, 
native 
2% PEG 3350, 250 mM 
MgCl2 
30°C 
200x30 
2.8 
(frequently 
anisotropic 
and 
multiple) 
 
 
Initial attempts to solve the structure from low resolution data 
 
In previous structural studies with hsRuvBL212,22, domain II was always 
truncated to increase the probability of crystallization. The full-length structure of 
RuvBL2 from a thermophilic fungus (Chaetomium thermophilum) was resolved only 
very recently, as part of the ctRuvBL1/ctRuvBL2 complex7,20, illustrating well the 
difficulties inherent to obtaining diffracting crystals of this protein, mainly due to 
the high mobility of domain II. Despite these difficulties, we managed the first 
successful attempt at the crystallization of full-length hsRuvBL2, which produced 
crystals diffracting to 3.4 Å resolution. 
The dataset was used to determine a preliminary structure of hsRuvBL2, in 
spite of the diffraction pattern being anisotropic and showing 20% twinning, as 
determined from the H-test53. Structure determination was performed by 
Molecular Replacement with PHASER46, as part of the CCP4 suite54, using 
hsRuvBL1 (PDB ID 2c9o) as search model. 
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The electron density maps from the initial MR calculations using the full 
hsRuvBL1 monomer as a single ensemble in PHASER did not show any electron 
density for domain II. To check the possibility that domain II might have adopted 
a different orientation in the hsRuvBL2 monomer, the hsRuvBL1 coordinates were 
divided into two separate ensembles: one contained domains I and III (the ATPase 
core), and the other comprised domain II alone. Furthermore, the connecting 
residues between both ensembles, Arg130 and Thr241 were removed to limit the 
possibility of solutions being rejected due to clashing between both ensembles. 
 
 
Initial hit  After optimization 
Crystal habit 
 
 
 
Crystallization 
condition 
JCSG+ screen 
condition B8: 
10% PEG 8000 
100 mM Tris pH 7 
200 mM MgCl2 
 
20°C 
 
2% PEG 3350 
250 mM MgCl2 
 
30°C 
Diffraction 
pattern 
N/A 
 
 
Figure 3.8 – Crystals of hsRuvBL2: the initial crystallization screening hit and the crystals after 
optimization. 
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These calculations gave a clear solution for the ATPase core but failed again for the 
domain II ensemble. This suggested that the domain II structure in hsRuvBL2 is 
sufficiently different from that in hsRuvBL1, precluding its use as search model in 
MR calculations, or may be an artefact of the low data resolution and quality, since 
domain II represents a much smaller fraction of the total scattering than the ATPase 
core. Nevertheless, the structure obtained for the ATPase core of hsRuvBL2 
provided insights into the crystal packing of full-length hsRuvBL2. The molecules 
associate to form hexamers, which stack along the short crystal axis c and form 
layers parallel to the ab crystal plane. Contacts between hexamers in the same layer 
appear to be weakly mediated by domains II. Combining these observations with 
the previously mentioned simulations by Petukhov and colleagues22, which show 
a very high mobility of domain II in hsRuvBL2, it is reasonable to admit that a better 
stacking of the domains II would be necessary to decrease anisotropy, increase 
resolution, and improve electron density map quality of this protein domain. 
In order to improve the stacking of molecules, two approaches seemed to 
slightly decrease anisotropy and enhance reflection definition, if not resolution: co-
crystallization with myo-inositol and dehydration. A small co-crystal of hsRuvBL2 
with myo-inositol was subjected to controlled dehydration from 98% to 90% 
relative humidity, using the HC-1 device at ESRF BM-14 (Grenoble, France), 
followed by a rapid exchange to the nitrogen gas nozzle (Oxford Cryosystems) for 
flash cooling of the dehydrated crystal. Thus treated, the crystal diffracted to 4.4 Å 
and its diffraction pattern could be indexed in space group P3. Upon analysis of 
that dataset, a blob of positive electron density could be seen in the space between 
the presumed locations of domains II in neighbouring hexamers which seemed 
able to accommodate one molecule of myo-inositol. This suggests the possibility 
that more ordered crystals may be obtained by promoting interactions that stabilise 
the highly mobile domain II. Also noteworthy was the absence of electron density 
in the nucleotide binding pocket, despite the addition of ADP prior to 
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crystallization. Although ADP was shown to increase hsRuvBL2 melting 
temperature (ΔTm = + 6°C), and to be essential during protein purification, we 
cannot exclude that although ADP binds at the active site, it may be somehow 
released during crystallization, unlike what we observed for hsRuvBL1. 
 
Data collection from crystals diffracting to 2.8 Å 
 
Prior to data collection, all crystals were transferred to a cryoprotectant 
solution composed of the mother liquor supplemented with 25% glycerol. Most 
crystals diffracted only to low resolution (around 4 Å) and were mostly anisotropic, 
even in in situ measurements at room temperature. Diffraction data from the best 
diffracting hsRuvBL2 crystal were collected to 2.8 Å resolution The initial analysis 
of the reciprocal lattice from two perpendicular diffraction images (performed with 
EDNA software55) suggested a space group, characterized the unit cell and 
provided a strategy for subsequent data collection (including optimal beam flux, 
so as to minimize radiation damage while maximizing the intensity of reflections, 
and thus amount of acquired data). 
 
Figure 3.9 – Stereo image of the electron density map of hsRuvBL2. Image created 
with Coot50. 
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Fig. 3.9 depicts a stereo view of the electron density calculated for the 
hsRuvBL2 structure, included for quality assessment. 
 
Atomic structure of full-length human RuvBL2 
 
We solved the crystal structure of the human RuvB-Like 2 (hsRuvBL2) in 
the apo form, at 2.8 Å (Table 3.4 and Fig. 3.10). The structure shows a hexameric 
arrangement of monomers similar to other structures in the RuvB-Like family4,7,12,20. 
The distribution of α-helices and β-sheets is represented as a cartoon, obtained with 
 
 
 
Figure 3.10 – Cartoon representations of the overall structure of hsRuvBL2 monomer and hexamer. 
(a) The full–length apo hsRuvBL2 monomer. Domains I, II and III are coloured blue, orange/yellow 
and green, respectively. The visible part of the N-terminal loop and the C-terminal helix are also 
identified in pink and light green, respectively. A linear schematic representation of the domains of 
RuvBL2, using the same colour, is shown below, highlighting the internal and external portions of 
domain II. (b) Side and bottom views of the RuvBL2 hexamer, highlighting the AAA+ core and 
domain II in blue and green, respectively. 
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Pro-origami56, in SI Fig. 7. The hexameric arrangement of hsRuvBL2 in solution 
was confirmed by SAXS coupled to size exclusion chromatography, which 
unequivocally showed the formation of a complex with a mean radius of gyration 
of ca. 52 Å throughout the elution peak (Fig. 3.11). The ring-shaped hsRuvBL2 
hexamer comprises an ATPase core that includes domains I and III, as well as the 
internal region of domain II from each protomer, and six outward-facing mobile 
units that comprise the external region of domains II. Protruding from the ATPase 
core are the six antennae-like α-helices from the C-terminus. The hsRuvBL2 
hexamer has a central channel 24 Å wide on its narrowest part and although a 
double-stranded B-DNA molecule could be tightly fitted (not shown; fitting done 
with PDB entry molecule 1BNA, not considering deviations from B-form caused 
by binding), it has been clearly demonstrated biochemically that hsRuvBL2 can 
only bind single-stranded DNA27. 
 
To the best of our knowledge, similar studies have not been made for 
RuvBL1. However, the smaller size of the inner channel of RuvBL1 (20 Å) and the 
 
Figure 3.11 – Small angle X-ray scattering coupled to size exclusion chromatography shows that 
hsRuvBL2 has a constant radius of gyration (Rg) throughout the elution peak that corresponds 
roughly to a hexamer. UV absorbance in open circles, Rg in closed blue circles. 
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marked differences in the surface electrostatic charge distribution (Fig. 3.12 and 
ref.21 for comparison with the truncated dodecameric complex) suggest the 
possibility of a different mechanism. Since their activities have been observed to 
increase when working together as a heteromeric complex, it is also possible that 
their individual characteristics complement each other, with a consequent increase 
in DNA processing efficiency. The hsRuvBL2 hexamer is 149 Å wide (compared to 
147 Å in hsRuvBL1, which crystallized in a slightly more compact conformation, 
with the domains DII folded backwards into the ATPase core – see figure 3.2) and 
the ATPase core is 51 Å high (compared to 50 Å in RuvBL14 and 51 Å in the 
truncated human dodecameric complex21). The ctRuvBL1:RuvBL2 dodecamer from 
Chaetomium thermophilum has a central channel with similar dimensions (25 Å) and 
is 118 Å wide7,9. The latter is a consequence of the compact conformation of 
ctRuvBL2 in this complex. The interface between protomers in the hsRuvBL2 
hexamer, analysed with LigPlot57 occurs mainly through hydrophobic interactions, 
but also through covalent bonds formed between residues: Asp352-Arg400, 
Arg273-Ser262, Ser310-Phe109/Ser106, Arg124-Phe261, Tyr340-Thr333, Arg314-
Glu112, Gln78-Met443, Asn329-Tyr442, Leu354-Gln404, Ile356-Leu434, His344-
Ser439 and Ser339-Arg334. 
hsRuvBL1 and hsRuvBL2 are homologous proteins with 43% sequence 
identity and 65% sequence similarity that work together as part of large chromatin 
remodelling complexes. However, they also work antagonistically in many 
situations. It has been suggested that the antagonistic activities of RuvBL1 and 
RuvBL2 are the consequence of interactions with different, more or less specific 
partners58. To assess the structural basis for these interaction specificities, we 
analysed the structures of hsRuvBL1 and hsRuvBL2 for differing characteristics at 
the surface of both complexes. A comparison of the surface charge distribution of 
hsRuvBL1 and hsRuvBL2 hexamers (Fig. 3.12) shows marked differences in 
electrostatic potential distribution, mainly on the inner surface of the central 
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channel and on domain II, which suggests different mechanisms/affinities for 
binding the DNA strand and other proteins. hsRuvBL1 and hsRuvBL2 have 
different oligomerization dynamics, since hexamer formation occurs at a much 
higher protein concentration for hsRuvBL1 than for hsRuvBL2 (ref.21 and this work). 
The sum of these observations suggests considerable differences in specificity that 
go beyond overall shape dissimilarity. 
 
Molecular dynamics studies highlighted a propensity of the external 
region of domain II in RuvBLs to acquire a variety of conformations in solution22. 
Comparison of the Guinier plot from an empirical SAXS profile of hsRuvBL2 (Fig. 
3.13, black) with a theoretical plot calculated from the crystallographic coordinates  
 
 
Figure 3.12 – Surface charge distribution in the hsRuvBL1 and hsRuvBL2 hexamers. Differences 
in the distribution of amino acid residues at the surface of the rings may underlie their antagonistic 
activities. Colour by electrostatic potential on solvent accessible surface. Scale bar at the bottom, in 
kT/e. 
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 (red) shows that, in solution, the hsRuvBL2 dmax is similar to that observed in the 
crystallographic structure: 140 – 150 Å in solution versus 149 Å measured between 
the extended tips of domain II. Comparison between the two profiles also shows 
an overall similar shape. However, while the crystallographic structure translates 
into a Guinier plot clearly divided into two well defined regions (which can be 
interpreted as the ATPase core and the domain II extension), the sample in solution 
produced an average curve consistent with a more homogeneous structure. Since 
dmax is similar, these results support a high mobility of the protruding domains in  
 
Figure 3.13 – Mobility of the domain II of hsRuvBL2. a. Guinier plot obtained empirically (black), 
superimposed with a theoretical plot calculated from the crystallographic coordinates (red). b. Side 
view of the hsRuvBL2 hexamer. Atoms are coloured according to B-factor: Blue – lowest; orange - 
highest. 
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the hexamer, as proposed by Petukhov and colleagues24, lending an appearance of 
homogeneity of structure to the plot obtained empirically. 
In addition to the overall mobility of domain II, there are three loop 
fragments that are too mobile to produce an electron density: D148 - S156, I202 - 
Q226 and R253 - Q255. The first two, larger, segments are naturally located on the 
external part of the domain. Using an available structure of domain II from 
hsRuvBL2 obtained by NMR (PDB ID 2cqa), the structural information on this 
domain could be complemented by superimposing the two (Fig. 3.14). It becomes 
apparent that the lack of electronic density is a result of an intrinsic high loop 
mobility that is not restricted by intermolecular contacts in the crystal structure. 
 
 
Figure 3.14 – Superimposition of the crystallographic structure of hsRuvBL2 (blue, PDB ID 5N7R) 
with the NMR model ensemble obtained for the external part of domain II (yellow, PDB ID 
2CQA). The loop on the tip of domain II (black arrow) is not ordered in the crystal structure, but can 
be observed as highly mobile in the NMR structure. Structure alignment performed with Chimera59. 
 
C 
Structure of hsRuvBL2 
 145 
  Structural basis for coupling ATP binding to mechanical action 
 
It is a sensible assumption that the basis of ATP-dependent activities in 
RuvB-Like proteins lies upon the mechanical consequences of ATP binding and 
hydrolysis. In order to elucidate what these consequences might be in the case of 
hsRuvBL2, we compared the structure of human apo hsRuvBL2 (this work) with 
the ADP-bound form of RuvBL2 from C. thermophilum9 (ctRuvBL2, PDB ID 4WW4), 
which has 68% identity and 85% similarity with hsRuvBL2, as well as a conserved 
disposition of the key residues that constitute the ATP binding pocket (Fig.  3.15). 
In ctRuvBL2, nucleotide binding leads to a tightening of the binding pocket near 
the phosphate tail. The β-phosphate of the ADP molecule interacts with 
neighbouring residues R399, K83 and N328 of ctRuvBL2 (which correspond 
 
 
Figure 3.15 – The nucleotide binding pocket and the N-terminus Histidines involved in the motion 
of the N-terminal loop towards the nucleotide. (a) Superimposition of the nucleotide binding pocket 
of C. thermophilum (yellow, 4WW4) with the human homologous residues (blue, 5N7R). The ADP 
(depicted in red) is from the fungal structure. Atoms are coloured as follows: N – dark blue; O – 
salmon; P – dark yellow. V47 from C. thermophilum is depicted in pink since it is part of the N-terminal 
loop. (b) Position of Histidines 24 and 26 in relation to ADP in the binding pocket of ctRuvBL2. The 
interatomic distances shown are in Å. 
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Figure 3.16 – Structural comparison between existing structures of RuvBL2 (human RuvBL2, 
human RuvBL2ΔDII and C. thermophilum RuvBL2) suggests a link between nucleotide binding 
and domain II motion. (a) The apo hsRuvBL2 (blue, this work, PDB ID 5N7R) is associated with a 
stretched, or at least loose conformation of the domain II. (b) The apo hsRuvBL2 is superimposed 
with the ADP-bound ctRuvBL2 from C. thermophilum (yellow, PDB ID 4WW4). When compared with 
the apo hsRuvBL2, the ADP-bound ctRuvBL2 displays a positioning of domain II proximal to the 
ATPase core and a more ordered N-terminal loop (pink). ADP is depicted in red sticks. (c) The ATP-
bound, domain II-truncated hsRuvBL2 (light pink, PDB ID 2XSZ) is superimposed with the full-
length ctRuvBL2 (4WW4). It becomes apparent that the absence of the external part of domain II has 
an influence in the organization of the N-terminal loop. In both nucleotide-bound forms, the N-
terminal loop interacts with the nucleotide through two conserved histidines; however, in the 
truncated hsRuvBL2, the N-terminal loop (blue) remains disordered from the first residue up to the 
place of interaction with the nucleotide. The histidines that interact with the nucleotide are depicted 
in green and the motif is highlighted; residues involved in electrostatic interactions between the N-
terminal loop and domain II are depicted in light blue and highlighted as well. 
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to R400, K83 and N329 of hsRuvBL2) (Fig. 3.16a). Concomitantly, nucleotide 
entrance into the binding pocket causes a displacement of Y361 and V47 (Y362 and 
V47 in the human protein) due to hydrophobic interactions with the adenine ring, 
driving the initial rearrangement of the N-terminal loop, into a more ordered 
position in close proximity with the nucleotide binding pocket. We propose that 
these interactions initiate the coupling between nucleotide binding and mechanical 
movement of domain II, depicted in Fig. 3.16. This figure shows that, while apo 
hsRuvBL2 has no electron density up to residue 47 (Fig. 3.16a, shown in pink), 
ADP-bound ctRuvBL2 could be modelled for most of the N-terminal loop (Fig. 
3.16b), supporting a connection between ADP binding and N-terminus 
reorganization, as previously suggested7. Furthermore, in ADP-bound ctRuvBL2, 
domain II is more tightly packed against the ATPase core, a conformation in which 
this domain interacts closely with the proximal part of the N-terminus. The apo-
hsRuvBL2 structure was further compared with the ATP-bound form in the 
hsRuvBL1ΔDII:RuvBL2ΔDII complex12 (Fig. 3.16c, PDB ID 2XSZ), showing that in 
the absence of an interaction between the N-terminus proximal segment and the 
 
Figure 3.17 – Model of domain II-truncated hsRuvBL2 monomer (PDB ID 3uk6)24. Of the twelve 
molecules in the asymmetric unit, most have the modelled N-terminal loop (pink). Only one does 
not have an ordered N-terminal loop, and two have a longer loop before the histidines, stabilised by 
interactions with the internal portion of domain II and the adjacent protomer. ATP depicted in red 
sticks (arrow). 
 
N 
C 
Structure of hsRuvBL2 
 149 
external region of domain II, the N-terminal loop is stabilized only from the point 
where it interacts with the bound nucleotide, through Histidines 40 and 42 (H24 
and H26 in ctRuvBL2, not visible in apo hsRuvBL2), and the proximal part remains 
unstructured. This was also observed in the structure of domain II-truncated 
hsRuvBL2 bound to ADP24 (Fig. 3.17). These observations support the proposal of 
the following sequential events: in ATP-dependent activities, the nucleotide first 
binds to the nucleotide-binding pocket, eliciting a rearrangement of the 
surrounding residues, which causes the most distal part of the N-terminus to move.  
The predicted movements that would occur in a RuvBL2 monomer, during 
its transition from the apo to the nucleotide-bound form include the movement of 
the N-terminal loop as it is tethered by interactions with the nucleotide through 
histidines 24 and 26 in ctRuvBL2 (Fig. 3.16b – the structured N-terminus from 
ctRuvBL2 is depicted in pink, with the tethered histidines in green). This initial 
interaction then draws the remaining part of the N-terminus into the close vicinity 
of the external region of domain II. Here, the conserved residues Glu11, Lys13 and 
Glu14 from the N-terminus, and Lys183 and Ile201 from domain II (Glu12, Arg14, 
Asp15 and Lys184 in hsRuvBL2) are responsible for the electrostatic interactions 
that sustain the positioning of domain II in close proximity to the ATPase core. 
Thus, our apo-hsRuvBL2 structure provides the missing link that supports the 
mechanism proposal whereby the N-terminal loop provides an interface between 
the external region of domain II and the ATPase core. Interestingly, key residues 
involved in the proposed mechanism are conserved between the human and fungal 
forms (Fig. 3.18). Recent work by Zhou and colleagues (2017) with the yeast 
Rvb1/Rvb2 complex and an Ino80 insert (Ino80INS) supports this connection 
between nucleotide binding and movement of domain II. In their work, they 
observe that a dodecamer previously assembled due to Ino80INS binding to 
domain II, can be collapsed into hexamers by ATP binding, concomitantly with a 
loss of binding to Ino80INS. The collapse of dodecamers into hexamers is correlated  
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to the changes in dodecamer conformation observed by Ewens and colleagues 
(2016) upon nucleotide addition62, which causes a significant reconfiguration of 
domains DII. These changes in configuration may also be responsible for the loss 
of affinity to Ino80INS. 
 
On the other hand, nucleotide binding to RuvBL1 does not seem to elicit 
the same structural changes as for RuvBL2. In fact, despite the similar initial 
interaction of the two conserved Histidines with the nucleotide, both in human and 
in C. thermophilum RuvBL1 the N-terminal loop is directed towards interactions 
with domain 1: Arg15 interacts with Pro96 from ctRuvBL1, and Lys11 with Pro95 
from hsRuvBL1. Most of the conserved residues highlighted in the proposed 
mechanism are also conserved in RuvBL1, which suggests that additional residues 
may have a significant influence in the outcome of nucleotide binding. Possible 
differences between action mechanisms of RuvBL1 and RuvBL2 may also be 
connected to the observed differences in stability in consequence to tag placement 
in the N-terminal loop: while hsRuvBL1 could be expressed and purified with no 
signs of instability, hsRuvBL2 had a tendency to aggregate at higher concentrations.  
Curiously, the opposite effect was observed upon tag placement in the C-terminal 
helix: while hsRuvBL2 retains some stability, hsRuvBL1 formed inclusion bodies 
during expression tests. The structural reasons behind these different consequences 
Figure 3.18 – Alignments of RuvBL2 from Homo sapiens and Chaetomium thermophilum. Top: 
alignment of protein sequences. The highlighted residues are involved in the reorganisation of the N-
terminal loop. Secondary structure elements (SSE) of hsRuvBL2 are depicted on top of the alignment. 
Alignment made with Clustal Omega60 and SSE depiction obtained with ESPript 3.061. Bottom: 
Structure alignment of the OB-folds from the two structures (human 5N7R, cyan and C. thermophilum 
4WW4, yellow) shows that the residues involved in the stabilisation of domain II have the same spatial 
distribution. The lysine residues depicted as sticks have a role in the proposed mechanism, and are 
conserved between the two organisms (as indicated by a triangle in the top panel). Structure alignment 
obtained with Chimera59. 
 
Chapter 3 
 152 
of tag placement on the C-termini may be related to the fact that in hsRuvBL2, this 
helix is longer than that of hsRuvBL1, while in the latter, the helix is shorter and is 
wholly involved in contacts with the adjacent monomer in the homohexamer. 
 
3.3 Structure of hsRuvBL2 by electron microscopy 
 
Single-particle electron microscopy (EM) is a technique used to determine 
the structure of individual molecules about 250-300 KDa in size, using information 
gathered from electrons transmitted through the dispersed molecules in the sample 
(Transmission Electron Microscopy). It can be divided into negative-staining EM 
and cryo-EM. Negative staining EM provides structures of lower resolution (up to 
15 Å), since contrast is provided by the use of a heavy atom salt, but it is easier to 
setup and process, as well as cheaper to perform, and thus is used for optimisation 
of sample preparation conditions. Cryo-EM has seen extraordinary improvements 
over the last few years as a technique capable of providing the atomic structures of 
molecules. The sample is directly cryopreserved in the sample buffer, and thus 
contrast is provided mainly through the phase differences caused by the 
interactions of the electron beam with the sample as compared to the surrounding 
buffer. It is much more expensive and challenging to setup and process, and thus 
it is only used after all conditions have been optimised using negative staining EM. 
The study of the structure of hsRuvBL2 was complemented by the use of 
electron microscopy in several ways. The hsRuvBL2 complex consists of six 
modules with mobile domains that most likely acquire different conformations in 
solution24, which in principle would not be observed by X-ray crystallography. 
Furthermore, EM allows the identification of all types of particles present in the 
sample (provided their number is high enough to generate sufficient signal 
intensity vs noise upon averaging). This is particularly useful to compensate for 
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other techniques, such as AUC, for which the associated error may not allow 
discerning large complexes with a difference of one monomer in their composition. 
 
3.3.1 METHODS 
 
     Protein production 
 
hsRuvBL2 was obtained to a high degree of purity and homogeneity using 
the previously described protocol. Prior to the electron microscopy experiments, 
hsRuvBL2 samples were dialysed to a buffer containing Tris pH 8.0 instead of 
phosphate buffer, since the latter reacts with the heavy metal salt (uranyl acetate) 
used for negative staining, producing salt crystals. Samples were kept at 4°C, since 
freeze/thaw cycles promoted dissociation of oligomers, and analysed as soon as 
possible after purification. 
 
   Sample preparation – negative staining 
 
Sample concentration in the grid was optimised to ca. 20 µg/mL; however, 
since sample concentration can be quite variable due to operator or equipment 
failures, concentrations were tested empirically by performing different dilutions 
with Tris-containing buffer. The method used in this work to perform negative 
staining is called the Flotation Method. The procedure involves floating the EM 
grid on a droplet of sample, to permit adsorption of the specimen. The grid is then 
blotted on filter paper, immediately transferred onto a nearby uranyl acetate drop 
for another 2 minutes, blotted again and it is then ready for use. Rhodium/Copper 
EM grids were pre-treated with a carbon coating, rendering the surface uniform. 
The hydrophobic surface of the grid was rendered hydrophilic through an 
electrical glow discharge. 
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Two forms of hsRuvBL2 were studied: untagged and with tag on the N-
terminus. The untagged protein was adhered to the EM grid for 2 minutes, blotted 
and stained with uranyl acetate for another 2 minutes. 
N-terminally tagged hsRuvBL2 forms dodecamers in the conditions used 
in this work. However, these are labile complexes, and easily separate into its 
constituent hexamers upon dilution, as demonstrated by analytical 
ultracentrifugation. In order to prevent dodecamer dissociation, glutaraldehyde 
was used in a very mild cross-linking procedure termed GraFix63, by which the 
sample was applied on top of a sucrose gradient, which was also a glutaraldehyde 
gradient. The final gradient parameters were as follows: 10 – 25% sucrose, 20 mM 
HEPES pH 8.0, 250 mM NaCl, 2 mM MgCl2, 1 mM ADP. The heaviest solution also 
contained 0.2% glutaraldehyde. Gradients were performed by applying the top 
(light) solution first, and then injecting the bottom (heavy) solution using a thin 
needle, at the bottom of an ultra-clear 11 x 60 mm tube, and dispensing slowly. 
Finally, both solutions were mixed to achieve a continuous gradient, with Gradient 
master (Biocomp). 40 µL of N-terminally tagged native hsRuvBL2 (0.3 mg/mL, 
equivalent to ca. 180 pmol), was then gently applied on top and ultra-centrifuged 
at 37000 rpm for 13.5 h, in a SW60 Ti rotor (Beckman), at 4°C. Fractions (200 µL) 
were collected from top to bottom with a micropipette, and aliquoted on ice. No 
glycine was added to inactivate the glutaraldehyde, since the samples were either 
immediately desalted into a buffer with Tris (compatible with EM reagents and less 
harmful to the sample than HEPES) or later on diluted in this buffer.  
Time for sample adhesion to the grid was increased for the N-terminally 
tagged hsRuvBL2 sample, due to the very low concentration obtained after the 
GraFix procedure, to ca. 15 h at 4°C, inside a closed Petri dish. After this incubation 
period, the grid was washed and stained for 2 minutes. Unfortunately, despite the 
fact that some molecules resembling dodecamers could be observed, the number 
of particles per micrograph was too low for data processing. 
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     Data collection - negative staining EM 
 
Micrographs were obtained using a Tecnai F20 or a JEOL JEM-1010 TEM, 
with exposure time per picture of 0.2 - 0.9 s and a dose of 20 - 25 e-/Å2s, and collected 
using a CCD camera. Between 200 and 400 micrographs were taken for each 
sample, depending on the observed concentration of molecules per micrograph. 
 
     Data processing and refinement of negative staining data 
 
In Transmission Electron Microscopy, in this particular case single particle 
EM, the objective is to produce a three-dimensional model (volume) of the 
macromolecule from 2-dimensional projections, by finding the relations between 
them. To achieve this, the collected data (projections, also called “particles”) are 
individually picked, and similar views are averaged to increase the signal-to-noise 
ratio. An initial density estimate is built by, e.g., applying the common lines 
method, which consists of performing the Fourier transform of the projections, 
finding the common lines between them, and building a 3D model in Fourier space, 
which is then back transformed in to real space. Different projection angles are 
generated and compared to the empirical projections, generating a cross correlation 
(similarity) coefficient. The projections with the highest cross correlation 
coefficients are assumed to have the same Euler angles as the empirical 
projections64–66. The best matching position for each particle image is determined, 
in an iterative refinement process, thus improving the model. 
The hexameric form of hsRuvBL2, has a molecular weight of about 300 
KDa, which lies on the lower limit of size that can be studied by cryo-EM (at the 
time of the experiment). This makes the identification of particles in micrographs 
very challenging, and it is essential that good contrast be obtained. It also renders 
essential an initial analysis of the molecules by negative staining, prior to the cryo-
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EM studies. This has allowed for preliminary knowledge to be gained on the 
behaviour of the molecule, especially its shape and size on the micrograph. 
Since we could observe both top and side views of the hsRuvBL2 hexamers 
on the carbon coated grids, low resolution 3D reconstructions were performed. The 
Scipion program package (developed by the Biocomputación Unit team at CNB), 
was used to import the micrographs. Before particle picking, the contrast transfer 
function was estimated with CTFFind67 and corrected using the Xmipp package. 
Particles were hand-picked with Xmipp68, by choosing all specimens that may 
correspond to individual particles, in all orientations found. 
Selected particles were divided into 2D classes with cl2d69. Each class is an 
average of a set of images with the same orientation/conformation. Similar 2D 
classes were used to produce an initial volume. All particles belonging to similar 
2D classes were chosen to produce a 3D class, using as template the previously 
obtained initial volume. The 3D class was then refined to the final structure. 
 
3.3.2 RESULTS AND DISCUSSION 
 
The analysis of hsRuvBL2 by negative staining EM has allowed us to 
greatly improve sample quality, by direct observation of the integrity of the 
hsRuvBL2 rings on the micrographs, in parallel with improvements of the 
purification protocol. This had great impact on the quality of crystals obtained for 
X-ray diffraction studies. 
 
Low resolution structure of hsRuvBL2 by negative staining EM 
 
The fact that hexamers have high symmetry greatly contributes to the 
achievable quality of the final structure. A low resolution volume of hsRuvBL2 was 
obtained (Fig. 3.19, grey surface), which fits nicely with the crystallographic model 
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of hsRuvBL1 (pink) as expected, due to the high degree of identity between the two 
proteins. The fit was not as good for the crystallographic structure of hsRuvBL2 
(blue), mainly because the domains II are in a more extended conformation. 
Additionally, the “antennae-like” C-terminal α-helices of hsRuvBL2 
positioned on top of the ring do not appear in the EM volume of hsRuvBL2. The 
technique used (negative staining) may provide an explanation for these 
observations: this technique implies that the molecules are deposited on the EM 
grid, and afterwards a layer of a heavy atom solution (uranyl acetate) is deposited 
on top of the molecules. This is known to lead to deformation of the sample, and 
possibly flattening, which may justify the absence of an envelope portion 
 
 
 
Figure 3.19 – Low resolution envelope of the human hsRuvBL2 hexamer, obtained by negative 
staining electron microscopy (gray), superimposed with the crystallographic structure of hsRuvBL1 
(pink) and hsRuvBL2 (blue). Left: side view. The C-terminal helices visible in the crystallographic 
structure protrude from the EM envelope. Right: top view. The alignment was made by the more stable 
ATPase core, since the rmsd values between the cores of hsRuvBL molecules are generally lower than 
for the domain II. Domains II from the crystallographic structure of hsRuvBL2 do not fit the volume, 
since the EM sample seems to be in a more compact conformation, more similar to that of the 
crystallographic structure of hsRuvBL1. Hence, the latter seems to be a better fit with the EM volume. 
Figure produced with Chimera59. 
 
Side view Top view 
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corresponding to these C-terminal α-helices and a more horizontal disposition of 
the mobile domains. 
Surprisingly, after averaging all particles picked, we observed that some 
2D classes unequivocally belonged to heptamers (Fig. 3.20). This form of the 
protein corresponds to about 10% of all picked particles, and may be due to 
different reasons. It is possible that it corresponds to an error in assembly of the 
protein, with no biological significance. However, if this were the case, the 
formation of other random forms, such as pentamers or octamers would also be 
expected (unless precluded by steric constraints due to the arc formed by the ring). 
It may also be the case that hsRuvBL2 can, in some conditions, assemble as 
heptamers, and since the currently used conditions are not optimal for heptamers 
formation, only a small proportion was formed, due to it being putatively pre-
designed for that. Refinement of observed heptamers was not possible due to the 
low number of particles obtained. 
The hsRuvBL2 rings acquired a very frequent open conformation about 5 
hours after the samples were extensively diluted. The structure became open in a 
U or V shape, with the hinges seemingly between dimers or trimers (Fig. 2.6, see 
chapter 2).  If the dilution of the sample was kept for extended lengths of time 
 
Figure 3.20 – hsRuvBL2 is able to form heptamers. 10% of the total picked particles corresponded 
to this oligomeric form, highlighted in red. 
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(days), the rings completely disaggregated into monomers. This seems to suggest 
that, under certain conditions, it may be possible for hsRuvBL2 to acquire an open 
conformation, a characteristic also observed in the Rho helicase70. The physiological 
significance of this finding is not yet understood, but it may be suggested that, 
upon hexamer formation, it can open up, in order, for instance, to bind DNA or 
release it. If a parallel is made between what is observed in this work for hsRuvBL2, 
and what is known of Rho helicase, it can be suggested that, either starting from a 
monomeric form, as observed by Papin and colleagues71, or from an open notch 
conformation, as observed for Rho72, hsRuvBL2 re-forms a closed ring after binding 
to a polynucleotide chain (see chapter 2). This conformational transition would 
activate all the nucleotide-binding sites, which are only completed by the 
contribution of two adjacent monomers. 
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4.1 Discussion 
 
At the onset of this work, the atomic-level structures available of proteins 
from the RuvBL family included the full-length structures of the Chaetomium 
thermophilum RuvBL1/RuvBL2 complex1,2, the human RuvBL1/RuvBL2 truncated 
complex (lacking the regulatory domain II)3, the full-length human RuvBL1 
complex4 and a partial structure of human RuvBL2, which also lacked the 
important regulatory domain II. Further, the pool of knowledge on the oligomeric 
behaviour of this protein in solution was practically non-existent, and the DNA 
binding behaviour still contained considerable gaps, particularly on the changes 
that occur upon binding. Considering the known involvement of hsRuvBL2 in a 
myriad of cancers and other pathologies, we felt it necessary to contribute to this 
area of knowledge (main gaps summarised in fig. 4.1), by focusing our efforts in 
the full-length hsRuvBL2 structure elucidation. We further aimed to complement 
 
Figure 4.1 – State of the art at the onset of the work of the main areas addressed in this thesis.  
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the high resolution structural information with low resolution information, using 
electron microscopy and small angle X-ray scattering. Information on protein 
behaviour in solution was obtained using size-exclusion chromatography, 
analytical ultracentrifugation and SAXS. We further aimed to gain further 
understanding on the mode of DNA binding of both human RuvBL proteins using 
electrophoretic mobility shift assays, and used electron microscopy to observe 
oligomeric changes of hsRuvBL2 in the presence of DNA. 
ATPase assays did not show any activity as compared with a positive 
control, even in the presence of ssDNA. This is probably because hsRuvBL2 was in 
the hexameric form, which has been shown to be inactive for ATP binding and 
hydrolysis. The use of monomeric protein was however precluded by the 
concentration required to overcome the relatively low sensitivity of the 
colorimetric assay used. We will attempt to overcome this limitation in future 
studies by looking at other methods for ATP hydrolysis assays with higher 
sensitivity, preferably high-throughput (HT) methods, in order to analyse the 
behaviour of RuvBL2 in the presence of chemical compounds. 
 
The main objective of this work was the structural study of the multi-
function human RuvB-Like 2 protein, RuvBL2. This protein is involved in several 
fundamental pathways, from transcription regulation and cell-cycle control to 
chaperone in the biogenesis of snoRNPs, with implications on several complexes, 
such as ribosomes and the Telomerase complex. Due to the high mobility of the 
RuvBL2 oligomer, the attainment of a crystallographic structure required a 
continuous and extensive optimization of the purification and crystallization 
protocols. The structure described here is topologically similar to others in the same 
family1,2,4, albeit with some distinguishing features. In particular, the comparison 
of the surface electrostatic charges of hsRuvBL2 and hsRuvBL1 suggests that the 
differences in the regulation of their activities may be related to interactions with 
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distinct binding partners, and possibly the addition of post-translational 
modifications at different sites. Additionally, the structure of apo hsRuvBL2, when 
compared to nucleotide-bound structures, suggests that upon nucleotide binding, 
the N-terminus undergoes reorganization through coordination with two 
conserved histidines (H24 and H26 in ctRuvBL2, H40 and H42 in the hsRuvBL2). 
As a consequence of this movement, the N-terminus becomes suitably positioned 
to act as an interface between the ATPase core and domain II, through electrostatic 
contacts mediated by a conserved lysine (Fig. 4.2). 
 
The hsRuvBL1 N-terminus also contains the conserved histidines that bind 
to ATP in the binding pocket. However, the fact that the nucleotide-bound 
structures of RuvBL1 do not display the same compact conformation for the 
domain 2 extension hints at a distinct mechanism of action and possibly regulation. 
The proposed mechanism of action for RuvBL2, which relies on the mobility of the 
N-terminus, would partly justify the, observed by us, disruptive effect on protein 
stability of an added purification tag at this extremity. These observations, together 
with the data obtained by analytical ultracentrifugation on oligomeric behaviour 
 
Figure 4.2 – Schematics of the N-terminus reorganization. Upon ATP (red star) entrance to the 
binding pocket (square), the N-terminal segment is re-organized, and forms an interface for 
interaction with domain II (DII). The latter domain thus moves into the close vicinity of the ATPase 
core, putatively stabilised by conserved charged residues. 
 
Chapter 4 
 170 
according to tag placement, also suggest that in hsRuvBL2, the N- and C-termini 
may have an influence in oligomerization. The opposite effect was observed for 
hsRuvBL1, which in our hands could only be expressed in soluble form with the 
tag on the N-terminus. This further supports different mechanisms of action for the 
two RuvBLs, despite their sequence and structural similarity. The proposed 
mechanism may also provide a rationale for understanding the effects of mutations 
that interfere with the activity of RuvBL2, such as the lik (FCR) mutation, in which 
Phe-Cys-Arg residues are inserted within the OB fold (located in domain II), 
between G190 and D191 (Fig. 4.3). This mutant has an increased and DNA-
independent ATPase activity, as well as an altered pattern of oligomerization, as 
compared to the wild-type protein5,6. In light of the mechanism of action proposed 
in this work, it is likely that the inserted residues in the lik mutant of RuvBL2 lead 
to the enhanced ATPase activity by increasing the bulk size of the OB-fold. The 
additional hydrophobic residue may further promote a preferentially compact 
 
Figure 4.3 – hsRuvBL2 monomer (cyan). The Phe-Cys-Arg insertion present in the lik mutant occurs 
between the G190 and D191 residues (orange sticks), within the OB-fold. This insertion increases the 
bulk size and changes electrostatic and hydrophobicity properties of the DII domain, which increases 
ATPase activity. 
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 conformation. Together, these effects may lead to an increased ATP turnover by 
decreasing the amplitude of domain 2 motion in relation to the ATPase core, 
thereby increasing its frequency. Alternatively, a preferentially compact 
conformation may translate into a more accessible nucleotide binding site of the 
oligomer, thus increasing the rate of nucleotide entry and exchange. These 
suggestions on the effect of this mutation are however very speculative, and 
require the analysis of more structural intermediates of action, both to clarify the 
proposed mechanism and the putative influence of functional mutations. 
The hsRuvBL2 crystal structure presented in this study provides insight 
into the mechanisms whereby this protein, alone or in combination with hsRuvBL1, 
may contribute to the regulation of diverse cellular functions. Distinct structural 
features of RuvBLs are the basis of different, and sometimes antagonistic roles in, 
e. g., the regulation of development. Other aspects that may regulate their activities 
differently are their different rates of dissociation into monomers (and how this 
modulates their roles), ATPase and DNA binding kinetics (data already published 
on this regarding RuvBL2, for monomers and hexamers)7. Although it must be 
considered that in the cell these rates may be affected by cell crowding and specific 
regulators depending on the cell cycle phase, localization etc., the kinetic values 
observed in vitro may provide some indication of their predispositions. 
Interestingly, the group of Claire Davies has observed that RuvBL1 R205 is 
methylated by PRMT5, in the context of TIP60 regulation of histone acetylation, 
but not the RuvBL2 equivalent R206 (Fig. 4.4). In their publication (in co-
authorship with our group), they base their justification for this fact on the 
observation that the location of these residues within domain II can adopt widely 
different orientations with respect to the ATPase core, and while so far all reported 
RuvBL1 structures show R205 to be exposed to the solvent (and therefore accessible 
to methylation), all RuvBL2 structures to date showed R206 to be occluded by the 
compact conformation of domain II8. The present study shows, however, that 
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RuvBL2 may acquire an open conformation of domain II, in which the discussed 
residues fall in similar topological areas, both solvent-accessible, as depicted in Fig. 
4.4. Therefore, the fact that this arginine is methylated in RuvBL1 but not in RuvBL2 
may be justified by either an increased prevalence of a compact conformation in 
RuvBL2, or the involvement of other regulatory factors. 
In order to gain insight into the flexibility of the hsRuvBL2 oligomer, a 
negative staining electron microscopy analysis was performed. The obtained low-
resolution structure is similar to others of the RuvBL family, and together with a 
SAXS analysis, supports a wide conformational flexibility of the outwards 
protruding domains II, as expected. Surprisingly, the EM particle averages also 
showed the presence of heptamers in the sample, in addition to the expected 
 
Figure 4.4 – Superimposition of hsRuvBL1 (pink) and hsRuvBL2 (cyan). R205 from RuvBL1 is 
depicted in green sticks, and K201 from RuvBL2 in yellow sticks. The latter is depicted for spatial 
location of the area where R206 is roughly located, since this residue falls within a loop for which 
there is no built model. These two residues seem to be located in similar topological locations, which 
would be exposed when domain II is in an “open” conformation. 
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hexamers. A cryo-EM analysis is currently being performed in order to obtain a 
higher resolution structure of this complex in conditions closer to the native state 
in solution. 
 
The structural analysis was complemented with a study of the 
oligomerisation behaviour in solution, by analytical ultracentrifugation. This 
analysis aimed at defining the influence of tags in the human RuvBL2 oligomer, 
since such an interference had been described for the yeast complex9. Indeed, the 
oligomerisation state of human RuvBL2, as well as its stability, is also affected by 
tags. As with the yeast Rvb1 and Rvb2, hsRuvBL2 forms dodecamers when 
expressed with affinity tags on the N-terminus (Fig. 4.5, left). Further, SEC and 
AUC analyses show that this construct also forms hexamers, monomers and high 
molecular weight species, with the proportion of each depending on protein 
 
Figure 4.5 – Influence of affinity tags in oligomer formation of hsRuvBL2. Left: hsRuvBL2 expressed 
with tags on the N-terminus (pink) will associate into various oligomeric forms in solution. Right:  
hsRuvBL2 expressed with tags on the C-terminus (green) associates into hexamers (with a small 
percentage of heptamers, identified by electron microscopy). 
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concentration. The formation of different molecular weight oligomers seems to be 
maintained after N-terminal tag removal, as demonstrated by SEC analyses. When 
the affinity tags were placed on the C-terminus of hsRuvBL2 however, only 
hexamers were formed at all concentrations tested, even after tag removal (Fig. 4.5, 
right). These observations suggest that oligomerization plasticity may be 
determined during protein biogenesis. 
 
Finally, an analysis of the DNA-binding properties of hsRuvBL2 was 
performed, by electrophoretic mobility shift assay. As previously observed in other 
studies7, hexameric hsRuvBL2 did not bind ssDNA in our hands. However, when 
the same form was co-incubated with monomeric hsRuvBL1, we observed binding 
of both hsRuvBL1 and hsRuvBL2. This binding ability was prevented by the prior 
co-incubation of hsRuvBL1 monomers with AMP-PNP, which suggests that ATP 
hydrolysis may be necessary for ssDNA binding. Furthermore, we observed by 
electron microscopy that monomeric hsRuvBL2 assembles into ring-shaped 
complexes in the presence of ssDNA. It is possible that hsRuvBL2 oligomerizes 
around the DNA molecule, but this hypothesis still requires confirmation. 
 
A collaboration with the group of Michael Sherman (Boston University 
School of Medicine) resulted in the publication of results connecting the 
hsRuvBL1/RuvBL2 complex and the disaggregation of amyloid fibrils10. In short, 
this group identified hsRuvBL1 and hsRuvBL2 as being associated to aggresome 
formation through a full-genome siRNA screen in mammalian cells. The 
aggresome is an organelle formed to transport polypeptide aggregates in the 
cytosol to the centrosome. This system comes into play in aged and diseased cells, 
which do not have functioning chaperones or an active ubiquitin-proteasome 
system. Deletion of either RuvBL1 or RuvBL2 abolished aggresome formation in 
mammalian cells. Additionally, a crosslinking-MS/MS analysis using aggresome 
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substrate synphilin-1, identified RuvBL1 as a direct binding partner. The 
crosslinked residues were K663 of synphilin-1 and K372 of RuvBL1, the latter 
located at the top of the ATPase core. Furthermore, it was shown that interaction 
of RuvBL1 with synphilin-1 targeted this protein to the aggresome. Further binding 
assays show that RuvBL1 interacts with other misfolded peptides, such as 
Amyloid-β and insulin fibres, with the consequent stimulation of the ATPase 
activity of the RuvBL1/2 complex, particularly of the domain II-truncated form.  
Our contribution to this work was in the form of pure hsRuvBL1/2 
complex, both full-length and domain II-truncated3. Briefly, for the production of 
the full-length complex, each tagged protein was separately expressed in E. coli, 
and the pellets of both expressions were re-suspended together before cell 
disruption and purification, in the presence of ADP. The final step was a size 
exclusion S200 26/60 HiLoad column, which produced three peaks, corresponding 
to complexes with the apparent molecular weights 659, 546 and 502 KDa. These 
indicate molecules around the size of a dodecamer, and suggest either partial 
monomer loss or differences in shape that cause different elution profiles. 
 
In cancer patients, hsRuvBL2 overexpression is considered a mark of poor 
prognosis11–15. Previous works have shown that, in hypoxic conditions, hsRuvBL2 
is methylated at K67 (Fig. 4.6), which leads to downregulation of pro-apoptotic 
BNIP3, pro-angiogenic PGK1, and VEGF. Combining these observations, it is 
conceivable that, when a tumour reaches hypoxic state, overexpression of 
hsRuvBL2, and its consequent methylation en masse, may contribute to a large-scale 
downregulation of this subset of hypoxia target genes16. The consequences could 
be an involvement in the already described increased resistance of hypoxic 
tumours to chemo and radiotherapy treatments17,18. The crystallographic structure 
of hsRuvBL2 can thus contribute to the development of small compounds or 
antibodies to either target the surface of hsRuvBL2-K67Me or aimed at the 
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disruption of the HIF-1α:hsRuvBL2-K67Me complex. Either way, an understanding 
of this interaction and its effects at the cellular (and organism) level is necessary 
prior to developing a strategy to modulate it. On the other hand, the structure of 
hsRuvBL2 may be of use in the development of a small compound targeted at the 
nucleotide-binding pocket, with the objective of decreasing hyperactivity, in the 
case, e. g., of the lik mutant or other mutations that result in heart hyperplasia or  
other malformations during development. 
 
Further studies on possible functions of RuvBLs and distinct modifications 
to their surface residues may provide a framework for the development of 
compounds that can regulate the specific activities of RuvBL1 and RuvBL2, 
depending on the tissue, cell stage or stress conditions of the target cells. By 
targeting specific modifications of RuvBLs that result from particular metabolic 
 
Figure 4.6 – Cartoon model of the hsRuvBL2 hexamer, highlighting the position of lysine 67. Left: 
one protomer is represented in cyan and the remaining five in grey. Right: all protomers represented 
in cyan. Lysine 67 is depicted in red sticks. The structure of hsRuvBL2 provides structural support to 
the biochemical results of post-translational modifications to specific residues. hsRuvBL2 is methylated 
in Lysine 67 in hypoxic conditions by the methyltransferase G9a. Methylated hsRuvBL2 binds to the 
promoters of a subset of hypoxia-responsive genes and negatively regulates transcription of these 
genes to modulate cellular responses to hypoxia. By combining biochemical and structural approaches, 
a rational strategy can be defined for the development of a targeted regulatory molecule. 
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cellular states, it might be possible to acquire the degree of specificity desired when 
aiming for the treatment of a specific cell subset. 
RuvBLs have been identified as taking part in many supramolecular 
assemblies, where their ATPase activity is not always required. Such versatility has 
long posed a mystery, since no specific function can be attributed to these proteins, 
and yet they appear to be critical for the regulation of an array of complexes, 
particularly related to the control of gene expression and DNA damage response. 
It is possible that one of the RuvBLs’ functions within larger complexes could be to 
recognize transient binding partners, translating cellular needs to the rest of the 
complex, and thus regulating its activity. The fact that only heteromeric RuvBL1/2 
complexes have been found to date adds another layer of complexity to their roles 
in transcription regulation. An interesting suggestion as to the function of RuvBLs 
has been put forward by Zhou and colleagues19, based on the fact that the unstable 
Ino80 insert could be stabilized by interactions with the yeast RuvBL1/RuvBL2 
hexamer, whereby the RuvBL1/RuvBL2 complex could have proteins as the most 
relevant substrates, instead of DNA. Indeed, so far a DNA-binding activity has 
been observed in vivo for both RuvBL1, RuvBL2 and their complex4,7,20, but cellular 
functions so far identified mostly pertain to its function as a chaperone in larger 
multi-protein complexes10,21–23. The aggresome-related function of human RuvBLs 
lends further support to this hypothesis10, as both RuvBL1 and RuvBL2 were found 
to interact directly with synphilin-1. This hypothetic function is reminiscent of that 
of the AAA+ ATPase katanin p60. This protein forms a hexameric complex with a 
central pore rich in basic residues, which are known to interact with the 
unstructured, acidic tails of tubulins24. 
When ATP binding is necessary for the dodecameric complex function, it 
is possible that the nucleotide drives the movement of domain II (of RuvBL2, at 
least) in a sequential way, causing a circular tilting of the barrel-shaped complex. 
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The consequences of this movement in the interacting partners of the RuvBL 
complex are still to be determined. 
During the timeframe of the work described in this dissertation, the 
advances in the area obtained by other groups, were significant. Notably, the 
crystallographic structure of the truncated human RuvBL2 was obtained by the 
group of Petukhov6, and the groups of Karl-Peter Hopfner and Christoph Müller1,2 
determined simultaneously the crystallographic structure of the RuvBL1/RuvBL2 
complex from the thermophilic fungus Chaetomium thermophilum. More recently, 
the cryo-EM structure of the yeast R2TP complex was determined at 8.37 Å25, and 
the cryo-EM structure of RuvBL1/RuvBL2 hexamer in complex with the Ino80 
insert was determined to about 12 Å resolution19. Our group, through the work 
described in this dissertation (summarily represented in fig. 4.7), has contributed 
to the advancement of the area through the determination of the full length 
structure of human apo RuvBL2, thus filling the gap on structural information 
about the regulatory domain II. We have complemented the structural information 
with data on the oligomeric behaviour of hsRuvBL2, providing some insight into 
how the use of tags may affect this protein, with putatively significant 
consequences at the regulatory level, since different oligomeric forms of the protein 
may be differently regulated. We also aimed to answer the question of what 
structural changes occur upon DNA binding. Since hsRuvBL2 is monomeric at very 
low concentrations, we resorted to electron microscopy to observe that the presence 
of ssDNA promotes the oligomerisation of initially monomeric hsRuvBL2. Whether 
that oligomerization occurs around the ssDNA strand is still to be determined. 
However, considering the mode of action of ring-shaped helicases, it can be 
speculated that that option is quite likely. 
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4.2 Concluding remarks and future perspectives 
 
With this work, we tackled the question of what makes RuvBL 
transcription factors similar and interchangeable, but also (and especially) what 
makes them different on a molecular level such that, when both are present 
simultaneously, they can be differently recognized by upstream regulators. To 
achieve this, we solved the missing structure of full-length human RuvBL2, and 
thus unveiled important structural features that differentiate RuvBL1 and RuvBL2. 
The differences in charge distribution reflect the surface exposure of distinct motifs, 
which may underlie their occasional non-interchangeability, even though they are 
able to perform the same biochemical activities. 
Overall, this work is a significant contribution to the area of RuvBL studies, 
and of great interest for pharmaceutical applications. Since RuvBL2 is directly 
 
Figure 4.7 – Main knowledge gaps that were filled with the work described in the present 
dissertation. 
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involved in many pathways involved in cancer and other pathologies, the future 
goals will involve steps to be taken in the short, medium and long term: 
 
The logical way to proceed with this project on a short term seems to be 
approaching it through several fronts. Importantly, it is necessary to analyse the 
structure and activity of specific hsRuvBL2 mutants, chosen for their putative 
influence on ATPase activity, in order to corroborate the proposed mechanism. In 
this regard, on the short term, it seems reasonable to: 
a) Produce mutants of the N-terminus Histidines H40 and H42, involved 
in the interaction with ATP, and of the conserved residues involved in electrostatic 
interactions between the N-terminus and the domain II, and study their 
biochemical activities and structure. 
b) Produce an ATP-binding site mutant (of the Walker A and B motifs), in 
order to obtain a structure with trapped nucleotide, both of hsRuvBL2 and of the 
hsRuvBL1/RuvBL2 complex. 
These studies will also be extended to hsRuvBL1, in order to further explore 
structural characteristics on the basis of differences in activity and regulation. 
 
On the medium to long term, we will study the interaction of hsRuvBL2 
and its homolog hsRuvBL1 with specific binding partners, respectively HIF-1α and 
c-Myc, in order to understand how these interactions may impact cells, with a 
particular interest on cancer cells. To accomplish this, a reasonable course of action 
includes: 
a) The determination of the structure of the HIF-1α-hsRuvBL2 and c-Myc-
hsRuvBL1/hsRuvBL2 complexes, with the purpose of understanding its effects at 
the cellular lever, and study ways to disrupt or regulate their interaction, by 
analysing their interface. 
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b) Performing high-throughput compound screenings for these targets 
using Surface Plasmon Resonance, with the final goal of producing a compound 
that can be altered to have enhanced affinity to target protein-protein interaction 
(PPI). Upon identification of strongly interacting compounds, co-crystallization 
can be performed in order to observe how the compounds interact with the 
interface pocket, and improve their binding affinity in a directed process. These 
compounds can then be tested in hsRuvBL1- or hsRuvBL2-overexpressing cancer 
cell lines and hypoxic cells, in order to study the interference in cell viability and 
resistance.  
c) Analysis of the stability of hsRuvBL2 in the presence of a library of 
compounds, in order to find interacting compounds that may be improved to 
regulate the activity of this target. We may accomplish this goal through the use of 
HT Differential Scanning Fluorimetry Assays to identify the first hits (compounds 
that interact with the target protein) and follow with activity assays using Surface 
Plasmon Resonance. Upon identification of strongly interacting compounds, co-
crystallization can be performed in order to observe how the compounds interact 
with the binding pocket. From those structure(s), the compound(s) can be 
improved to use the binding pocket to full capacity, increasing its binding affinity, 
in an iterative process. 
 
In parallel, also in the medium to long term, we aim to study the 
crystallographic structure of larger complexes, such as the R2TP and INO80. For 
these studies, the most rational approach is probably the collaboration with groups 
that are able to complement the X-ray crystallography limitations, such as groups 
working with resort to electron microscopy. In this way, we can tackle the structure 
of subcomplexes, previously identified through crosslinking and activity assays, 
done either by us or in collaboration. To produce such multiprotein assemblies, we 
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will attempt both co-expression and co-incubation of individually expressed 
proteins. 
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SI.1 Chromatograms of RuvBL2 purification 
 
 
 
 
 
 
 
 
 
 
SI Figure 1. First purification step: HisTrap HP (GE Healthcare). Black line: absorbance at 
280 nm (left axis); green line: concentration of buffer B (right axis). RuvBL2 is eluted almost 
pure on the second step of elution with buffer B (red box). 
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SI Figure 2. Second purification step: HiPrep 26/10 Desalting (GE Healthcare). Black line: 
absorbance at 280 nm (left axis); orange line: buffer conductivity (right axis). The red box 
indicates the collected peak. 
 
SI Figure 3. Third purification step: HisTrap HP in tandem with a GSTrap 4B column (GE 
Healthcare). Black line: absorbance at 280 nm (left axis); green line: concentration of elution 
buffer (right axis). The red box indicates the collected peak. 
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SI Figure 4. Fourth purification step: 6 mL Resource Q column (GE Healthcare). Black line: 
absorbance at 280 nm (left axis); green line: concentration of elution buffer (right axis). 
Orange line: sample conductivity (right axis). The red box indicates the collected peak.
 
SI Figure 5. Inset of the fifth purification step, a HiLoad 16/60 Superdex 200 pg (GE 
Healthcare). Black line: absorbance at 280 nm. The red rectangle indicates the collected 
fraction, which produced crystals diffracting to 2.8 Å. 
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SI.2 SDS-PAGE gel of RuvBL2 purification 
 
 
 
 
 
 
 
 
 
 
 
 
SI Figure 6. Sodium dodecyl sulphate polyacrylamide gel electrophoresis analysis of 
samples from steps of RuvBL2 purification. 1 - BioRad Un-stained Protein Markers, 161-
0363 (8 µL); 2, 3 – Size-exclusion pool (tagged RuvBL2) (0.2 and 0.4 µL); 4,5 - Size-
exclusion pool (untagged RuvBL2) (0.16 and 0.32 µL); 6 – Pool eluted with 170 mM 
Imidazole (cleaning step); 7 – Pool collected from HisTrap (18 µL); 8 – Pool eluted with 1 
M Imidazole (cleaning step); 9 – Sample injected in SEC (tagged RuvBL2, 1 µL); 10 - 
Sample injected in SEC (untagged RuvBL2, 1 µL). 
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SI.3 hsRuvBL2 structure diagram 
 
SI Figure 7. Cartoon diagram of hsRuvBL2, obtained with Pro-origami. Individual 
subdomains formed by β-sheets are highlighted in blue, and those formed by α-helices 
are highlighted in pink. Sheets from a continuous string have the same colour. Clearly 
identified are the two clusters of  β-sheets from the ATPase core (top), the linker to the 
OB-fold within the domain II (middle), and the OB-fold itself (bottom). All clusters of α-
helices present are part of the ATPase core. 
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